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Executive Summary
A large body of evidence has shown that excess salt intake is associated with hypertension
and nutrition related non-communicable diseases (NCDs). Global salt intake is high with
populations consuming as much as twice the World Health Organization (WHO)’s
recommended intake of 5g/day. Low- and middle-income countries (LMICs) are
disproportionately affected due to the nutrition transition taking place in those countries
that is associated with an influx of highly processed foods that are becoming more
affordable, and accompanied by changing lifestyles and changing dietary preferences. This
has increased the availability and intake of energy dense nutrient poor (EDNP) foods that
are particularly high in salt in LMICs.
This thesis outlines six studies that sought to provide a systematic approach towards finding
evidence, building advocacy and developing strategies to curb excess salt intake and rising
hypertension in Ghana. Data used in studies that comprise the thesis were collected in the
WHO’s Study on global AGEing and adult health (WHO-SAGE); a multi-country
longitudinal study conducted in six LMICs namely China, Ghana, India, Mexico, Russia and
South Africa (SA). Within each country, the WHO-SAGE study has recruited a nationally
representative sample of predominantly 50+ year old participants. In the two WHO-SAGE
countries from the African continent, namely Ghana and SA, a nested sub sample was
additionally selected in Wave 3 to provided 24hr urine samples for the analysis of sodium
(Na), potassium (K), creatinine (Cr) and iodine (WHO-SAGE Salt and Tobacco study). This
thesis is largely based on data from the salt sub-study, and the PhD candidate was heavily
involved in the planning and data collection for the Ghana sub-study. This thesis reports
analyses from WHO-SAGE datasets from Ghana for Waves (W) 1 (2007/8), 2 (2015) and 3
(2019) and makes comparisons with corresponding WHO-SAGE data from South Africa
Waves, where appropriate.
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In order to understand the context of the food environment in terms of food intake, it was
important to identify food sources in LMICs that contribute most to dietary salt
consumption. A systematic literature review was conducted to evaluate the dietary sources
of salt in LMICs (Study 1). The review identified that breads, meat and meat products,
bakery products, instant noodles, salted preserved foods, milk and dairy products, and
condiments were major sources of salt in LMICs. The data summarized in this review is
useful to inform development of health and consumer education programmes and policy
directives related to reduction in the production and consumption of such foods, provide
evidence to advocate for reformulation of these foods to be lower in salt, and identification
of alternative food sources.

In addressing population salt reduction, identification of consumer knowledge, attitudes
and behaviours (KAB) are critical to influence food literacy and identify interventions
required to drive food behaviour change. We examined the KAB of the Ghanaian main
survey sample in WHO-SAGE W2 and compared the data with that of the W2 South African
sample (Study 2). Comparison between the two countries is of interest because South Africa
has a long history of nutrition education related to its Food Based Dietary Guidelines that
encourage reduction of salt added to foods (discretionary salt) and avoidance of salty foods,
as well as mass media campaigns targeting improved awareness of the association between
salt and raised blood pressure - while Ghana does not. Ghana has only focused on the
iodine-related message that iodised salt helps prevent iodine deficiency disorders. South
Africans were more likely than Ghanaians to add salt to food at the table (OR 4.80, CI 4.071–
5.611, p < 0.001) but less likely to add salt to food during cooking (OR 0.16, CI 0.130–0.197,
p < 0.001). Surprisingly, despite greater exposure to consumer education strategies on salt
reduction, South Africans were less likely to take action to control their salt intake (OR 0.436,
CI 0.379–0.488, p < 0.001). The findings emphasized a need to intensify consumer awareness
on discretionary salt use and behaviour modification in both countries.
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An important component of this thesis was the quantification of population salt intake in
Ghana, using the gold standard methodology of 24hr urinary sodium measurements, and
its association with blood pressure (BP) (Study 3). BP was measured in triplicate and 24hr
urinary Na, K and Cr levels were determined. Median salt intake was 8.3g/day (IQR 7.5)
and approximately two-thirds of participants had potassium intakes below the WHO
recommended level of 90mmol/day. Despite a lack of association between salt and BP, Na:
K ratios above 2mmol/mmol were positively associated with the slope of increasing BP with
age. This study highlights an urgent need for salt reduction policy in Ghana, that is
accompanied by strategies to increase dietary K intake.

A follow-up study (Study 4) was conducted in participants who were 50+ years old at
baseline in the WHO-SAGE Ghana W1 survey (data collected in 2007/9) and who
participated in the WHO-SAGE Ghana W3 survey (data collected in 2019). Assessment of
BP change over time showed that diastolic BP decreased by 9.7mm Hg and pulse pressure
(PP) increased by 9.5mm Hg. Hypertension prevalence remained consistently high (W1:
52.0%, CI = 0.48-0.55; W3: 48.8%, CI = 0.45-0.52) in the cohort. Hypertension awareness
increased by 37% with no differences among hypertensives who were on antihypertensive
medications nor those that were both on antihypertensive medications and had controlled
BP. Reduction in DBP was associated with increasing age, living in rural areas and having
health insurance while increased awareness of hypertension was associated with residing
in urban areas, having health insurance and increasing body mass index (BMI). The data
highlights the need to intensify the treatment of hypertension.

Universal iodization of salt and its compatibility salt reduction has been widely discussed
in contemporary public health research. A comparative study assessed urinary iodine
excretion (UIE) among a sample of adults from Ghana and SA – both countries with national
salt iodization programmes but only one (SA) that has implemented mandatory salt
legislation (Study 5). Comparing data from the salt sub study in W3 in both countries,
associations between salt and iodine intakes could be assessed. In Ghana, median Na
iv

excretion was equivalent to a salt intake of 10.1g/day (IQR 7.6) while median UIE was 182.4
µg/l (IQR 162.5), with a weak correlation (r = 0.1501, p < 0.0011) between salt intake and UIE.
In SA, salt and iodine values were both lower (median salt = 5.6g/day (IQR 5.0) and median
UIE = 100.2 µg/l (IQR 129.6) with a moderate positive association (r = 0.4050, p < 0.0001)
between salt intake and UIE.
An important part of the thesis was to disseminate and translate the novel findings for
uptake by policy makers in Ghana. As well, as conventional outputs such as publications in
international, peer reviewed journals, participatory action research (Study 6) was
undertaken to discuss the evidence from this thesis and develop a road map for advocacy
and support for salt reduction interventions in Ghana. To achieve this objective a
stakeholder meeting involving representatives from government agencies, academia, NonGovernmental Organizations (NGOs), Civil Society Organizations (CSOs) and international
partners was organized in Ghana in February 2019. The conference reached a consensus
with recommendations that are being considered for inclusion in the revision of Ghana’s
national NCD policy.
Overall, this thesis provided a synthesis of the literature and has conducted original
research to provide a basis for action for salt reduction interventions in Ghana. It has
identified that a multisectoral approach is essential to address discretionary salt use and the
high intake of salt from other food sources and that there is a need to intensify efforts in the
prevention and management hypertension.
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Chapter 1
Hypertension prevalence, risks factors for hypertension
and salt reduction strategies
1.1 Introduction
This chapter provides an overview of the global burden of hypertension, its scope,
measurement, risk factors and management through a narrative literature review. It
gives an insight into hypertension in low- and middle-income countries (LMICs) with
reference to Ghana. It further explains the link between hypertension and salt intake by
reviewing literature on the role of sodium (Na) and potassium (K) vis-a-vis vascular
conditions and discusses population salt reduction strategies and interventions. This
chapter also highlights the gaps in the literature which will be addressed in subsequent
chapters of this thesis.
1.2 Hypertension
Cardiovascular diseases (CVDs) are one of the major health concerns facing
governments and nations globally. CVDs accounts for the greatest number of deaths
every year, with 17.9 million death globally in 2016, representing 31% of all global deaths
[1]. Though age-standardized CVD mortality rates have decreased globally between
2006 and 2016 - more than three-quarters of these deaths have been attributed to heart
disease and stroke and increased numbers of deaths related to these causes are expected
to reach 23.3 million by 2030 [1, 2]. CVD burden continues to be relatively higher in
LMICs compared to high-income countries (HICs) due to adverse lifestyle-related
factors associated with the nutrition transition and poor-quality care [1, 3]. Risk factors
for CVD, including hypertension, hypercholesterolemia and high body mass index
(BMI) are among the major contributors to higher disability-adjusted life years [4].
Hypertension is serious medical condition in which blood pressure (BP) is consistently
elevated in the blood vessels [5] and is now considered to be one of the most important
independent risk factors for developing CVD [5-7]. Of the 17 million CVD deaths in 2008,
complications of hypertension accounted for 9.4 million [8, 9]. Evidence from clinical
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research studies and randomized controlled trials (RCTs) attributed the decline in stroke
mortality to hypertension treatment and control strategies [10]. Similarly, posthoc metaanalysis of 123 studies emphasized that systolic blood pressure (SBP) should be reduced
to less than 130 mm Hg to reduce CVD [11]. The relationship between hypertension,
coronary artery disease (CAD) occurrence and premature death is well established [1214]. Data from several studies have described hypertension as the most prevalent risk
factor for stroke and has been reported in about 64% of patients with stroke [15, 16].
Findings suggest that at ages 40 – 69y, each 20 mm Hg increase in SBP or each 10-mm
Hg increase in diastolic blood pressure (DBP), is associated with more than two-fold
increase in stroke death [15].
Prolonged hypertension is also a risk factor for developing heart failure unless other
mitigating factors such as reduction in excess salt intake exist [16]. In the Framingham
Heart Study, which incorporated 5,143 participants, hypertension preceded the onset of
heart failure (HF) in more than 90% of all newly diagnosed HF patients in a 20-year
follow-up [17]. Further analyses indicated that hypertension was the most attributable
risk factor to HF and responsible for 39% of cases in men and 59% in women. At age 80,
the lifetime risk of developing HF was about 20% in the Framingham cohort, and this
risk doubled for participants with BP of 160/100 mm Hg compared with those with
140/90 mm Hg [18]. However, among populations with either acute or chronic HF,
increased SBP is associated with greater negative health outcomes [13, 16].
Globally, hypertension has been increasing over time; the number of people living with
hypertension increased from 600million in 1980 to 1billion in 2008 [19], while in 2015 one
in four men and one in five women had hypertension [20] making it challenging to
achieve World Health Organization’s (WHO) target of a 25% decline by 2025 [21].
1.3 Hypertension in LMICs
Over 75% of global CVD deaths are occurring in LMICs whose populations have
marginal access to integrated primary health care programmes and effective or equitable
health care services to address CVDs [1, 22]. Additionally, CVDs were more prevalent
among younger, middle-aged groups in LMICs. For example, in sub-Saharan Africa
(SSA) half of CVD deaths occurred among the 30–69 age bracket [23]. A projected
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economic loss of $3.7 trillion attributed to CVDs was estimated between 2011 and 2015,
representing about 50% of the NCD economic burden and 2% of Gross Domestic Product
(GDP) across LMICs [24].
Populations in LMICs may experience a higher burden of hypertension in comparison
to the global average due to factors such as the ongoing nutritional transition, increasing
trends in sedentary lifestyle, inadequate health care systems and the non-control of
modifiable risk factors LMICs. Projections estimate that three-quarters of the world's
hypertensive population will reside in LMICs within the next decade [25]. China, for
example, reported 20% all deaths were from hypertension in 2005 [26] The overall
prevalence of hypertension in China has risen substantially between 2002 and 2010 –
from around 20% to 34% [27-29] while a 68% increase in hypertension within sub SSA
by 2025 has been predicted [30]. Despite the interventions and use of innovative
approaches, BP levels remain high in several LMICs [31]. Findings from a systematic
review of hypertension prevalence across LMICs reported a pooled hypertension
prevalence (for all 242 studies) of 32.3% [32]. A recent systematic review and metaanalysis of hypertension prevalence in older adults from 15 African countries indicated
a prevalence range of 22.3% to 90.0% [33].
Health systems in many LMICs do not have the capacity to diagnose and manage
hypertension successfully [34, 35]. As the means of diagnosing hypertension becomes
possible in LMICs, along with the absence of adequate prevention and control measures,
the former can account for rapid increase in the prevalence of hypertension [36]. For
example, evidence from a series of cross-sectional studies conducted over a period 25y
in India indicated rising hypertension levels from 29.5% in 1992-1994, to 36.0% in 2015
[37, 38]. In many countries in Africa, more than 40% (and up to50%) of adults are
estimated to be hypertensive however, many individuals are living with undiagnosed,
untreated and/or uncontrolled hypertension [39, 40].
1.4 Hypertension awareness, treatment and control in LMICs
Though many national and global organizations have endorsed the importance of
identification and control of hypertension [41, 42], poor access to available and effective
medicines, together with challenges in rolling out screening programmes and the burden
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of already stretched healthcare services remain barriers to hypertension control. Other
setbacks include limited knowledge about prevention and management of hypertension
among health practitioners and patients alike, and non-adherence to treatment among
hypertensives [43]. Additionally, lack of governmental commitment in many LMICs to
comprehensive public health policies to manage hypertension compounds the
difficulties [44]. Despite global efforts to combat hypertension, treatment and control
rates are very low in LMICs [45].
LMICs disproportionately share low levels of hypertension awareness, treatment and
control with rising hypertension [45, 46]. In a Chinese population-based screening
project that recruited 1,738,886 participants, 44·7% (95% CI 44·6-44·8) of the
hypertensives were aware of their diagnosis, 30·1% of whom (95 CI 30·0-30·2) were
taking antihypertensive medications, and only 7·2% (95% CI 7·1-7·2) had achieved BP
control [47]. Similarly, a Vietnam cross-sectional survey involving 9,832 adults reported
that only 48.4% of hypertensives were aware of their hypertension, 29.6% were receiving
treatment for the condition and only 10.7% had controlled BP [48]. A community-based
study of 1,203 elderly participants from two sites in Bangladesh and three sites in India
reported that, of those with hypertension, only 45% were aware of their hypertension,
40% were on antihypertensive medication and 10% had the condition controlled [49].
Evidence from SSA indicated that, of those with hypertension only 27% (95% CI, 23%31%) were aware of their condition. Overall, 18% (95% CI, 14%-22%) of hypertensives
were receiving treatment across the studies, and only 7% (95% CI, 5%-8%) had controlled
BP [50].
1.5 Measurement of Hypertension
Different guidelines are available worldwide regarding how BP is classified. Most
guidelines classify hypertension as SBP ≥ 140 mmHg and/or ≥ DBP 90 mmHg in
individuals 18y and older, apart from in the most elderly (<150/90mm Hg for 80y+) based
on an average of two or more measurements taken after the participant has been seated,
legs uncrossed, for about 3 minutes. This cut-off is based on the existing evidence which
shows that treatment of patients to reduce BP below these values is beneficial in reducing
the risk of developing NCDs [51]. This guideline is supported by the American Heart
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Association, American College of Cardiology, Centres for Disease Control and
Prevention, American Society of Hypertension and the International Society of
Hypertension [42, 52]. However, RCTs (2014 evidence-based guidelines for management
of hypertension in adults) recommended a new target <150/90mm Hg for ages 60+y due
to physiological changes taking place among that age group [53]. Tables 1.1 and 1.2 are
the hypertension classifications.
Table 1. 1 BP classification
Category

Systolic

(mm

Diastolic

Hg)

(mm Hg)

Normal

<120

And

<80

Elevated

120-129

Or

<80

Stage 1 hypertension

130-139

Or

80-89

Stage 2 hypertension

≥140

Or

≥90

New ACC/AHA High Blood Pressure Guidelines [54].
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Table 1. 2 Definition and classification of office BP levels according to the 2018 ESH/ESC
guidelines for the management of arterial hypertension
Category

Systolic

(mm

Diastolic

Hg)

(mm Hg)

Optimal

<120

And

<80

Normal

120-129

and/or

80-84

High normal

130-139

and/or

85-89

1 140-159

and/or

90-99

2 160-179

and/or

100-109

3 ≥180

and/or

≥110

And

<90

Grade
Hypertension
Grade
Hypertension
Grade
Hypertension
Isolated

≥140

Hypertension
The BP category is defined by the highest level of BP, whether systolic ordiastolic. Isolated
systolic hypertension should be graded 1, 2 or 3 accordingto systolic BP values in the ranges
indicated; ESH, European Society of Hypertension; ESC, European Society of Cardiology [42].

1.6 Risk factors for Hypertension
In most cases, hypertension has no identifiable physiological cause and is generally
classified as primary, essential or idiopathic. In a few cases, a weakened reninangiotensin system, increased adrenal medulla catecholamine secretion or increased
adrenal cortex aldosterone secretion may result in renal alterations that could result in
some form of hypertension [55, 56]. There are many known lifestyle risk factors that are
associated with hypertension among various populations [39, 57] such as ageing, poor
diet, excessive alcohol intake, lack of physical activity excess weight and exposure to
persistent stress and are summarized further in Figure 1.1
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Modifiable
Risk Factors
Residence
Diet
Consequences
Physical
Activity

Cardiovascular
disease

Alcohol
Obesity
Smoking

Hypertension

Chronic kidney
disease
Renal failure
Neurological
disease and stroke

Non-modifiable
Risk Factors

Premature death
and disability

Ageing
Gender
Heredity
Figure 1.1 Risk factors of hypertension
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1.6.1 Age
The association between age and risk of hypertension is well known [58-62]. Rising BP
is regarded as a common occurrence as people age with raised BP more prevalent among
older people. Longitudinal data from the Framingham Heart Study, which followed
participants for three decades, demonstrated a continuous rise in SBP between the ages
of 30 and 84 years or over. Diastolic blood pressure however, has a varying pattern with
ageing, increasing until the fifth decade and slowly decreasing from the age of 60 to at
least 84 years of age. This causes a steep rise in pulse pressure with ageing [63]. In
support, SBP was found to progressively increases with age, leveling at an average of
about 140 mm Hg by age 80y [64]. The prevalence of hypertension is more than doubled
in the elderly than in the young population with more than two-thirds of individuals
aged 65 and above being hypertensive [65, 66]. In recent years, metabolic syndrome and
hypertension are increasingly seen in the middle-aged and young populations. Among
young adults (18-39 years), approximately 20% of men and 15% of women have
diagnosed hypertension with an expected increase in prevalence due to rising rates of
obesity [67]. Stiffening of blood vessels with age is conventionally associated with
occurrence of systolic hypertension [68]. The wall of large arteries, thicken and lose
elasticity over time, resulting in an increase in pulse wave velocity which increases both
systolic and pulse pressure, Therefore, aging-related hypertension is characterized by a
significant increase in systolic blood pressure with no change or even a decrease in
diastolic blood pressure [69, 70].Aging also causes an overall decline in cardiac output,
heart rate, stroke volume, intravascular volume, renal blood flow and plasma renin
activity, all of which are indicative of increasing BP [69]. Subsequently, the kidneys
become less efficient at excreting salt loads, thereby compounding the effect of ageing
on rising BP [70].
1.6.2 Gender
Though several studies have showed conflicting results, men generally are at a greater
risk of hypertension than premenopausal women of the same age [71, 72, 73]. Men have
greater prevalence of hypertension from 20 until age 65 where the gap between the
genders is narrowed, yet more women over age 75 remain hypertensive [74]. NHANES
data which studied 10,380 people from 1999 to 2006, indicated a 36.3% prehypertensive
8

status, of which men had a much higher prevalence of prehypertension prevalence
compared with women [75]. This finding is further supported by a recent meta-analysis
of 250,741 individuals (120,605 men and 130,136 women) from 13 countries, where the
the pooled prevalence of prehypertension was 40% among men vs. 33% among women
[76]. These data further demonstrated that young women between 20-40y were relatively
protected from developing hypertension compared with their male counterparts. There
is substantial evidence that male and female hormones, particularly testosterone and
estrogen may be responsible for gender-associated differences in BP status, but the
underlying mechanisms for such occurrence needs further study [77-78]. Estrogen has
the potential to regulate endothelial vasodilation, inhibit sympathetic and reninangiotensin system (RAS) activity, enhance the production of endothelin, reduce
oxidative stress, increase antioxidant production and reduce inflammation - all of which
may alter BP (79-81). After menopause, where estrogen levels fall a rapid increase in the
prevalence of hypertension to about 75% is evident in women [82]. The difference in
hypertension prevalence across age and sex may be partially attributed to true biological
differences; however, gender-specific differences in access to care may also partially
account for this [83].
1.6.3 Area of Residence
Residential location often influences exposure to environmental risk factors associated
with lifestyle and access to healthcare. Generally, urban residence is associated with a
higher risk of hypertension compared to rural dwelling. Evidence from several LMICs
suggest higher prevalence of hypertension in urban areas [84-86]. That notwithstanding,
data from the Chinese Health and Retirement Longitudinal Study 2015 indicated that
rural residents were more likely to have undiagnosed hypertension compared to their
urban peers [87]. Comparably, Pakistan’s National Diabetes Survey, 2016–2017, reported
hypertension prevalence to be 44.3% and 46.8% for urban and rural dwellers,
respectively [88], while hypertension prevalence among Zambian adults in the rural
setting (46.9%) was double that observed in urban areas (22.9%) [89].
Despite contradictory findings, hypertension has increased in both urban and rural areas
over time. A general increase in hypertension prevalence from the previous decade was
reported between 2000 and 2016, ranging from 13-70% in rural, and 12-65% in urban
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settings [90-94] necessitating urgent public health interventions by both local and
international health bodies [57, 95].
1.6.4 Heredity
Several studies have identified associations between genetic polymorphisms and the
development of hypertension [96, 97]. It is estimated that heredity contributes 30–60%
to the pathogenesis of essential hypertension [98-100]. The interaction between genes
and environment, may influence risks of hypertension among different populations
[101]. Genetic predisposition for increased BP spanning the lifetime has been
investigated in a number of studies showing that higher genetic risk scores in childhood
had significantly higher DBPs and were more likely to be hypertensive in adulthood
compared to those with a lower risk score [102, 103].
Several twin and family studies that have relied on both conventional office BP
measurements and ambulatory BP (ABP) measurements have shown substantial genetic
contributions to individual differences in BP [104-106]. Various SNPs have been found
to influence hypertension in many pediatric populations studied recently [107, 108].
In terms of ABP, heritability estimates ranging from 22% to 62% for SBP and from 38%
to 63% DBP have been reported [106, 109, 110]. In a study to explore the familial
aggregation and heritability of hypertension among the extended family, hypertension
distribution was found in first, second and third-degree relatives with hypertension
prevalence reducing as level of relatedness declined [101]. Similarly, twin studies have
demonstrated the heritability of SBP and DBP based on studies conducted in over 4000
twin pairs from seven countries. Findings from this study showed a range of 52-66%
heritability in SBP and 44-66% in DBP, with differences in sex and shared family
environments [104].
1.6.5 Diet
1.6.5.1 Salt consumption
Several nutrients have different impacts on BP, however, many meta-analyses have
established well-known effects of Sodium (Na) and potassium (K).
Sodium, consumed as salt (NaCl) is considered to be a major risk factor in cardiovascular
events [111-113]. Sodium is required by the body to ensure acid-base balance, maintain
plasma volume, and transmit nerve impulses [114, 115]. Though essential, Na is needed
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only in small quantities by the human body [116]. Sources of Na can be described as
discretionary (salt added to food during cooking or at the table) or non-discretionary
(salt present in foods, which is inherent, or which were added during food processing)
[117-119]. While low amounts of Na are naturally found in vegetables, oils and cereals,
meat and fish products contain relatively higher amounts. Food processing plays a large
role in the amount of Na present in foods [114]. Processed foods contribute the most to
salt consumption worldwide, with breads, meat and meat products, bakery products,
instant noodles, salted preserved foods, milk and dairy products providing more than
70% of all salt consumed in westernized diets [120]. In LMICs, a much greater
contribution of salt in the diet is provided through discretionary sources [121, 122].
There is a strong evidence from various studies showing a positive and direct
relationship between salt consumption and BP. The International Study of Sodium,
Potassium, and Blood Pressure (INTERSALT), involving over 10,000 participants aged
20-59y from 32 countries provided both within and between population estimates of
24hr Na excretion and found a significant positive relationship between 24hr Na
excretion and SBP. Adjusting for underestimation, Na intake higher by 100 mmol/d was
accompanied by a corresponding higher SBP/DBP by about 3-6/0-3 mm Hg. This
relationship was found for both normotensives and hypertensives participants [123]. In
the International Population Study on Macronutrients and BP (INTERMAP) studies,
significant positive associations between 24hr urinary Na excretion and urinary Na/K,
and BP were reported among 4,680 participants from 17 populations across five
countries [124].
Population-wide intervention studies have demonstrated that reduced salt consumption
results in a corresponding decline in population-level BP. In a 2-year study, extensive
health education to reduce salt intake, particularly from foodstuffs known to contribute
significantly to salt in the diet of that population, resulted in approximately 50%
reduction in salt intake between intervention and control villages and was associated
with a decrease of 13/6mm Hg in BP in the intervention group [125]. Another
intervention study conducted in two communities in northeastern Japan demonstrated
a decline in salt consumption by 2.3 g/day through dietary counselling and an associated
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reduction of 3.1 mm Hg in systolic BP [126]. Conversely studies that did not achieve
significant reduction in salt intake failed to accomplish declines in BP [113, 127].
A meta-analysis of randomized trials demonstrated that a long-term gradual decline in
salt consumption resulted in substantial reductions in BP, in both hypertensive and
normotensive individuals, irrespective of gender, age and ethnicity, with a variation in
the gradient of the decline in BP within different populations, and indicative of a doseresponse relationship [128, 129]. Similarly, the Dietary Approaches to Stop Hypertension
(DASH)-sodium trial showed a dose-response relationship with BP reduction [130].
The WHO recommends <2gNa/day, equivalent to 5g salt/day beyond which there is risk
for developing CVDs. However, global mean Na intake is almost twice the WHO
recommendation [131]. Sodium intakes exceed the recommended levels in almost all
countries with small differences by age and sex [132]. Some studies have emphasized a
U-shaped relationship between Na intake and CVD mortality which has raised a debate
about the optimal lowest intake of salt [133, 134]. The Prospective Urban Rural
Epidemiology (PURE) study suggested that salt reduction efforts should be limited to
only populations where salt intake exceeds 12.7 g/day. However, the findings from the
PURE study have been widely criticized for their methodological flaws, such as using
spot urine samples instead of 24hr collections and procedural biases [135-139].
Reduction of salt consumption in countries such as United Kingdom (UK) [140] and
Finland [141]) have refuted claims of the PURE study [142] by demonstrating public
health benefits [143, 144]. In England, mean population level salt intake declined from
9.5 g/day to 8.1 g/day between 2003 and 2011 which, in turn, resulted in substantial
decline in population BP and mortality from stroke and ischaemic heart disease [145].
The body of evidence to support global salt reduction to 5g/day is considered
overwhelming [146].
Some studies have suggested that the association between Na consumption and
development of hypertension may be due to the degree of salt sensitivity among
populations [147]. Most excess salt consumed is excreted from the body by the kidneys
or as sweat. Yet, for some people, response to limited or large intake of salt results in
differential changes in BP (‘salt sensitive’) [148]. Several mechanisms including blunted
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activity of the renin–angiotensin–aldosterone system (RAAS) and dysfunctional or
defective Na+/Ca2+ transport and exchange system, have been suggested to be implicit
in this phenomenon [149] as such, individuals respond to salt intake differently
irrespective of their hypertension status [150]. In populations where BP changes are
parallel to changes in their salt consumption, a higher BP is needed to sufficiently excrete
Na [151]. In that sense, salt sensitivity may be associated with raised cardiovascular
morbidity and mortality [152, 153]. The causes underpinning salt sensitivity trait have
not been investigated thoroughly [154], but there is evidence suggesting genetic
proposition may play a role [153, 155]. Other factors include race/ethnicity, age, gender,
BMI and diet [148, 156]. Salt sensitivity is particularly common in older adults, people of
African descent and people with hypertension or other related diseases [157].
1.6.5.2 Potassium
Potassium is an important micronutrient required for regulating and maintaining body
fluid volume and acid-base balance [158]. An inverse relationship has been established
between K intake and BP, and more generally with CVDs risks [159, 160]. A recent metaanalysis of 11 cohort studies reported an increased K intake was associated with reduced
risk of stroke [161]. In another meta-analysis of 32 randomized controlled trials, SBP and
DBP were reduced by 4.9 mm Hg and 2.7 mm Hg, respectively, when K consumption
was increased by 75mmol/day (median) in both hypertensive and normotensive
populations [159]. Not all studies are consistent; however, a meta-analysis including
only hypertensive participants showed no association between increased K and BP,
[162]. In response to the large body of evidence that supports a beneficial role of dietary
K intake on blood pressure regulation, the WHO suggests an intake of at least 90
mmol/day (3510 mg/day) from food sources for adults and downward adjustment for
children based on their energy requirements []. Many populations around the world
consume less than the recommended amount of K, thus making the achievement of the
WHO global target of 25% hypertension reduction by 2025, challenging [163].
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1.6.5.3 Na/K Ratio
Both Na and K intakes are associated with BP regulation, however the ratio between
these two cations may be more important than either one alone. Several mechanisms
have been suggested as means by which the interaction between Na and K may control
BP. One such, is molecular mechanisms implicated in the retention of sodium and loss
of K (Fig. 1.2).

Figure 1. 1 Molecular Mechanisms Implicated in the Retention of Sodium and Loss of Potassium
by the Kidneys in Primary Hypertension. Solid arrows indicate an increase or stimulation, and
the broken arrow indicates inhibition. Numbers on the left denote the approximate percentage
of reabsorption of filtered sodium in each nephronal segment during normal conditions. Several
influences acting on the luminal sodium transporters and the basolateral sodium pump
stimulate sodium retention and potassium loss. Promotion of sodium reabsorption by the
activated epithelial sodium channel (ENaC) generates a more negative luminal membrane
voltage (Vm) in the collecting duct that enhances potassium secretion through the luminal
potassium channel and promotes kaliuresis. NHE-3 de-notes sodium–hydrogen exchanger type
3, ACE angiotensin-converting enzyme, NKCC2 sodium–potassium2 chloride cotransporter,
and NCC sodium–chloride cotransporter. PST 2238 (rostafuroxin) antagonizes the effect of
digitalis-like factor on the sodium pump [164].

Furthermore, renal vascular K channels could be implicit in the regulating BP [165].
Reabsorption of Na and K secretion in the distal nephron is fundamental in the long14

term control of arterial pressure [166]. As such, even in hypertensives, a high K diet could
significantly reduce the thickening of arterial walls, thus reducing BP [167].
The interdependency between Na and K and their effect on BP is well known [164].
Several studies have demonstrated that a high K intake lessens the effect of high salt
intakes on BP levels thereby reducing CVD risk [168-170]. To improve dietary Na/K
ratio, many studies have assessed dietary strategies such as the DASH diet, either with
or without salt restriction [130, 171, 172]. The DASH diet recommends 2300mg of sodium
intake per day.
The Na/K ratio may be better placed and can be used for dietary approaches meant to
reduce BP across populations [173]. Proportions of Na and K is an essential metric in
relation to the presence and development of CVDs and death [167, 172]. Evidence is also
provided by experimental RCTs [175, 176]. A reduction in the urinary Na/K molar ratio
from 3.09 to 1.00 results in a 3.36 mm Hg reduction in population systolic BP [173, 177].
In support, the WHO has emphasized that attaining the targets for both Na and K
consumption levels would result in an Na/K molar ratio of about 1.00 [163]. Relatively,
Na/K molar ratios less than 2 predicted the least probability for CVD occurrence [169].
At the same time, a lowered Na/K ratio is indicative of a higher quality diet [178] with
dietary approaches to reduce BP shown to be effective and used as evidence to provide
global recommendations for upper limits of Na and minimum K consumption levels
[179].
1.6.5.4 Iodine Intake
Iodine is a trace element that is found in most vegetables and seafood and is very
important for optimal functioning of the thyroid gland. Iodine is required for normal
physical growth, particularly during pregnancy and infancy. Due to the absence of
iodine in a large variety of everyday foods, it has become a public health concern
particularly for children and lactating mothers [180]. Globally, approximately 2 billion
people are living with iodine deficiencies (ID), out of which about 50 million show severe
manifestations [181]. Inadequate iodine has been implicated in increased risk of
stillbirths, abortions, perinatal mortality, congenital abnormalities, cretinism impaired
growth [181, 182]. Iodine deficiencies cause irreparable but preventable brain damage
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and are associated with lower intelligent quotient (IQ) among children born to mothers
who were iodine deficient during pregnancy [183, 184]. Urinary iodine is mostly used in
assessing population iodine intake with a recommended median urinary iodine
concentration (UIC) of ≥100μg/l [180].
The WHO upon its evaluation of the global magnitude of the ID, and in keeping with its
mandate of monitoring each country’s progress towards addressing global iodine
deficien.cy disorders (IDD), as a public health concern, launched the universal salt
iodization (USI) programme in 1991[185]. Over the years, various food vehicles such as
bread, milk [186], water [187] and, most widely, salt have been used for iodine
fortification. To meet the iodine requirements of a population it is recommended to add
20 to 40 parts per million (ppm) of iodine to salt (assuming an average salt intake of 10
g per capita/day). Most countries have implemented the USI and ID have been greatly
reduced, with 66% of households worldwide using iodized salt [188, 189].
While USI strategies are emphasized by the WHO, member countries are encouraged to
ensure its compatibility with salt reduction, so that both public health goals of reducing
salt intake and maintaining optimal iodine consumption are achieved [190].
1.6.6 Physical Activity
The relationship between physical activity and CVDs in general has been well
established [191-194]. Large prospective studies from HICs have demonstrated an
inverse relationship between self-reported physical activity and cardiorespiratory
fitness, and hypertension [195, 196]. In the Aerobic Center Longitudinal Study (ACLS),
participants who maintained or improved fitness (metabolic equivalents (METS), 0.465.64) had a 26% and 28% lower risk of incident hypertension, respectively, compared
with those who lost fitness overtime (METS < 0.46) [197]. Similarly, in another study,
participants with reduced cardiorespiratory fitness over 5y of follow-up, had an
increased

risk

of

hypertension

compared

to

participants

with

improved

cardiorespiratory fitness [198].
Several studies have shown positive impacts of physical activity on hypertension
management with associated declines in BP as high as 5–7 mm Hg for both SBP and DBP
[199, 200]. For the most part, physical activity has been linked with acute substantial
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declines in SBP, with its most profound impacts were well demonstrated in
hypertensives [201].
The decline in BP with physical activity may result from mitigation in peripheral
vascular resistance, which may be due to neurohormonal and structural responses, with
reductions in sympathetic nerve activity and increased arterial lumen diameters [202].
Figure 1.3 depicts the effect of physical inactivity on hypertension.

Figure 1. 2 Hypothesized considerations by which physical inactivity may influence risk for
hypertension and cardiovascular complications [203]

Other explanations for BP decline included beneficial impacts on oxidative stress,
inflammation, endothelial function, arterial compliance, body mass, renin-angiotensin
system activity, parasympathetic activity, renal function, and insulin sensitivity [192].
Variability in types and intensity of physical activity together with environmental and
hereditary aspects may result in significant between and within-study variation in
participants’ BP response to physical activity [204].
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1.6.7 Alcohol
Alcohol consumption is a risk factor for several disease conditions including certain
cancers, liver cirrhosis and CVDs [205]. The relationship between alcohol consumption
and BP has been investigated in several epidemiological studies. Regular consumption
of alcohol was found to increase BP even among men who reported moderate
consumption. Women who reported excessive alcohol consumption were three times
more likely to be hypertensive, and heavy consumers had a 70% probability of
developing hypertensive [206-208]. Longitudinal studies indicated that, compared with
abstainers, drinking frequency of 2 or more times per week was associated with a
significant increase in the risk of hypertension in both genders [209]. The link between
high levels and specific patterns of alcohol consumption (such as binge drinking) and
growing risk of hypertension is also well established [206, 209, 210]. Additionally, among
the youth, increased risks for hypertension have been reported for females consuming
more than 14 drinks per week, and for men consuming between 15–28 drinks per week,
together with monthly heavy drinking [211]. However, there is some evidence that
indicates moderate consumption of alcohol may have health benefits [212, 213].
Due to the immense burden that alcohol use poses on society, particularly in SSA where
consumption rates have been consistently high since 2005 [214, 215], monitoring and
surveillance at both local and international levels are recommended within [216].
1.6.8 Body weight and obesity
A linear association between obesity (BMI ≥ 30) and hypertension has been documented
in several epidemiological and clinical studies [217, 218]. Obesity is a worldwide
epidemic with a global fatality rate of at least 2.8 million people annually [219], and a
major risk factor for hypertension [220-223]. It is established that this association exists
from early in life at around age 8–11y [224]. In a systematic review involving 30,044
individuals across 13 African countries, obese participants were more than twice as
likely to be hypertensive [225]. Data from a 30y follow-up in the Framingham Heart
Study, indicated that more than three-quarters and two-thirds of primary hypertension
in males and females, respectively, was attributed to excess weight gain [226]. The
Tecumseh Study also reported higher waist/hip ratio in the hypertensive participants
compared to the non-hypertensive group. Additionally, familial predisposition to
hypertension was associated with excess weight accumulation, suggesting an
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association between the mechanisms that cause a rise in BP and those that stimulate
increased food intake or sedentary living [226]. Clinical studies have emphasized the
importance of maintaining a BMI of <25 kg/m2, as a prudent way to prevent primary
hypertension and have demonstrated weight loss to be an effective strategy in
hypertension reduction [218, 228].
Despite the enormous evidence implicating the role of excess weight gain in higher BP,
not all obese persons are hypertensive. Yet, individuals identified as obese
normotensives have higher BP than their age-matched peers who have lower body
weight [229]. Not only the amount of excess weight is important, but the distribution of
body fat, with visceral abdominal fat being a better predictor hypertension than BMI
[230].
Mechanisms linking obesity to hypertension are not well established. However, studies
have shown that blood volume and osmosis taking place in the kidneys play important
roles in the development of hypertension [231]. Obese populations may have relatively
higher likelihood of being hypertensive due to the increased presence of
hyperinsulinemia. This may trigger the stimulation of the sympathetic nervous system,
which in turn, may cause a rise in BP either through vasoconstriction or increased Na
retention [232]. Other mechanisms postulated included activation of the renin–
angiotensin–aldosterone system, abnormal levels of certain adipokines such as leptin,
altered spectrum of cytokines and the role of perivascular adipose tissue damage [233235]. Given the rising trends of obesity worldwide [219], body weight management
may be an effective remedy for hypertension prevention.
1.6.9 Smoking
Though it is overwhelmingly established that cigarette smoking causes various adverse
cardiovascular events [236-238], studies on the association between cigarettes smoking
and hypertension have produced conflicting results [239-242]. The nicotine in cigarettes
has been described as an adrenergic agonist, with a sympathomimetic ability to raise the
heart rate and BP levels [243]. Smoking has a direct association with endothelial damage
[14], which in turn, plays an essential role in development of hypertension [244, 245]. In
a case control study measuring ambulatory systolic BP in hypertensive smokers and
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non-smoking hypertensives, smokers recorded a higher mean daytime ambulatory SBP
than nonsmokers [246]. A meta-analysis involving 16,980 participants from 18 countries
across Africa showed that smoking was positively associated with hypertension [247].
However, findings from some epidemiological studies have provided contrasting
findings. A five-year follow-up study conducted among Japanese men found that the
adjusted mean change in BP of current smokers was lower than in nonsmokers [248].
The findings suggest that weight loss/gain may be a possible mediator of the association
between smoking and BP.
Other epidemiological studies have reported no dose-effect association between
frequency of smoking and SBP or DBP [249]. Another study on the effect of smoking on
BP and resting heart rate found no causal relationship between smoking amount in
current smokers and SBP nor DBP [250]. Smoking analyses are important in salt and BP
studies, as smoking affects taste perception [241], and preference for salty food items
[252].
1.7 Salt reduction strategies and interventions
Population salt reduction has remained high on the agenda of the United Nations (UN),
the World Health Assembly (WHA) and WHO because of the looming pandemic of
CVDs due to the persistent risk factors including increasing salt intake. In view of this,
in 2011, world leaders pledged through a political declaration of the high-level meeting
of the UN General Assembly on the Prevention and Control of NCDs, to decrease
population’s access to poor diets. Subsequently, in 2013, the WHA approved 9 global
voluntary targets for the prevention and control of NCDs, which included a 30% relative
reduction in the intake of salt by 2025 [129]. In line with these projections, various
policies, programmes, strategies and interventions have been developed which included
actions and expectations from governments, civil societies, manufacturers, retailers,
consumers, and the general public [57]. Though many countries are taking action to halt
increasing salt consumption, more intensive effort is required, especially in LMICs
where the risk of morbidity and mortality from hypertension far outweigh that present
in HICs [253].
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In addition to population salt consumption, many studies report on community
knowledge, attitudes and behaviours in relation to salt use, and food sources that
contribute most salt to the diet [122, 123, 132, 254]. These resources inform the planning
of programmes and strategies to address excessive salt use. For example, in 2003/2004,
in the UK, a salt reduction programme was initiated following a baseline study which
determined salt consumption levels and food sources thereof. That study assisted in (1)
setting a target for population salt intake and developing a salt reduction strategy; (2)
setting progressively lower salt targets for different categories of food, with a clear time
frame for the industry response (3) working with the industry to reformulate food to
contain less salt; and (4) conducting consumer awareness campaigns. As a result, the salt
content in many processed foods was reduced substantially from 9.5 to 8.1 g per day
(p<0.05) over a 7year period [138]. For each gram of salt eliminated from the usual UK
diet, it has been estimated that 4,147 lives could be saved annually through a decline in
stroke and heart attack mortality [255].
Periodic collection of information and monitoring of population salt intake is essential
to track changes in salt content and sources of food. In the UK salt reduction programme
[138], periodic assessments were carried to assess whether manufacturers and retailers
were adhering to the voluntary reformulation targets and to determine whether there
was a need to adjust the targets [256, 257]. Mongolia with an intervention that aimed to
lower salt content in factory meals resulted in a 2.8g/day reduction in salt intake,
alongside improvements in consumer awareness, and an average of 1.6% reduction of
salt content in bread among 10 bakeries in the country. These pilot salt reduction
activities were influential in the drafting of the Mongolian National Salt Reduction
Strategy, 2015−2025 [258].
Interventions through voluntary commitment and pledges from food industries are
effective ways of reducing salt in the diet. This involves robust leadership from
government, good partnership with the food industry, and availability of accurate
information on the Na content of targeted foods, and the publication of monitoring data
to encourage action by food industries [259]. For instance, in Kuwait, an agreement was
reached between the Kuwaiti Ministry of Health and food industries to voluntarily
reduce the salt content in bread and cheese over a 10y period. Prior to this, the ministry,
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in partnership with food industries, embarked on an education campaign on approaches
for reducing salt content for the overall benefit to the country. The targeted 10%
reduction in the salt content of bread was met in the first quarter of the 10year period
with an accompanying 1.7% decline in hypertension among adults in Kuwait between
2010 and 2014 [260]. The success story of Kuwait has motivated other countries in the
Gulf particularly, Bahrain, Oman, Qatar, Saudi Arabia and the United Arab Emirates to
initiate similar interventions [261]. Similarly, in the UK, voluntary salt reduction
methods were associated with a 20−30% reduction of the salt content in processed foods
which led to approximately 6000 fewer CVD deaths [138, 262].
Legislation on levels of salt permitted in foods and meals have been used in a few
countries to promote reformulation. Food industries are mostly the target of this
approach, where clear and gradual targets for maximum salt levels in specific foods are
set to be reached within define time. Salt targets need to be achievable but also
sufficiently stringent to result in the magnitude of population salt reduction that has
been planned [263]. This involves setting the maximum levels of Na content of each food
category and ensuring that the Na content of all food items within each category falls
below the maximum level. Another method is to have weighted average targets for each
food category. Using this approach, Na content level of food items within a certain food
category can be altered to meet the overall average for that category. This latter approach
is preferred by most countries but monitoring and surveillance required to ensure
compliance is often unattainable and costly. Efforts such as food reformulation requires
effective engagement with government, academia and industry and food supervision by
international authorities to encourage uptake. Ideally and in many populations, initially
targets are set for foods that contribute most salt to the diet [264] while other foods can
be included later [259]. In South Africa (SA), the government passed new mandatory
regulations specifying the maximum Na limits permitted in various categories of
processed foods. The legislation was implemented in June 2016 with a further reduction
of Na content in those foods and which came into effect by June 2019. The legislation
included mechanisms to ensure compliance and enforcement, such as random and
frequent chemical analysis of food products, and punitive measures for food
manufactures that did not comply with the regulations [264].
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As well as instituting salt reduction goals for the food industry, other interventions such
as taxes on high-salt products, clear food labelling and effective health communication
approaches have been shown to be beneficial [265]. Hungary introduced a public health
product tax on salty snacks and condiments with Na content > 1g per 100g and > 5g per
100g, respectively. Similarly, in Portugal a value added tax is in place for salty foods
[266]. Though the evidence is substantial in terms of the effectiveness of higher taxes on
the control of tobacco use, the evidence of the impact of such strategies on salt intake is
not yet well established [267].
Nutrition labelling (ie providing the list of the main nutrients in a food product) has been
described as an effective way to influence for consumer food selection towards healthier
choices that contain less salt. This approach requires food industries to declare the
content of salt in their food products, thereby giving consumers the option to compare
the salt content in similar products and make better choices. Labelling is most effective
when carried out in conjunction with consumer education, communication and
marketing strategies that explain the labels and its health implications. Many countries
have mandatory regulations that specify type and number of nutrients to be labelled,
whether the information appears on ‘front-of-pack’ or ‘back-of-pack’, ‘the use of
signposting such as colour codes to indicate the salt content in in food products, and
whether the label provides further information to the consumer [259]. Labelling policies
in Finland have influenced the food industry to reduce the salt content of products to
avoid a “high salt” label. This policy resulted in 20−25% decline in the levels of salt in
bread, meat products, cheeses and ready meals [268], and other food products [269]. As
a result of the labelling policies and other salt reduction actions, a 4g salt/day decline in
population salt consumption in Finland between 1979 and 2007 was reported [270, 271].
There have been suggestions for ‘shelf labelling’ at the point of purchase. This involves
displaying warning signs in supermarkets and stores about the nutrient content of foods,
so that consumers can make healthy choices. This intervention is presently being used
in supermarkets in Marshall Islands (52). Another option is Australia’s FoodSwitch app
which makes use of mobile phone applications allowing the retrieval of nutrient content
information at the point of purchase and providing comparative alternatives to a food
product based on the level of salt by scanning the bar code [272].
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To target food consumed outside the home; in hotels, restaurants and cafés, menu
nutrition labelling has been suggested, where regulations will require the hospitality
industry to provide information relating nutrient composition and quantities on the
menu or at a noticeable area within the premises. This has been successful in New York
City where high-salt warning labels have been attached to menu items and information
provided on levels of salt in composite meals [273].
Educating and communicating the health benefits of salt reduction is the most used
intervention because of its relative ease and cost effectiveness [24]. When implemented
successfully, this intervention has a high potential of changing dietary practices, by
augmenting the desire for improved and reduced salt products, and generally enhancing
the total health and wellbeing of populations. Education and communication
approaches work better when they are implemented comprehensively within an overall
environment that supports healthy eating [259]. A successful example is available from
Vietnam where salt intake levels, consumer knowledge, attitudes and practice improved
following a nutrition education campaign resulting in a 2.2g/day reduction in salt intake,
with most of the population showing an increased understanding of the health risks
associated with higher salt intake and embracing actions to reduce their salt intake [274].
Similarly, a school-based cluster randomized control trial involving 28 primary schools
and their families in Changzhi, northern China, resulted in SBP reduction of 2.3 mm Hg
and 9.5 mm Hg in adults (<60y) and older adults (60+y), respectively, after an 8-lesson
(40 minute each) programme on salt reduction [275]. Effective communication for salt
behaviour change has also been demonstrated in Australia in an 18-month study which
involved comprehensive consultation with key stakeholders and the larger community.
Through the use the Communication for Behavioural Impact (COMBI) framework, the
‘FoodSwitch’ app and the provision of a salt substitute, a significant decline of 0.8g/day
of urinary salt equivalent excretion was achieved, together with a significant surge in
knowledge related to salt reduction [276, 277]. Several studies have offered support for
health education and communication as one of initial approaches and a compelling
measure in salt reduction interventions [57, 259]. Varying approaches are recommended
in terms of public advocacy, community mobilization, advertising, interpersonal
communication and point-of-service promotion. That notwithstanding, limitations to
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health education and communication needs to be identified to provide complementary
methods

better

suited

for

constructs

such

as

attitudes,

perceptions

and

environmental/social support [257].
The WHO has introduced the ‘SHAKE’ package which is evidence-based resource and
to assist WHO member states with the development, implementation and monitoring of
salt reduction strategies, and to enable countries to achieve a reduction in population
salt intake. The package outlines the policies and interventions which have proven to be
effective, provides evidence of the efficacy of the recommended interventions, and
includes a toolkit containing resources to assist member states to implement the
interventions.
Few countries have engaged with all the strategies outlined in the ‘SHAKE the salt Habit’
but cost-effectiveness of salt reduction programmes to reduce morbidity and mortality
from NCDs may drive further uptake in the future [278].
1.8 Hypertension in Ghana
Epidemiological studies on hypertension in Ghana over the past few decades have
reported an increase in hypertension prevalence and an increased impact on disability
and death [279, 280]. Hypertension was found to be a significant cause of renal and heart
failure in Ghana [281] and remains consistently high in both urban and rural
communities [282, 283]. Records obtained from the national hospital in Ghana between
1994 and 1998 showed that 11 % of deaths in adults aged 20y and older were as a result
of stroke, with hypertension being the underlying factor [284]. In 2005, hypertension was
described as the second principal cause of outpatient morbidity in adults older than 45y
in Ghana [285]. In the capital city of Accra, hypertension increased from fourth place to
become second only to malaria as the leading cause of outpatient morbidity in 2007 [286].
The incidence of hypertension in outpatient public health facilities in the country
increased more than ten-fold from 49,087 in 1988 to 505,180 in 2007 [287]. Consequently,
hypertension became the major cause of hospital admissions and death, due primarily
to its association with heart disease and renal failure [281]. A nationwide study
conducted in 2008 (WHO’s Study on global AGEing and adult health (WHO SAGE)
Ghana W1) which included 5,526 nationally representative participants reported a high
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hypertension prevalence of 58.9% using the BP threshold of ≥ 140/90 mm Hg [62].
Despite rising hypertension levels, awareness, treatment and control of the condition
remains low [62, 288], indicative of the poor state of the health system in Ghana.
There is an urgent need for the health system in Ghana to improve its performance to
adequately address the rising demands of hypertension and related CVDs. Issues
concerning funding, uncoordinated care, shortage of qualified health workforce, low
insurance coverage and inconsistent supply of medication remain the main setback to
effective healthcare delivery in Ghana [289, 290]. Despite the rising burden of
hypertension and its related CVDs, the allocated budget to NCD prevention and
management was meagre; approximately 80% of the health budget goes to infectious
diseases [291]. There is also the challenge of traditional and faith-based healers whose
practices and approaches to the management of hypertension is questionable and often
not regulated [292].
1.9 Summary of evidence and gaps in literature
The narrative literature review has emphasized the rising trend of hypertension
particularly in LMICs and highlighted the need for countries to develop strategies to
better prevent and manage the occurrence. A modifiable risk factor for hypertension is
diet, particularly salt consumption. However, population studies that assess relative
hypertension and salt consumption are lacking in Ghana, a West African country that
has a high burden of disease from hypertension. Gaps in the literature identified need
for updated and valid data on population salt consumption levels, iodine intake levels,
salt intake behaviours, and hypertension prevalence associated risk factors - to drive the
salt reduction agenda through increased political will for policy formulation. This thesis
will provide evidence to address some of the gaps.
1.10 Hypotheses
Hypertension prevalence has increased in Ghana particularly among older people and
is associated with several modifiable risk factors.
Salt consumption is high in Ghana, in terms of WHO recommendations, and is
associated with hypertension.
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1.11 Research Questions
1. What are the dietary sources of salt in the diets of populations in LMICs?
2. What are the salt use behaviors of Ghanaians and how do they compare with SA
population that has had a relatively increased salt reduction messaging and a salt
legislation?
3. How much Na and K is consumed by Ghanaians at the population level and what is
the relationship between urinary Na, K, N:K ratio, and hypertension?
4. Did BP change in Ghana between 2007/8 and 2019 and what were the determinants
thereof?
5. How do salt and iodine intakes in Ghanaians compare with those of South Africans?
6. What do stakeholders in Ghana perceive to be viable approaches to addressing high
salt intake and hypertension in the country?
1.12 Aims of the Study
Study 1 – To identify and synthesize available evidence related to dietary sources of salt
in LMICs through a systematic literature review.
Study 2 – To examine salt knowledge, attitudes and practices of the Ghanaian population
and compare it with a South African sample.
Study 3 – To determine the current population salt consumption level and its relation to
BP in Ghana.
Study 4 – To identify any changes in BP levels between 2007 (WHO SAGE Ghana W1)
and 2019 (WHO SAGE Ghana W3) and determinants thereof.
Study 5 – To ascertain iodine levels in relation to salt intake in Ghana and compare that
to SA, a country with salt reduction legislation and effective salt iodization
programme.
Study 6 – To conduct a high-level stakeholder meeting in Ghana, with the view of
discussing the current hypertension situation in the country, salt
consumption levels, and consolidate efforts at drawing the government’s
attention to salt reduction approaches as a viable and cost-effective means of
addressing hypertension.
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1.13 Significance of the Study
Hypertension and salt consumption are both rising among adults in LMICs. This thesis
will primarily provide current knowledge relative to Ghana on salt intake and
hypertension to drive policy, planning and further research. It will serve as a strong
foundation of knowledge for other LMICs as it draws comparisons with SA. By
emphasizing the sources of dietary salt in LMICs and evaluating salt behaviours among
two countries in SSA, the thesis will provide direction for advocacy and support for salt
reduction interventions.
By evaluating the changes in BP overtime, this novel study will provide new knowledge
about trends in BP, hypertension prevalence, awareness, treatment, control and the
predictors of such in Ghana; which are critical in monitoring and policy formulation.
The study will offer LMICs the opportunity to evaluate their salt iodization programmes
alongside salt reduction strategies using Ghana as a case study, to ensure optimal iodine
consumption while reducing salt intake. This study will create a road map for advocacy
and support towards salt and hypertension reduction.
1.14 Theoretical Framework
The theoretical framework was inspired by ‘WHO’s SHAKE the Salt Habit’, which
required identification of dietary sources of Na, determination of salt use behaviours
and population salt intake, and development policy action to drive governmental efforts
towards the reduction salt intake and hypertension [291]. The thesis followed the
theoretical framework below.
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Fig. 1.4 Theoretical framework for the thesis
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Chapter 2
Methodology
2. 1 Introduction
As discussed in Chapter 1, hypertension is a major public health concern and a risk factor
for developing CVDs [1, 2]. Dietary sources with high amounts of Na and low levels of K
have been established as contributory factors to raised BP [3, 4]. To place this study in
perspective and to provide a context, a systematic review was conducted on dietary sources
of salt (Chapter 3). Systematic reviews are important in providing a strong evidence by
compiling and synthesizing findings from various studies [5]. Our review followed the
evidenced protocols of the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines with a checklist and a flow diagram to guarantee reliability
and uniformity [6, 7]. It was registered with International Prospective Register of Systematic
Reviews (PROSPERO CRD42016038173) and rated highly on the National Health and
Medical Research Council (NHMRC) recommendations [8, 9].
2.2 WHO-SAGE Study Design
Apart from the systematic literature review (Chapter 3), the entirety of this thesis was based
on primary data collected during WHO-SAGE Ghana/SA Waves 1-3. Brief details of the
study are provided within the published/submitted papers in chapters 4-8. Nonetheless, this
chapter provides an in-depth description of the study design and scope, sample and
sampling methods, instruments for data collection, validity of instruments, data collection
techniques, ethical approval and data analysis for WHO-SAGE countries; Ghana and SA.
Additionally, details of the nested sub study embedded with WHO-SAGE Ghana and SA
W3 will be described.
The WHO-SAGE longitudinal study was created by the WHO Evidence, Measurement and
Analysis unit (formerly the Multi-Country Studies unit) as part of an existing program of
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work to collect comprehensive longitudinal data on the health and well-being of adult
populations and the ageing process for the purposes of planning, policy and research.
A baseline cohort study created during the 2002–2004 World Health Survey (WHS) and
implemented in about 70 countries formed the basis of WHO-SAGE study. The WHS study
included six LMICs (i.e. China, Ghana, India, Mexico, Russia and SA), and data collected in
these countries became what is known as WHO-SAGE W0 [10]. WHO-SAGE W1 was
implemented from 2007 to 2010 as follow up to participants from W0. WHO-SAGE W2
follow up was implemented by the end of 2015. The most recent WHO-SAGE W3 follow-up
was completed in 2018/19 in China, Ghana, India, Mexico and SA.
WHO-SAGE is a longitudinal cohort study that typically collects data on adults aged 18+y
with about 70% of the participants being 50+y in a face-to-face interview that lasts 90-120
minutes. Nationally representative samples are drawn from the six LMICs and were
followed up in each wave with new households and participants included in the subsequent
data collections to account for participant attrition [11].
In terms of its scope, WHO-SAGE broadly incorporates the collection of data on household
and related characteristics, risk factors and preventive health behaviours, subjective wellbeing and quality of life, as well as biomarkers among others. Participants also performed
objective health tests such as grip strength, cognition tests and 4-metre timed walks.
2.3 Geodata
To assist in determining the sample, enumeration areas (EAs) were randomly selected using
on Geo-coding/Global Positioning System (GPS) information based on the 2000 and 2001
census in Ghana and SA respectively. Geo-reference data which included Geographical
Information System (GIS) coordinates of latitude and longitude gave the physical location
of EAs and households selected for WHO-SAGE. Geographical data served several
purposes, first, the accurate recording of coordinates of sampled households was necessary
to assist with locating potential participants for subsequent rounds of the WHO-SAGE
longitudinal data collection. Second, the EA and household GIS coordinates were stored in
the WHO-SAGE database to be used for further spatial analyses of health and illness data.
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Finally, the data may be linked with other data sources to measure distance between
selected households and health-care facilities [12, 13].
2.4 Population
The total population was 24,658,823 in 2010 in Ghana, a figure representing an increase of
30.4 percent over the 2000 census population of 18,912,079. Ghana has a youthful population
consisting of a large proportion of children under 15 years, and a small proportion of elderly
persons (65 years and older). The distribution of the population by sex indicates that women
(51.2%) are more than men and there are more people living in urban areas (50.9%) than
rural areas. Akans are the predominant ethnic group in Ghana (47.5%), followed by the Mole
Dagbani (16.6%), the Ewe (13.9%) and Ga-Dangme (7.4%). The Mande forms the smallest
ethnic group (1.1%) in Ghana. Majority (74.1%) of the population 11 years and older is
literate with variations in the levels of school attendance [14].
In the case of SA, 44, 819, 778 and 51, 770, 560 people were counted in 2001 and 2011,
respectively. Relative to Census 2011, 25.2 million (48.7%) males counted were compared to
26.6 million (51.3%) females. Almost 29.6% of the population of SA is aged between 0-14
years and a further 28.9% is aged between 15 – 34 years, SA has five racial groups (Black
African, Coloured, Indian or Asian, White and other) with Black African forming the
majority of the population (41, 000, 938) and ‘other’ forming the least (280, 454).
Additionally, the population is differed along 13 main ethnic lines with ‘Africans’ forming
the majority (6, 855, 082) [15, 16]. For the purposes of WHO-SAGE, the target population
was adults aged 18y+. Study sample was drawn from nationally representative frames using
general population parameters.
2. 5 Sample and Sampling Techniques
WHO-SAGE targets two adult populations: a large sample of persons aged 50y and older,
and a smaller comparative sample of persons aged 18–49y; in line with the focus of the
study. In all countries, households were used as primary sampling units and classified into
one of these two mutually exclusive categories.: In the older households, all persons aged
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50y and older, including spouses and siblings, were invited to participate. Proxy
respondents were identified for participants who were unable to respond for themselves. A
total of 250 and 396 EAs were randomly selected from Ghana and SA, respectively. Within
each EA, 24 households were selected, comprising twenty 50+y households and four 18-49y
households. The sample sizes varied over the three study waves based on feasibility and
survey costs. Stratification for households was conducted according to region, provinces,
population, and location (urban/rural) [12, 13]. For households that could not be accessed, a
replacement was chosen. In Ghana, this was done by inviting all households within the EA
that were originally not part of the study, but expressed willingness to participate, and
randomly selecting those to participate. In SA, replacements for sample attrition used a
systematic sampling approach to randomly select new households as previously described
[17]. The sample sizes for Ghana and SA are given in Table 2.1:

Table 2. 1 Sample sizes for Ghana and SA (WHO-SAGE W1-3)
SAGE W1

SAGE W2

SAGE W3

Ghana

5,110

4,704

Pending

SA

4,223

3,153

Pending

WHO-SAGE Ghana, SA; sample sizes [18].

2.6 Nested Sub Study
WHO-SAGE Waves 2 and 3 included the nested sub study undertaken in Ghana and SA
only. For the sub study, approximately one-fifth of the total number of EAs in each country,
were randomly selected with the aim to recruit about 1200 participants who in addition to
the main WHO-SAGE survey, provided urine samples. The sampling process for these
participants was the same as those employed in the main survey. Details of the urine
collections, handling, transportation, storage and analysis of the electrolytes have been
described accordingly. For the purposes of this thesis, only participants recruited in the sub
study during the WHO-SAGE W3 study were included. In total, 2,310 participants (Ghana,
1121; SA, 1189) provided urine samples.
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2.7 Instruments for data collection
The SAGE survey is a composite document made up of three different questionnaires. Each
questionnaire consists of several sections focusing on distinct facets of health and well-being
among populations: 1) household questionnaire 2) individual questionnaire and (3 proxy
participant questionnaire (Appendix B).
2.7.1 Household questionnaire
This questionnaire collected information about the household members, housing
characteristics, assets, income and money transfers between household members and those
outside the household. This data provides background characteristics for analyzing health
outcomes. The household informant agreed to be interviewed through understanding and
signing of a household consent form [12, 13].
2.7.2 Individual questionnaire
This questionnaire sought information about the individual’s sociodemographic
characteristics, work history and benefits, health state and descriptions, anthropometrics,
performance tests and biomarkers, risk factors and preventive health behaviours, chronic
conditions and health services coverage, health care utilization, social cohesion, subjective
well-being and quality of life, and impact of caregiving. The survey required the collection
of health measurements and conducting health tests. All participants including those of the
nested sub study responded to this survey.
2.7.2.1 Anthropometric measurement
The stadiometer, weighing scale and a flexible measuring tape were used to measure
participants’ height, weight and waist/hip circumference respectively. In using the
stadiometer, a firm flat floor close to a wall was selected. Participants were barefoot, stepped
onto the base of the stadiometer with feet together, knees straight, back and head against
the wall, looking straight ahead, chin tucked slightly to the chest and eyes same level as
ears. The top of stadiometer was stretched to topmost point on the head with enough force
to compress the hair. To weigh participants, the calibrated weighing scale was placed on a
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flat, firm surface. Participants removed their shoes and any heavy accessories and stood on
the scale facing forward, arms placed at their side with palms facing inwards and not
holding onto anything. In terms of waist measurement, the measuring tape was placed
directly on the skin, or over no more than 1 layer of light clothing. The measurement was
taken round the body and halfway between the lowest rib and the top of your hipbone;
roughly in line with the belly button while the participant stood with feet together and arms
to the side with palms facing inwards. The same procedure for waist measurement was
applied to hip measurement, but with measuring tape going around the participants
buttocks [19].

2.7.2.2 BP measurement
Wrist worn Omron BP devices with positional sensors (Omron R6, Kyoto, Japan) were used
to measure BP. These devices satisfied the validation standards of the International Protocol
for SBP and DBP [20, 21]. Following 5 minutes of seated rest, three BP readings were
recorded on the left wrist (one-minute between each measurement) while the participant sat
with legs uncrossed and the wrist positioned precisely at the level of the heart. An average
of the second and third readings combined with self-reported use of hypertension
medication was used in categorizing hypertension status.

2.7.2.3 Urine collection
Screw cap bottles, funnels, measuring cylinders and 5ml tubes were used to collect 24hr
urine samples from nested sub study participants only. Fieldworkers handed a bag
containing 1) a 5L capacity screw cap bottle to store urine, 2) a 1L container with a wide
opening into which urine is voided with the use of a funnel, 3) 2L capacity screw cap bottle
for temporal collections of urine made away from home, 4) funnel to be used during urine
collection, kept inside a resealable plastic bag when not used, 5) plastic carrier bags for
transporting the equipment away from home and 6) an aide-memoire to help participants
to remember to collect their urine [22], selected participants for 24hr urine collection.
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Fieldworkers explained urine collection requirements (both verbal and written) to
participants and supervised the beginning and end of the collection periods. The
instructions for the urine collection were that the participant should: 1) void the first urine
of the in the morning of the start of the 24hr period, 2) record the time of the first urine
collected, 3) collect all urine within the day and night into the 5L bottle including the first
urine of the following morning, 3) only a participant’s urine should be collected into the
bottles, 4) continue with urine collection if they missed a collection during the day, 5) take
the 2L bottles out when they were leaving the house so all urine passed outside the house
could be collected, 6) keep the urine bottles away from children, and at a cool place, 6) record
time of the last collection, and 7) leave the urine bottles at a place that field workers can
access to, after completion of urine collection [22].
The bottles contained 1g thymol which has the property to preserve urinary creatinine, Na
and K concentrations for a period up to 5 days [23]. The urine bottles were picked up after
24hrs, the content thoroughly mixed up and volume measured. Volumes that were below
300ml were discarded [2, 25] and the participant was rescheduled. The urine was then
aliquoted into 5ml tubes and transported in cold boxes and stored at -20 0C at the Noguchi
Memorial Institute of Medical Research, University of Ghana (NMIMR-UG) and Global
Clinical and Viral Laboratories and North-West University Centre of Excellence for
Nutrition in SA. Aliquoted samples were given codes that corresponded with the
identification numbers of the participants so that samples could be linked to the survey data
of the participants.
2.7.3 Proxy Questionnaire
This questionnaire collected characteristics of participants who were incapacitated at the
time of the survey, by requesting close relatives or care givers of the participant to provide
participant’s information (Appendix B).
2.8 Data collection procedures and management
Prior to data collection for each wave of the study, the WHO-SAGE team in Geneva, visited
Ghana and SA conducted training sessions for all fieldworkers including nurses and
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technicians using standardized training and survey materials [11]. This training lasted 10
days on average, and taught fieldworkers the rudiments of survey, teamwork, general
interviewer skills, ethics of research, how to use and complete WHO-SAGE survey, as well
as collection and handling biological samples.
Fieldworkers conducted face to face interviews with participants, either in the households
or participant’s workplaces. Field teams worked in groups of 3-5 interviewers with a
supervisor. Households or participants that could not be reached at the time of data
collection were replaced. For the first two waves of the study where data were collected on
paper questionnaires, whilst CAPI was used to collect data during W2 and W3. Interviews
were conducted in the participants’ home language while incomplete interviews
rescheduled. During data collection, supervisors checked the quality and consistency of
data collected, and took custody of the survey (W1), and urine samples (W2 and W3).
Tracking sheets were used to track day to day progress of activities on the field, to serve as
reminders of incomplete interviews, correct errors and deal with missing information.
Supervisors were silent observers of the interviews - a responsibility that was considered a
marker of quality assurance. During W1, completed questionnaires and tracking sheets
were collected and posted to the principal investigator’s office while in W3, collected data,
were accumulated on a local server and later transferred onto a centralized server. Urine
samples were sent directly to the laboratories with tracking sheets to monitor samples sent
and those received (nested sub study).
2.9 Study measures
One question investigated knowledge about salt and health - “Do you think that a high salt
diet could cause a serious health problem?”- with answer options “yes” or “no”. Another
investigated attitudes about salt- “How much salt do you think you consume?”- with
answer options of “far too much”, “too much”, “just the right amount”, “too little”, “far too
little”, “don’t know”, and “refused”. Three questions assessed salt use behaviours: (1) “Do
you add salt to food at the table?”; (2) “In the food you eat at home, salt is added in
cooking?”; and (3) “Do you do anything on a regular basis to control your salt or Na
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intake?”- with answer options “always”, “often”, “sometimes”, “rarely”, and “never” for
items 1 and 2, and “yes”, “no”, “don’t know”, and “refused” for item 3. Likert type response
scales were provided, but for analysis of responses to the salt use behaviour questions
categories of “always” and “often” were combined to represent “frequent” use, whilst
“rarely” and “sometimes” were combined to represent “infrequent” use.
Regarding national health insurance status, ‘voluntary’ contributors were defined as those
individuals who were not captured by the health insurance scheme as public or civil service
workers, while ‘mandatory’ contributors were employees from the public, civil and private
sectors. For questions on alcohol and working status, responses were reduced to categorical
variables.
Physical activity was measured using the International Physical Activity Questionnaire
(IPAQ) through its long form questions. The level of physical activity was calculated based
on type of activity, and number of days, hours and minutes participants engaged themselves
in those activities per week. IPAQ has a high reliability and validity and has been used
extensively in urban communities in both developed and developing countries [26]. BMI
was calculated as the ratio of body weight in kilograms divided by the square of the height
in metres.
A BP measurement was determined valid if: Systolic (SBP) > Diastolic (DBP); and SBP was
between 80-270 mm Hg; and DBP was between 40-180 mm Hg; and SBP minus DBP (Pulse
Pressure, PP) > 13mm Hg. Hypertension classification was determined according to the
European Society for Hypertension Guidelines (2018), that is, systolic ≥140 and/or diastolic
≥90 mm Hg [27]. Hypertension status was classified as self-reported treatment or having a
measured BP ≥ 140/90mm Hg, while hypertension awareness was based on self-reported
previous diagnosis of hypertension in those with BP ≥ 140/90mm Hg. Hypertension
treatment was determined as self-reported medication use for hypertension in at least two
weeks prior to data collection. Hypertension control was assessed as those who selfreported antihypertensive medication use within the last two weeks and had a BP
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measurement of less than 140/90 mm Hg. PP was measured as difference between SBP and
DBP, representing the force that the heart generates each time it contracts.
Sodium and K concentrations were determined by indirect ion-specific electrodes, Cr
concentration by using the Jaffe reaction colorimetric method iodine by Sandell-Kolthoff
method with ammonium persulfate digestion and microplate [23]. Sodium (mmol/l) in the
24 h urine sample was converted to salt (g/d) using the formula: Na mmol/l x 24 h volume
(litres) x 23.1 (molecular weight of Na)/390 (390 mg Na per 1 g Nacl (salt). From this variable,
participants were categorized as having low (<5 g/day), medium (5-9 g/day) or high (>9
g/day) salt intake. K (mmol/l) in the 24 h urine sample was converted to K (mmol/d) using
the formula: K (mmol/l) x 24 h volume (litres) [28].
2.10 Ethical considerations
The study complied with the standards of the Helsinki Declaration [29] and approved by
WHO Research Ethics Review Committee [RPC149] (appendix C). Country specific ethics
approval was granted from the University of Ghana (MS-Et/M.03-P 3.1/2005-2006),
(Appendix D), North-West University and University of Witwatersrand (SA). Only
participants that reviewed and signed informed consent forms could participate in the study
(Appendix B).
2.11 Data analysis
All statistical analyses are described in the respective chapters.
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Chapter 3
Dietary Sources of Salt in Low- and Middle-Income
Countries: A Systematic Literature Review
This chapter describes a systematic literature review conducted to ascertain the sources of
food that contribute most salt to the diet in in LMICs. Urbanization and population growth
coupled with the nutrition transition occurring in LMICs is transforming lifestyles and
dietary patterns. As such, there has been a shift from the consumption of traditional staples
to an increased reliance on energy dense foods that are high in salt. This chapter evaluates
and synthesizes the evidence gathered from published literature and makes inferences.
The most of this chapter is the substantive content of the published work:
Menyanu, E., Russell, J. & Charlton, K. (2019). Dietary Sources of Salt in Low- and MiddleIncome Countries: A Systematic Literature Review. International Journal of Environmental
Research and Public Health, 16 (12), 2082-1-2082-17.
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Abstract
Rapid urbanization in low- and middle-income countries (LMICs) is transforming dietary
patterns from reliance on traditional staples to increased consumption of energy-dense
foods high in saturated fats, trans fats, sugars, and salt. A systematic literature review was
conducted to determine major food sources of salt in LMICs that could be targeted in
strategies to lower population salt intake. Articles were sourced using Medline, Web of
Science, Scopus, and grey literature. Inclusion criteria were reported dietary intake of
Na/salt using dietary assessment methods and food composition tables and/or laboratory
analysis of salt content of specific foods in populations in countries defined as low or middle
income (LMIC) according to World Bank criteria. Of the 3207 records retrieved, 15 studies
conducted in 12 LMICs from diverse geographical regions met the eligibility criteria. The
major sources of dietary salt were breads, meat and meat products, bakery products, instant
noodles, salted preserved foods, milk and dairy products, and bouillon cubes. Identification
of foods that contribute to salt intake in LMICs allows for development of multi-faceted
approaches to salt reduction that include consumer education, accompanied by product
reformulation.
3.1 Introduction
Cardiovascular diseases (CVDs) are the leading cause of death worldwide [1], with
hypertension accounting for more than 50% of premature deaths [2]. Globally, the
prevalence of hypertension has been rising from a ﬁgure of 25% reported in 2000 [3] to 40%
reported by others in 2008[4]. Hypertension is the leading single risk factor contributing to
overall Global Burden of Disease [2] through its association with cardiovascular disease.
Low-and middle-income countries (LMICs) already share the highest prevalence of
hypertension [5], with predictions that three quarters of the world’s hypertensive
population will be found in these countries within the next 10y [3]. This may be in part due
to the larger population sizes in LMICs compared to high-income countries, but also
because of the inability of their health care systems to cope with the management of chronic
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diseases. This results in large numbers of people with undiagnosed, untreated, and
uncontrolled hypertension [6]. LMICs are currently facing an unprecedented hypertension
burden [6]. The past four decades have seen a shift in the highest blood pressure (BP) levels
from high-income countries to LMICs, particularly in some South Asian and sub-Saharan
African countries [7] where more than a third of adults report being hypertensive [6].
Additionally, there is low awareness, treatment, and control measures for hypertension in
LMICs [8], rendering current practices to reduce hypertension ineﬀective [9,10]. Ultimately,
the worsening situation of hypertension together with increased prevalence of cancers,
diabetes, and chronic respiratory diseases have culminated in nearly 80% of all deaths from
NCDs occurring in LMICs [11]. The nutrition transition in many LMICs is occurring due to
the rapid urbanization which has led to widespread availability of energy-dense foods that
are high in saturated fats, trans fats, sugars, and salt. This has resulted in a shift in dietary
patterns from a reliance on traditional staples such as maize and sorghum to more processed
foods [12]. At the same time, food insecurity remains a challenge in LMICs [13]. Preserving
food using traditional methods (e.g., salting) is important in ensuring food availability and
addressing hunger in many communities [14,15]. Further, limited water supplies [16] have
exposed populations to unhealthy water sources which often contain toxins or unacceptable
levels of nutrients [17,18]. A mean Na concentration of about 700 mg/L (with extremes
exceeding 1500 mg/L) was found in drinking water in coastal areas of Bangladesh [19]
contributing to the overall daily Na consumption of people living along the coast. With this,
the WHO’s recommended daily limit of 5 g salt [20] can easily be exceeded by just drinking
2–3 L of water in some countries. There is compelling evidence from epidemiological,
clinical, and experimental studies showing a positive and direct relationship between salt
consumption and BP. It is widely accepted that high intakes of salt in food (beyond the
WHO’s recommended level of 5 g salt or 2 g Na/day) and in water (>0.2 g Na/L) are major
risk factors for hypertension [20,21], heart disease, and stroke [22]. Sodium is an important
nutrient required by the body to ensure ion balance, maintenance of plasma volume, and
transmission of nerve impulses [23]; however, when in excess, has been implicated in the
development of kidney disease, gastric cancer, and hypertension [24,25]. Lower levels of Na
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(<3 g/d) have also been identiﬁed to be associated with higher risk of death and
cardiovascular events [26]. Several prospective cohort studies have indicated a U-shaped
relationship between salt consumption and cardiovascular disease or mortality, with
increased risk at both high- and low-intake extremes [27–30]. In comparison with a
moderate consumption of salt, observational data demonstrate that very high intakes (>6 g
Na/day, representing only 10% of the population studied) are associated with an excessive
risk of cardiovascular events and death, but only in the case of those with hypertension.
This study also reported associations between low salt intakes and increased risk of
cardiovascular events and death in both hypertensives and normotensives [31]. While the
optimal lowest intake of salt is still being debated, there is no question that in most countries,
population-level estimates of salt far exceed the commendation of a maximum 5g/day, thus,
necessitating salt reduction strategies [20]. In 2004, the WHO released its “Global Strategy
on Diet, Physical Activity and Health” that was adopted by the World Health Assembly and
which called upon all governments and stakeholders to work towards improving the
healthfulness of diets [32]. More recently, WHO member states have agreed to work
towards voluntary targets to reduce NCDs by 25% by 2025, with one of the nine global
targets being a reduction in population salt intake by a relative 30% [22]. In order to develop
national policies and strategies to lower population-level salt intake in LMICs, it is necessary
to understand the main dietary sources of salt. This information is required to assist
governments to enact policies and programs, and to concentrate on particular food items
that are of relative importance to excessive salt consumption in LMICs. The aim of this
systematic literature review is to identify the major food sources that contribute to salt
consumption in populations in LMICs.
3.2. Methods
A literature search was conducted in March 2017 using the Medline, Web of Science, and
Scopus databases. Hand searching of the reference lists was performed from articles
retrieved from these databases. Grey literature was also searched by visiting institution and
government websites and other sources. Data collected were synthesized according to the
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Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [33]
(Figure 3.1). The research question investigated was: “What are the dietary sources of salt
in LMICs?” Search terms are listed in Table 3. 1. Outcome measures include dietary sources
of Na/salt. Only articles reported in English were included. All countries in the LMIC
bracket were listed among the search terms. Low-income economies were deﬁned as those
with a gross national income (GNI) per capita, calculated using the World Bank Atlas
method, of $995 or less in 2017; lower middle-income economies were those with a GNI per
capita between $996 and $3895; and upper middle-income economies were those with a GNI
per capita between $3896 and $12,055 [34]. The search was restricted to articles published
from 1960 onwards.
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Table 3. 1 Search strategy
Searches

Search Terms

Medline

"source of salt" OR "dietary salt" OR "discretionary salt" OR "salt intake" OR "salt in food" OR "salt added at the table” OR “dietary sources of sodium” AND “Algeria” OR

Scopus

“Angola” OR “Benin” OR “Botswana” OR “Burkina Faso” OR “Burundi” OR “Cameroon” OR “Cape Verde” OR “Central African Republic” OR “Chad” OR “Democratic

Web of

Republic of Congo” OR “Republic of Congo” OR “Cote d'Ivoire” OR “Equatorial Guinea” OR “Ethiopia” OR “Gabon” OR “Gambia” OR “Ghana” OR “Guinea” OR “Guinea

Science

Bissau” OR “Kenya” OR “Lesotho” OR “Liberia” OR “Madagascar” OR “Malawi” OR “Mauritius” OR “Mozambique” OR “Namibia” OR “Nigeria” OR “Reunion” OR
“Rwanda” OR “Sao Tome and Principe” OR “Senegal” OR “Seychelles” OR “Sierra Leone” OR “South Africa” OR “Swaziland” OR “Tanza nia” OR “Togo” OR “Uganda”
OR “Zambia” OR “Zimbabwe” OR “Afghanistan” OR “Albania” OR “American Samoa” OR “Armenia” OR “Azerbaijan” OR “Bangladesh” OR “ Belarus” OR “Belize” OR
“Bhutan” OR “Bolivia” OR “Bosnia and Herzegovina” OR “Brazil” OR “Bulgaria” OR “Cambodia” OR “China” OR “Colombia” OR “Comoros” OR “Costa Rica” OR
“Cuba” OR “Macedonia” OR “Malaysia” OR “Maldives” OR “Marshall Islands” OR “Mexico” OR “Micronesia, Fed. Sts.” OR “Moldova” O R “Mongolia” OR “Montenegro”
OR “Myanmar” OR “Nepal” OR “Nicaragua” OR “Pakistan” OR “Palau” OR “Panama” OR “Papua New Guinea” OR “Paraguay” OR “Peru” OR “Philippines” OR
“Romania” OR “Rwanda” OR “Samoa” OR “Dominica” OR “Dominican Republic” OR “Ecuador “ OR “Serbia” OR “El Salvador” OR “Solomo n Islands” OR “Fiji” OR
“Sri Lanka” OR “St. Lucia” OR “Georgia” OR “St. Vincent and the Grenadines” OR “Grenada” OR “Suriname” OR “Guatemala” OR “Syria” OR “Tajikistan” OR “Guyana”
OR “Haiti” OR “Thailand” OR “Honduras” OR “Timor-Leste” OR “India” OR “Indonesia” OR “Tonga” OR “Iran” OR “Iraq” OR “Turkey” OR “Jamaica” OR
“Turkmenistan” OR “Jordan” OR “Tuvalu” OR “Kazakhstan” OR “Ukraine” OR “Kiribati” OR “Uzbekistan” OR “Korea, Dem. People’s Rep.” OR “Vanuatu” OR “Kosovo”
OR “Vietnam” OR “Kyrgyz Republic” OR “West Bank and Gaza” OR “Lao PDR” OR “Yemen” OR “Lebanon”
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Identification

Prisma Flow Diagram
Records identified through
database searching
(n=3184)

Grey Literature
(n=23)

Duplicates excluded
(n=197)

Records excluded
based on titles
(n=2833)

Abstract screened
(n=177)

Abstract excluded
(n=143)

Screening

Records screened based on titles
(n=3010)

Eligibility

Full text articles excluded (n=19)
Full-text articles assessed for
eligibility
(n=34)

11 did not report Na content of
specific foods
4 full texts could not be
retrieved

Included

2 were on apparent
consumption data
Articles included in qualitative
analysis
(n=15)

1 was a methodology paper
1 compared Na content on food
labels with established
maximum levels

Figure 3. 1 Flow Diagram
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Data extraction was completed by the lead author (EM) and reviewed by the second author
(KC). Endnote X4 (Clarivate Analytics, Philadelphia, PA, USA) was used to manage the
citations. Each article was ranked for level of evidence using the National Health and
Medical Research Council (NHMRC) recommendations [35]. A narrative synthesis of the
studies was completed because of the heterogeneity in reporting outcomes of the studies. In
this literature review, Na and salt were used interchangeably. Studies were included if a
study (a) reported actual quantities of Na/salt in foods (b) data were collected from food
diaries, diet recalls, food frequency tables and (c) laboratory analysis of salt content in food.
Data were extracted by ﬁrst reviewing the title and selecting abstracts of those with relevant
titles. If the abstract met the inclusion criteria, the full article was retrieved (Figure 3.1).
Studies were summarized according to descriptive characteristics, including the region,
country, data collection period, study emphasis, and the study design. Each paper was
categorized also by the author, population, outcome measured, method of measurement,
and the results. Quality rating was conducted using appraisal tools for cross-sectional
studies for nine articles that utilized a human population [36] (Appendix A). This systematic
review was registered with the International Prospective Register of Systematic Reviews
(Prospero CRD42016038173).
3.3 Result
Our search of data bases and additional records yielded 3207 titles. One-hundred-andseventy-seven abstracts (23 hand-searched) were retrieved after duplicates and irrelevant
papers were excluded, thereafter resulting in 34 full papers being assessed for eligibility and
inclusion. Of these 34 articles, 15 were included in the ﬁnal review. Reports from the country
level WHO Stepwise Surveillance surveys were hand-searched but did not yield relevant
information. Figure 3.1 shows the PRISMA ﬂow diagram providing details of the search and
included studies. Of the ﬁnal included articles grouped according to WHO-deﬁned
geographical regions [37], the greatest number of articles (i.e., four each) were from Africa
and the Western Paciﬁc (though in the Western Paciﬁc region, all the articles came from
China), whereas the least number of the articles (i.e., one) came from European countries
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(appendix K). Fifteen of the included studies were conducted in 12 countries and most of
them had been published within the last two decades (1991–2016). Six of the articles did not
report data collection periods. With the exception of one randomized controlled trial, all
other studies were cross-sectional and descriptive in design and concentrated on dietary
behavior and product reformulation. Analytical values for the salt content of bread were
reported in ﬁve articles (Table 3.1). Zibaeenezhad et al. [38] included the highest number of
samples of bread that were examined, whereas Ferrante et al. [39] recorded the greatest
number of bakeries that were sampled within one study. For studies that included samples
of bread from diﬀerent suburbs and locations, salt content varied depending on the
municipality and producer. The highest salt content found in bread was 1.80g/100g in
Nigeria [40]. The average salt content in bread from all articles was more than the voluntary
targets and recommended quantities in other countries (380–400 mg Na per 100 g bread)
[41–43]. One study from Ferrante et al. [39] analyzed salt content in French bread, croissants,
and cookies and crackers using dietary recall and additionally used biochemical analysis for
French bread. Results from the two methods used for French bread indicated an
underestimation of salt use with the dietary recall. Financial constraints did not permit
chemical analysis of the other food items. There were three articles that reported salt content
of additional foods other than bread, including preserved ﬁsh, cookies, crackers, as well as
water (Table 3.2) and seven articles assessed total dietary salt intake (Table 3.3). Two of the
included articles [44,45] investigated children’s’ dietary salt intake. Four of the articles that
measured dietary intake also included biomarkers of participants’ 24hr urinary Na excretion
[46–49]. The major sources of dietary salt were breads, meat and meat products, bakery
products, noodles, salted preserved foods, milk and dairy products, and bouillon cubes.
Additionally, some articles reported that a high amount of salt in the local diet came from
discretionary salt [45,49,50], but this was not consistently measured.
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Table 3. 2 Summary table of studies that reported salt content of bread by chemical analysis
Reference

Population

Outcome
measured
Na content in
bread.

Method of
measurement
Flame photometry.

Results

Silva et al., 2015 [43]

All bakeries (n=17) situated in
Maputo city that were listed
in the Mozambican Yellow
Pages were included.

Nwanguma &
Okorie, 2013 [39]

Retail samples of 100 brands
of white bread made from
wheat flour, representing the
major brands were purchased
from 10 standard retail
outlets in Nsukka and Enugu
towns, both in Enugu State in
South-Eastern Nigeria.

Na content in
bread.

Flame photometry.

Na ranged from 396g to
1332g/100g.Mean= 544mg/100g.
Mean Na > a, b, c and d.

Hussain & Takruri,
2016 [44]

68 samples of seven types of
bread were collected from 13
different bakeries in the city
of Amman.

Na content in
bread.

Flame photometry.

Mean Na content of bread was
450 mg/100 g, ranging between
255 mg/100g and 638 mg/100g,
with no significant differences
between bakeries and traditional
markets. Most samples (88 %) did
not meet the regulation for SA.
Mean Na > a, b and c.

Mean Na content = 476 ±
84g/100g ranging between 168 ±
20g for White Arabic bread* to
824 ± 76g/100g for Shrak bread*.
Mean Na > a, b and c.
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Reference

Population

Outcome
measured

Method of
measurement

Zibaeenezhad et al.,
2010 [37]

204 bakeries in districts of
Shiraz city in Iran: 408 bread
samples
were
collected
representing from bakeries
for measuring their salt
content 6 different kinds of
bread.

Na content in Laboratory testing of
bread.
salt percentage in
bread as outlined by
Iran’s Organization for
Standards
and
Industrial
Investigations [45].

Vukić et al., 2013 [46]

12
samples
of
bread Na content in
purchased in stores from the bread.
3 municipalities: Bijeljina,
Zvornik and East Sarajevo in
Bosnia. In each municipality 8
samples were randomly
selected.

Atomic
absorption
spectrophotometry
(AAS)
using
an
instrument VARIAN
SpectrAA-10.

Results

Mean Na = 524g/100g ranging of
0-1400g/100g bread.
Mean Na > a, b, c and d.

Mean Na = 405 ± 177mg/100 g, 489
± 174mg/100g and 673 ±
119mg/100g for East Sarajevo,
Bijeljina and Zvornik respectively.
Bread samples from East Sarajevo,
mean Na > a and b
Bread samples from East
Bijeljina, mean Na > a, b and c.
Bread samples from East
Zvornik, mean Na > a, b, c, d
and e.

White Arabic and shrak bread are bread types in Amman.
a. > 380g/100g - maximum level of Na in bread established by the South African Government; effective June 2019 [40].
b. > 400mg/100g - maximum level of Na in bread recommended by the Government of Australia [41, 42].
c. > 450mg/100g - maximum level of Na in bread recommended by the National Heart Foundation of New Zealand [41].
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d. > 490mg/100g - Level of Na that is required by the Finish Government for the designation of ‘highly salty’ on a label [47].
e > 550mg/100g - maximum level of Na in bread established by the Portuguese Government [48].
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Table 3. 3 Summary table of studies that assessed consumption of salt from specific foods and water
Reference
Kerry et al.,
2005 [51]

Population
12 villages (6 rural, 6 semi-urban
were chosen in Ghana. Between 95
and 250 subjects aged 40–75 years
from each village, for a total = 1,896,
selected by stratified random
sampling from a census of all
inhabitants of the village.

Outcome measured
Frequency of consumption of
high salt foods.

Method of measurement
FFQ asked about the
consumption of five salty
foods: koobi, momoni,
kako (all salted ﬁsh), salted
pig’s feet and salted beef.
Also questioned the use
discretionary salt, stock
cubes or monosodium
glutamate (MSG).

Results
92% reported eating salted fish. While salted meat
(pig’s feet and beef) was eaten more often by semiurban villagers, salted ﬁsh was eaten more often by
rural villagers. Majority of the respondents (98%)
frequently added salt to food in cooking.

Ferrante et al.,
2011 [38]

25 000 bakeries countrywide
affiliated to Argentinean
Federation of Bakeries.

Na
content
products.

Dietary recall and Flame
photometry.

Self-reported (using food composition table) mean
Na contents: French bread = 1440mg ranging 8003200mg/100g, croissants and cookies = 1440mg
ranging 800-2800mg/100g, crackers = 2320mg
ranging 1760-4000mg/100g, and flat rounded
crackers = 1760mg ranging 960-2720mg/100g.
Chemical analysis of French bread showed a mean
Na concentration of 1600mg ranging from 11202400mg/100g.

Khan et al.,
2011 [52]

343 pregnant Dacope women from
Bangladesh recruited for a pilot
phase of a larger study.

Na intake from drinking
water sources.

Indirect estimates of
individual salinity intake
from groundwater and
river water, determined
using salinity data for
1998-2000; Centre for
Environment and
Geographic Information
System (CEGIS) in
Bangladesh.

Na from drinking water = 2064mg/day during the dry
season (depending on the water source) and
480mg/day during the monsoon season assuming a
conservative water intake of 2 L/day/person.

in

bakery

Note: 5g/d salt = 2000mg Na
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Table 3. 4 Summary table of studies that assessed total salt intake using dietary assessment methods
Reference
Charlton et al., 2005
[54]

Population
300 men and women from three
different ethnic groups (black,
mixed ancestry, and white), aged
20 to 65 y, conveniently sampled
from place of work, Cape Town
City Council, SA. Equal numbers
of hypertensive (BP ≥ 140/90 mm
Hg and/or on antihypertensive
medication) and normotensive
(blood pressure < 140/90 mm
Hg,) men and women were
planned (n = 150/group, 50 from
each ethnic group).

Outcome measured
Dietary intake of Na.

Method of measurement
Interviewer-administered
3-repeated
24-h recalls. Standard
household
measuring
utensils, rulers and food
photographs of typical
South African foods [57]
used to quantify food
portion sizes. The average
daily
nutrient
intake
calculated
using
Foodfinder
III
computerized
dietary
assessment
program,
based on Medical Research
Council Food Composition
Tables [58].

Results
In all three subsamples,
cereals were the main
contributor
to
total
reported dietary Na intake
(45.9% to 48.6%), followed
by
meat
and
meat
products (20.3% to 23.6%)
and milk and dairy
products (6.3% to 8.1%). In
all groups, bread was the
major source of dietary Na
(25.2% to 40.5%).

Liu et al., 2014 [53]

726 Chinese postmenopausal
women who attended a
screening visit for a randomized
controlled trial testing the effect
of soy products supplementation
on BP were conveniently
sampled.

Dietary intake of food
substances from which Na
content was determined.

3-day
food
records
questionnaire was used to
estimate dietary nutrients
intake. Food items were
those most frequently
consumed
based
on
previous local surveys [59,
60]. Subjects received a 30min training on estimation
of food amounts, portion
and utensil sizes. Dietary

Major sources of nondiscretionary salt include
soup (21.6%), rice and
noodles (13.5%), baked
cereals (12.3%), salted/preserved foods (10.8%),
Chinese dim sum (10.2%)
and sea foods (10.1%) of
the total salt intake.
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Reference

Population

Outcome measured

Method of measurement
nutrients were calculated
based on the China Food
Composition Table and
local Na database [61, 62].
Total Na intake was
calculated by summing the
estimates
from
all
contributory food items or
groups.

Results

Zhao et al., 2015 [50]

903 families were conveniently
sampled for the study. 2952
participants were recruited from
families in urban (Xicheng
District) and suburban (Huairou
District) Beijing. Study families
were recruited through public
primary and junior high schools.
Eligible families were those with
a child from the enrolled schools.

Dietary salt intake and
sources of salt in the diet.

Questionnaire;
a
simplified “one-week salt
estimation method” was
designed to measure each
family member’s daily salt
intake and determine the
sources of salt in the diet.
This method estimates salt
intake from three sources:
household
cooking,
processed
food,
and
cafeterias or restaurants.
The
methodology
is
previously published [63].

Soy sauce, vinegar, other
sauces
and
MSG
contributed 47%, 34%, 12%
and 7% to total Na intake.
The mean Na intake was
5360 (SD 3320) mg/day.
Adults consumed more Na
6080(SD 3640) mg/day
than
children
and
adolescents 4400 (SD 2480)
mg /day and senior
citizens 4080 (SD 1920)
mg/d.

Health Promotion Board,
Singapore, 2011 [64]

National Nutrition Survey 2010
comprised 739 subjects aged 1869 years conveniently sampled.

Na content in selected
foods.

Face-to-face
interviews
were conducted where
dietary practices and food
frequency questionnaires
were
administered.
Nutrients and various

Fish balls, fish cakes,
breads and noodles were
estimated to contribute
37% of the population’s
salt intake. Daily salt
intake was 3320mg/day.
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Reference

Population

Outcome measured

Method of measurement
food groups were assessed
by comparing the levels of
intake
with
dietary
standards including the
Recommended
Dietary
Allowances (RDAs).

Results
Most of the salt (60%) came
from table salt and sauces.

Du et al., 2014 [65]

Secondary data from China
Health and Nutrition Survey
(1991-2009) comprising 16,869
adults aged 20–60y was used.

Na intake from foods and
condiments

Three consecutive
24-h dietary recalls in
combination with
weighing methods. All
foods and condiments
recorded and measured.
Na intake (ie, Na from all
foods and condiments)
were based on their
compositions in the
Chinese food-composition
table.

The major source of
dietary Na was added salt,
followed by soy sauce,
processed foods, and MSG.
The average soy sauce
intake was 6.9 g/d,
accounting for 8.5% of total
Na intake. The average
processed food intake was
244.7
g/d,
which
represented 20.8% of all
food
consumed
and
accounted for 6.8% of total
Na intake. The average
MSG intake was 1.5 g/d,
accounting for 3.4% of total
Na intake.

de Moura Souza, 2013 [49]

Nationwide dietary survey. Food
consumption of a representative
sample
of
the
Brazilian
population 10 years of age or
older (n = 34,003).

Na content in foods and
beverages.

24hr dietary recall using
the nutrition data system
for Research software
version 2008, the Brazilian
Food Composition Table

Foods with high Na
densities (>600mg/100g)
included salty preserved
meats (997 mg/100 g),
processed meats
(974
mg/100 g), cheeses (883
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Reference

Population

Outcome measured

Method of measurement
[66], and Brazilian studies
on regional foods [67].

Results
mg/100 g), crackers (832
mg/100 g), sandwiches
(800 mg/100 g), pizza (729
mg/100 g), and breads (646
mg/100 g), as well as oils,
spreads,
sauces,
and
condiments (804 mg/100
g). Altogether these food
groups contributed 25%
(811mg/100g)
of
the
average daily Na intake.
The mean Na intake was
3190mg/day.

Anderson et al., 2010 [55]

Participants were 4,680 women
and men aged 40 to 59 years,
recruited by stratified random
sampling from 17 diverse
populations—community-based
or workplace-based—in Japan
(four samples), People's Republic
of China (three rural samples),
the United Kingdom (two
samples), the United States (eight
samples).

Na intake was calculated
by summing estimates
from all contributory food
sources, including foods
and beverages, ingested at
home or away from home.

24-hour dietary recall. Na
content of each food item
was determined using the
enhanced national food
database for each country.

For China, mean Na intake
=
3,
990±
1943
mg/person/day; Soy sauce
= 256mg/person/ day,
mustard, turnip greens,
and
cabbage
=
143mg/person/day,
sodium bicarbonate and
sodium
carbonate
(tenderizers) = 98mg/
person/day and noodles
was
89mg/person/day.
Japan, mean Na intake =
4651
±1279,
United
Kingdom mean Na intake
= 3406±1162 and United
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Reference

Population

Outcome measured

Method of measurement

Results
States
mean
3660±1343.

Na

=

Note: 5g/d salt = 2000mg N
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3.4 Discussion
To reduce population salt intake, the WHO “SHAKE the Salt” framework strongly
emphasizes a need to identify major sources of salt in the diet and to embark on strategies
that include product reformulation, taxation, nutrition labelling, and nutrition education
[69]. The current review has identiﬁed bread as the major food source that provided the
highest amounts of salt to the diets of populations in 12 LMICs. Meat and meat products,
salted meat and ﬁsh, sauces, spreads, bouillon cubes, pizza, sandwiches, seafood, and
ground or river water were also identiﬁed as major contributors to non-discretionary salt
intake. Contribution of each of these foods diﬀers by cuisine of the country, for example
among Asian countries, sauces and MSG are prevalent [45,50,66], whereas in Africa and
Latin America it is bakery, meat, and dairy products [40,44,49]. The average Na content for
bread was above 400 mg per 100 g bread, which exceeded the generally accepted target for
salt content of bread [41–43,70]. Similarly, in high-income countries such as Australia, some
loaves provide more than 25% of the maximum daily recommended intake of salt in bread
in just two slices [71], with bread and bread rolls contributing 25% of total salt provided by
processed foods [72]. The consumption of bread has increased in LMICs [73] due to the
decline in traditional staples such as maize, millet, and sorghum to the rise in wheat [74]. In
India, the production of wheat increased from 75.81 million MT in 2007 to 94.88 million MT
in 2012 [75], while Pakistan experienced a 3.2% increase between 2012 and 2013 [76]. Food
preferences have changed, and this has altered the consumption of traditional staples.
Relatively, there has been a global shift in dietary patterns from the reliance on traditional
staples to processed foods due to the increased production of processed foods and changing
lifestyles [20]. The Food and Agriculture Organization predicts that with the rise in income
levels, preference for wheat products will increasingly overshadow traditional coarse grains
[77]. In many LMICs, wheat is gradually replacing roots and tubers [78]. Furthermore, rapid
urbanization in LMICs is changing diets such that “fast foods” (ready-to-eat), which
typically contain excess salt, have replaced core staple plant-based foods, thereby increasing
the demand for processed foods [79]. Other reasons for shifts to a greater reliance on
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processed foods may be related to an increase in the number of women in the workforce,
which has aﬀected roles within the household related to food preparation [80]. The rising
trend of eating away from home or eating prepared food away from home has contributed
to the increased consumption of bakery products [81,82] in urban settings. Bread has
virtually become a staple food [83], and which for many, forms the basis of breakfast, lunch,
and dinner. For example, in some parts of the Democratic Republic Congo, bread has
substituted cassava, the traditional starchy staple used in preparing “foufou” (dough made
from boiled and ground plantain or cassava) [84]. Similarly, bread intake is higher than
traditional staples in southern Mozambique [85,86] and is widely eaten as a snack or as a
complete meal in Nigeria [87]. Bread is easily accessible from stores and vendors, and more
convenient than traditional cereal and root staples, both of which require time and eﬀort for
preparation before consumption. In the Seychelles, there has been a decreased consumption
of the traditional staple (ﬁsh) as a result of increased intake of meat, poultry, processed meat,
and snacks [88]. There have been major increases in meat (i.e. beef, pork, and poultry) in
LMICs [89, 90], including processed meat that is high in salt [91, 92]. Increased consumption
of processed meat products has the potential risk of coronary heart disease, type-2 diabetes,
and colorectal cancer [93, 94]. In Australia, processed meat contributed 10% of daily Na
intake [95] and is a major contributor to salt intake in the United Kingdom [96]. Bacon for
example, contains more than twenty times the quantity of salt compared to fresh pork of the
same weight [97]. As countries are becoming more economically wealthy, there has been an
increased demand for animal source products with livestock being one of the fastest
growing agricultural subsectors in LMICs [98], and accompanying advancement in food
technology in these countries resulting in increased availability of processed animal
products. These processed animal products may be contributing to the increase in salt intake
within LMIC populations. A potential strategy to reduce salt intake would be to reduce
processed meat intake. This would have the additional beneﬁt of reducing climate change
issues such as high green-house gas emissions from cattle and diverting agricultural land
use from human consumption to animal consumption [99,100]. Highly palatable, energydense, low-cost, ultra-processed foods, snacks, and beverages are commonplace within the
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food supply in LMICs [101,102]. This is evident in the growing number of supermarkets that
are replacing open public markets in LMICs [12]. Consumers are attracted to these foods
because of their aﬀordability, ease of access, availability, and taste, which are often
accompanied by intensive marketing by the food industry sector [103], particularly in
poorer environments where alternatives are limited [104]. In most LMICs, food security is a
major issue and food preservation using salt is commonplace. In these countries, food
production is seasonal but in greater quantities during harvest, after which production
dwindles signiﬁcantly [14, 15]. Ghana, for example, experiences two rainy seasons a year
(with the major one in June and the minor in October) and those are the times for crop
production in most parts of the country [105]. The major ﬁshing season shares the same
timeframe [106,107], thus, the bulk of the country’s food supply is produced in one-half of
the year, thereby warranting preservation, one of which is using salt [108] to ensure its
availability and maintenance for oﬀ-season supply [14,15]. Often, an under-estimated
source of dietary salt relates to the contribution from the water supply. Studies on river and
underground shallow water salinity are lacking in the face of severe drought in LMICs [109–
111]. More challenging is the fact that there are no guidelines for safe salinity levels in
drinking water [21]. During the dry season in Bangladesh, it is estimated that up to 5–16 g
salt per day may be consumed from river and shallow underground drinking water [47].
There are many places in Africa and Asia where the sources of water are unsafe for human
consumption [112–114] and the likelihood for excess salt provided by water bodies remain
high as environmental and climatic conditions worsen [115]. This issue has been ignored in
recommended global strategies [20] to reduce population-level salt intake. The shift in
dietary patterns is also driven by the promotion of Western culture through media outlets,
international trade, and other channels related to globalization [74]. Many supermarkets,
hotels, restaurants, and fast food outlets in LMICs are multinational establishments that
provide the same menu as their partners in higher income countries. These food outlets are
a major driving force changing the food environment and dictating food preferences in
LMICs [12]. Globalization of food systems in this way, undermines traditional dietary
practices and creates an avenue for food and nutrient insecurity. Greater availability and
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access to these cheap, imported, energy-dense, nutrient-poor foods have culminated in an
increased prevalence of obesity and a myriad of NCDs plaguing many African countries
(that are already burdened with infectious diseases) [116]. A challenge is for LMICs to
consider agriculture within economic growth and development, to ensure that food
insecurity is not exacerbated by increasing urbanization. A deliberative approach should be
developed and geared towards the production, availability, accessibility, and consumption
of a wide range of traditional staples in the face of rapid development. Countries in South
East Asia provide exemplars as they have encouraged and improved the traditional cuisine
to meet current developmental changes [117,118]. The United Nations’ Sustainable
Development Goals provide a framework against which country progress towards 17 goals
will be reported by governments [119]. Partnerships and global solidarity between countries
should include commitments by major food companies to limit and standardize acceptable
maximum limits of harmful components allowed in imported or branded foods sold across
the globe and prevent dramatic diﬀerences currently seen in the salt content of similar
products and fast food meals across countries. An urgent need to address food systems in
LMICS is required in order to stem the pandemic of NCDs, as more than three-quarters of
premature NCD deaths occur in these countries [20]. South Africa serves as an example
where the government has mandated maximum salt levels permitted across a wide range
of processed foods, in an eﬀort to reduce the burden of hypertension [8, 120, 121] and its
related morbidities [122]. Though the impact of this legislation is yet to be demonstrated
[123], it is seen as a bold step towards saving lives and reducing health care costs [124, 125].
The WHO has emphasized that government policies and programs, collaboration with
private sector organizations, and monitoring of population salt intake are key measures to
population salt reduction [20]. Understanding salt use behaviors at the population level is
required in order to determine best approaches to salt reduction in countries [126]. Many
governments have focused on individual consumer behavior change [127], focusing on salt
added at the table and during cooking. Though commendable, a multi-faceted approach
which targets both discretionary and non-discretionally salt use is encouraged [20]. This
review collated the available information on dietary sources of salt in LMICs in an eﬀort to
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identify the food sources that contribute to total salt intake. Many LMICs do not have
reliable assessments of dietary salt intake nor do they have national targets and timelines
towards ensuring a decline in salt consumption. This makes it challenging to assess progress
towards achieving the WHO’s voluntary salt reduction target of a relative 30% by 2025 [20].
Advocacy by civil society groups, organizations, institutions, and professional health
associations for salt reduction in foods is required to lobby governments whose health
agenda does not include changes to the food supply. This approach has been demonstrated
by the Australian Division of World Action on Salt and Health, whose eﬀorts have resulted
in voluntary salt targets for the food industry [71]. The legislative approach adopted by the
South African government [41] may serve as blueprint for LMICs [128]. Limitations to the
review relate to the selection criteria being based on the English language only. This may
have limited the scope of the search and subsequent data retrieved for consideration.
Nonetheless, studies included covered all WHO global regions. Many of the cited papers
did not provide information on the actual dietary consumption patterns of the populations
residing in the areas from where the food samples were obtained. This means that overall
contribution of individual foods to total salt intake could not be determined.
3.5 Conclusions
Processed foods that have a high salt content are becoming common place in the diets of
populations in LMICs. Major sources of salt are provided by bread, meat and meat products,
salted meat and ﬁsh, sauces, spreads, bouillon cubes, pizza, and seafood. Diﬀerences exist
between WHO regions regarding sources of food products that contribute to total salt
intakes. Water sources in drought-aﬀected areas also warrant further attention as sources of
Na intake. Besides foods that contain high salt, discretionary salt use is widespread in
LMICs.
Supplementary
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Chapter 4
Salt use behaviours of Ghanaians and South Africans: A
comparative study of knowledge, attitudes and practices
This chapter describes a cross-sectional study of salt use behaviours among Ghanaians and
South Africans during WHO-SAGE W2 study. In terms of advocacy and affirmative action
for population salt reduction, salt knowledge, attitudes and practices are the targets of
public health education. A comparison between the two SSA countries, with SA having
implemented a salt reduction legislation, in addition to a massive salt reduction campaign,
and Ghana without such, this novel study gives an insight into salt behaviours among these
two different environments.

This chapter is the substantive content of the published work:
Menyanu, E., Charlton, K. E., Ware, L. J., Russell, J., Biritwum, R. & Kowal, P. (2017). Salt
use behaviours of Ghanaians and South Africans: A comparative study of knowledge,
attitudes and practices. Nutrients, 9 (9), 939-1-939-13.

106

Abstract
Salt consumption is high in Africa and the continent also shares the greatest burden of
hypertension. This study examines salt-related knowledge, attitude and self-reported
behaviours (KAB) amongst adults from two African countries—Ghana and South Africa
(SA)—which have distributed different public health messages related to salt. KAB was
assessed in the multinational longitudinal World Health Organization (WHO) study on
global AGEing and adult health (WHO-SAGE) Wave 2 (2014–2015). Respondents were
randomly selected across both countries—Ghana (n = 6746; mean age 58y old; SD 17; 41%
men; 31% hypertensive) and SA (n = 3776, mean age 54y old; SD 17; 32% men; 45%
hypertensive). South Africans were more likely than Ghanaians to add salt to food at the
table (OR 4.80, CI 4.071–5.611, p < 0.001) but less likely to add salt to food during cooking
(OR 0.16, CI 0.130–0.197, p < 0.001). South Africans were also less likely to take action to
control their salt intake (OR 0.436, CI 0.379–0.488, p < 0.001). Considering the various salt
reduction initiatives of SA that have been largely absent in Ghana, this study supports
additional efforts to raise consumer awareness on discretionary salt use and behaviour
change in both countries.

This data was presented at a conference in Accra, Ghana:
Menyanu E, Charlton K. Salt use behaviours of Ghanaians. International Conference on
Non-Communicable Diseases in Ghana February 15-16, 2019. Noguchi Memorial Institute
of Medical Research, University of Ghana. Ghana.
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4.1 Introduction
The Global Burden of Disease study has demonstrated that diet contributes significantly to
risk of non-communicable diseases (NCDs) such as cancer, cardiovascular diseases (CVDs)
and diabetes [1]. Dietary risk factors include diets low in fruits, vegetables, whole grains,
nuts and seeds, fibre, omega-3 oils, and polyunsaturated fatty acids and diets that are high
in Na, red meat, processed meat, sweetened beverages, and trans fats [2,3,4,5,6]. The
nutrition transition in many Sub-Saharan countries is resulting in a change in dietary
patterns from traditional, plant-based diets to increasing intakes of processed foods that
tend to be high in sugar and/or fat, known as energy dense, nutrient poor (EDNP) foods
that are generally also high in salt [7]. Excess salt intake has been identified as one of the
leading global health risks [8] and population level salt reduction is recognized as a costeffective means of reducing BP [9,10,11,12] and, in turn, reducing the risk of heart disease
and stroke [13,14]. A 30% reduction in population level salt by 2020 is one of the voluntary
global health targets identified by the WHO [7].
On a global scale, it has been estimated that 1.7 million lives could be saved annually if salt
consumption levels were decreased to recommended levels of less than 5g per day [15].
Across high and low-middle income countries, interventions to reduce population salt
intake are considered cost effective (less than $1USD per person per year) [16, 17].
Over 75% of cardiovascular deaths take place in low and middle-income countries [18] with
the African region estimated to have around 20 million people with CVD [18]. As such,
Africa shares the greatest burden of hypertension with almost half of adults aged 25 and
older diagnosed and potentially more adults with undiagnosed, untreated and uncontrolled
hypertension [19]. In Ghana, the prevalence of hypertension has continued to rise over the
past 40y [20, 21, 22]. South Africa (SA) equally shares a large burden of hypertension [23,
24]. The direct healthcare costs attributable to non-optimal BP in Sub-Saharan Africa (SSA)
in 2001 were estimated to be two billion US dollars [25].
Despite the global targets to reduce the burden of NCDs, there are still limited examples of
effective strategies to reduce population‐level dietary salt consumption globally, especially
from African countries [26, 27]. In most African countries, salt is commonly added to food
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at the table and during cooking, and is a major ingredient found in commonly used sauces
and seasonings [28, 29]. Salted fish and meat are eaten frequently [30] while bread contains
levels of salt that are generally higher than in countries in Europe and North America [31,
32]. In SA, other sources of salt include cereals, meat and meat products, milk and dairy
products, processed meats, meat pies and margarine. In that country, it is estimated that
discretionary salt intake accounted for almost half of the total dietary intake in a sample of
black urban dwelling people [33]. This represents a greater contribution as compared to
many high-income countries, where 75–85% of dietary salt intake is estimated to come from
processed foods [34]. The Ghana Demographic and Health Survey indicated that 84% of
women surveyed reported that someone in their household had consumed processed foods
containing salt within the past 24 hours, while more than a third had consumed salted dried
fish, 21% reported having had canned fish, meat and legumes and 24% reported the use of
other processed foods containing salt [35]. The report identified a high use of salty foods in
both rural and urban areas. Similarly, the South African Demographic and Health Survey
2003 indicated that more than 30% of survey respondents reported adding salt to food at
the table and consuming salty snacks more than twice a week [36].
To reduce discretionary salt consumption in SA, there has been a concentrated focus on
consumer education and awareness in recent years [37]. In addition, in June 2016, the SA
government implemented mandatory legislation related to maximum levels of salt
permitted in a wide range of processed food categories, including breads, meats, cereal
products, fat spreads, snack foods and savoury products [38]. These foods have previously
been shown to contribute significantly to overall non-discretionary salt intake in the South
African population [33]. In contrast, in Ghana, there have been no concerted efforts by
government or non-governmental organizations to implement salt reduction strategies.
Instead, there has been a focus on the prevention of iodine deficiency through universal salt
iodization programmes [39, 40, 41] with the message to consume iodized salt widely
disseminated through the mass media [39]. Public health concerns related to the association
between increased salt intake and cardiovascular risk in Ghana have received
comparatively little attention despite promising proof of concept studies [42]. Iodization
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programmes and salt reduction strategies are not mutually exclusive, as has been
demonstrated [43]. However, for both programmes to successfully coexist, different sectors
of government (nutrition and NCDs) need to work together, to effectively monitor the
iodine status of populations as salt content in the food supply decreases.
Given that the population in Ghana has been urged to consume iodized salt [39,40,44]
combined with the generally increased accessibility of EDNP processed foods, it is timely to
investigate knowledge, attitudes and behaviours (KAB) related to salt use in Ghana and to
compare these against SA, an African country in which salt reduction has been strongly
emphasized. Ghana and SA share similar socio-demographic characteristics, as well as a
high hypertension burden. The findings will be important—particularly for low and
middle-income countries—for informing approaches to reducing the health risks through a
better understanding of salt intake behaviours.
4.2. Methods
The study methodology has been comprehensively described in Chapter two. Specific to
this chapter, WHO-SAGE Ghana/SA W2 dataset was utilized. A total of 10,522 adults were
recruited: n = 6746 in Ghana and n = 3776 in SA. In selecting the sample, all WHO-SAGE W1
households were included for WHO-SAGE W2 data collection [45]. Field teams used an 11month period (September 2014 to June 2015) and a 5-month period (August to December
2015) to complete data collection in Ghana and SA, respectively.
4.2.1 Study Measures
The main outcome of this analysis relates to reported salt KAB captured using a five-item
questionnaire adapted from the WHO/PAHO protocol [46]. KAB is the usual term for such
research and has been widely used in the context of salt behaviours [47, 48, 49, 50]. The
congruence between attitudes and perceptions has been explored [50], but for the purposes
of comparison with other studies we prefer to retain the terminology of “attitudes”. Age,
sex, residential location (urban/rural), education, marital status, employment status, alcohol
intake, smoking status, blood pressure (BP) and salt behaviour variables were recorded, as
110

shown in Table 4.1.

Approval for the study and informed consent statements from

participants have been described in Chapter 2.
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Table 4. 1 Sociodemographic characteristics and selected health characteristics of the study samples in Ghana and South
Africa, Study on Global Ageing and Adult Health (SAGE) Wave 2.

Age Categories—Countries Combined
Characteristics

18–49 years
old (n = 2279)

50+ years
old (n =
5860)

p
Value

Age in years, median (IQR)
50 plus years, n (%)
n = 2277
Sex male, n (%)

871 (38.3)

Residence urban, n (%)

n = 2110
1176 (55.7)

Ghana
n = 4753

South
Africa
n = 3392

p
Value

n = 4743
58 (19.0)
3569 (75.2)

n = 3396
54 (24.0)
2291 (67.5)

<0.01
<0.01

n = 5857
2171 (37.0)

0.32

n = 4753
1954 (41.1)

n = 3392
1094 (32.3)

<0.01

n = 5560
2918 (52.5)

0.01

n = 4728
1970 (41.6)

n = 2924
2124 (72.8)

<0.01

n = 5546
3327 (60.0)

<0.01

n = 4734
2764 (58.4)

n = 2920
2402 (82.3)

<0.01

n = 5493
1646 (30)

<0.01

n = 4706
678 (14.4)

n = 2886
696 (24.1)

<0.01

n = 4832
2611 (54.0)

<0.01

n = 4537
3169 (69.8)

n = 1768
566 (32.0)

<0.01

Education
Ever attended school, n
(%)
Educational level high
school or above, n (%)
Employment status:
currently working, (%)

n = 2108
1839 (87.2)
n = 2099
1164 (55.5)
n = 1473
1124 (76.3)
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Age Categories—Countries Combined
Characteristics

Marital status:
married/cohabiting, n (%)
Waist to height ratio <0.5, n
(%)
Body Mass Index (BMI),
median (IQR)

18–49 years
old (n = 2279)
n = 937
231 (24.7)
n = 1853
693 (37.4)
n = 1904
25 (7.7)

Ghana
n = 4753

South
Africa
n = 3392

p
Value

<0.01

n = 4738
2692 (56.8)

n = 2921
915 (31.3)

<0.01

<0.01

n = 4347
1553 (35.7)

n = 2313
509 (22.0)

<0.01

50+ years
old (n =
5860)

p
Value

n = 1984
684 (34.5)
n = 4807
1369 (28.5)
n = 4883
24.2 (8.4)

<0.01

n = 4456

n = 2331

22.9 (6.2)

28.6 (9.9)

<0.01

Alcohol intake
Never n (%)

n = 1597
397 (24.0)

Recently yes, n (%)

n = 515
351 (68.2)

Frequent, n (%)

n = 508
203 (40.0)

Smoking status, current use
of tobacco, n (%)

n = 1616
137 (8.5)

Systolic blood pressure mm
Hg, median (IQR)

n = 2030
119 (20.0)

n = 1625
400 (24.6)

0.87

n = 1168

n = 2054

786 (67.3)

1639 (80.0)

<0.01

n = 1379
912 (66.1)

0.41

n = 1379
916 (66.4)

n = 515
347 (67.4)

0.69

n = 1371
595 (43.4)

<0.01

n = 1369
635 (46.4 )

n = 510
163 (32.0 )

<0.01

<0.01

n = 1340
208 (15.5)

n = 2160
403 (18.7)

0.06

<0.01

n = 4674
124.67
(28.0)

n = 2726
130.7 (26.0)

<0.01

n = 1884
474 (25.2)

n = 5370
131 (28.0)
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Age Categories—Countries Combined
Characteristics

Diastolic blood pressure mm
Hg, median (IQR)

18–49 years
old (n = 2279)
n = 2030
75.7 (15.0)

50+ years
old (n =
5860)

p
Value

n = 5370
79.3 (17.0)

<0.01

Ghana
n = 4753

South
Africa
n = 3392

p
Value

n = 4674
77 (16.0)

n = 2726
80.67 (16.0)

<0.01

n = 2079
n = 5455
n = 4675
n = 2859
<0.01
<0.01
401 (19.3)
2320 (42.5)
1444 (30.9) 1277 (44.7)
Data recorded as median (inter quartile range) and frequencies (%). Smokers identified by self-report. Frequent alcohol use
defined as the consumption of one or more alcoholic drinks a day/week. Hypertensive categorized as BP ≥ 140/90 mm Hg
or previous diagnosis. Continuous variables were compared using the Independent Samples Mann Whitney U test;
categorical variables were compared using the Chi-Square test.
Hypertensive, n (%)
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4.2.2 Statistical Analysis
All data were collated and analysed using IBM SPSS Statistics for Windows, Version 20.0.
(IBM Corp., Armonk, NY, USA). The normality of the data was checked by visual inspection
and the Kolmogorov-Smirnov test. Descriptive statistics of frequencies, percentages and
median (IQR) were used to describe respondents’ characteristics and responses to survey
items. Country differences were evaluated using Chi-square and Independent Samples
Mann Whitney U tests. The significance level was set at p < 0.05. Logistic regression was
applied to compare the probability of various salt behaviours between Ghana and SA and
odds ratios and 95% confidence intervals (95% CI) were computed. The model was adjusted
for potential confounders which included age, sex, residential location, educational level
and hypertension prevalence as demonstrated in other studies [51-53]. BMI was not
included in the final regression model as it was not statistically significant.
4.3 Results
Approximately 30% of the recruited samples in both countries had data that could not be
retrieved due to technical and data management issues during data collection and retrieval
using the CAPI system. This loss of data was non-systematic and the sample size on which
the current analysis is based is on a total samples size of n = 8145 (by sex). As such, in the
sample for Ghana (41.1% (n = 1954) were male and 58.9% (n = 2799) were female, 75.2% (n =
3569) aged 50+y old and 24.8% (n = 1174) aged 18–49 years old) and for SA (32.2% (n = 1094)
were male and 67.8% (n = 2298) were female, 67.5% (n = 2291) aged 50+y old and 32.5% (n =
1105) aged 18–49y old). The characteristics of the population are presented in Table 4.1. Due
to non-responses for some questionnaire items, the number of responses (n) for each
variable is included in the tables. Significant differences were recorded between the two
countries, with more older people (Ghana 75.2%; SA 67.5%; p < 0.01) and more men (Ghana
41.1%; SA 32.3%; p < 0.01) in Ghana than in SA, whereas SA had more urban residents
(Ghana 41.6%; SA 72.8%), and more participants from SA had a higher educational status
(Ghana 14.4%; SA 42.1%) and a higher level of hypertension prevalence (SA 44.7%; Ghana
30.9%; p < 0.01)
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4.3.1 Knowledge
Approximately one-third (31.3%; n = 2190) of all respondents were not aware that a high salt
diet could cause a serious health problem. This was consistently observed among older and
younger adults, men and women and across both countries (Table 5.2). Significant
associations were recorded between respondents’ knowledge and their ethnicity within the
South African cohort. Those with a “coloured” ethnic background recorded the highest
knowledge (84%, p < 0.01).
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Table 4. 2 Association between salt knowledge, attitudes and behaviours (KAB) and demographic characteristics of
Ghanaians (n = 6746) and South Africans (n = 3776); younger (n = 2279) and older (n = 5860); men (n = 3048) and women
(n = 5860), SAGE Wave 2.

Age Category—Countries

Sex—Countries Combined

Combined
18–49 years

50+ years

old

old

n = 2279

n = 5860

cause a serious

n = 1940

n = 5061

health problem?

1309 (67.5)

3502 (69.2)

n = 2047

n = 5392

1613 (78.8)

3957 (73.4)

at the table?

n = 1453

n = 4026

“Always” and

311 (21.4)

673 (16.7)

Ghana

SA
p

p

Men

Women

p

Value

n = 3048

n = 5097

Value

n = 4753

n = 3392

n = 4328

n = 2673

Value

Do you think that a
high salt diet could
0.16

n = 2602
1756 (67.5)

Yes n (%)

n = 4399

2920

1891

(69.4)

3055

0.09

(67.5)

(70.7)

n = 4635

n = 4622

n = 2817

3510

2060

(75.9)

(73.1)

n = 3552

n = 1927

350 (9.9)

634 (32.9)

<0.01

How much salt do
you
think you
consume?
Just the right

<0.01

n = 2804
2176 (77.6)

3394

<0.01

(73.2)

<0.01

amount, n (%)
Do you add salt to
food

“Often” n (%)

<0.01

n = 2024
393 (19.4)

n = 3455
591
(17.1)

0.31

<0.01
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Age Category—Countries

Sex—Countries Combined

Combined
18–49 years

50+ years

old

old

n = 2279

n = 5860

n = 1822

n = 4771

1689 (92.7)

4310 (90.3)

n = 1990

n = 5249

688 (34.6)

2034 (38.8)

Ghana

SA
p

p

Men

Women

p

Value

n = 3048

n = 5097

Value

n = 4753

n = 3392

n = 4459

n = 2134

4294

1705

(89.7)

(96.3)

(79.9)

n = 4521

n = 4518

Value

In the food you eat
at home,
salt is added in
cooking…?
“Always” and

0.03

n = 2552
2374 (93)

n = 4041
3625

<0.01

<0.01

“Often” n (%)
Do you do
anything on
a regular basis to
control
your salt or sodium

0.01

n = 2718
970 (35.7)

1752
(38.8)

<0.01

1939
(42.9)

n = 2721
783 (28.8)

<0.01

intake? Yes n (%)
Note: “All” represents respondents from both countries. Data was recorded in frequencies. Chi square tests were conducted.
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4.3.2 Attitudes
Three quarters (74.9%; n = 5570) of all respondents perceived that they consumed just the
right amount of salt. The perception of consuming “just the right amount of salt” was more
frequently observed in younger adults, men, and in Ghanaians compared to South Africans.

4.3.3 Salt intake behaviours
Among all respondents, 18% (n = 984) reported that they “always” and “often” (frequently)
added salt to food at the table and the majority (n = 5999, 91%) reported that they frequently
added salt to food at home during cooking. Almost two-thirds (62.4%) reported that they
did not take any action to control their salt intake. The response to “taking actions to control
salt intake on a regular basis” significantly differed according to knowledge about salt
(knowledge and health, p < 0.001). For the two countries, fifty-two percent of respondents
who did not think high salt could cause health problems reported that they never took
actions on regular basis to reduce salt intake. Reported frequent alcohol intake was found
to relate to less desirable salt intake behaviours. While 96.7% of respondents reporting
frequent alcohol intake (n = 1971) also reported always or often adding salt to food while
cooking, this behaviour was significantly lower (86.1%) in teetotallers (n = 756; p < 0.01).
Additionally, significantly more teetotallers (51.0%) reported regularly attempting to
control their salt intake when compared with frequent drinkers (33.7%; p < 0.01). Significant
associations were recorded between respondents who frequently added salt to food at the
table and their ethnicity within the South African cohort. Those with African/black ethnic
background reported adding more salt to food at the table than any other group (36.5%, p <
0.01).
Younger adults more frequently added salt to food at the table, added salt to food eaten at
home during cooking and did less on a regular basis to control their salt intake than did
older adults (Table 4.2). More South Africans than Ghanaians reported that they frequently
added salt at the table (SA 32.9%; Ghana 9.9%; p < 0.001) and did not take actions to control
their salt intake (SA 28.8%; Ghana 42.9%). Significantly more Ghanaians than South Africans
reported frequently adding salt to food during cooking (SA 79.9%; Ghana 96.3%; p < 0.01).
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Multivariate analysis adjusted for sex, age, residence, educational level and hypertension
prevalence showed that South Africans were more likely than Ghanaians to add salt to food
at the table (OR 4.80, CI 4.071–5.611, p < 0.001) but less likely to add salt to food at home
during cooking (OR 0.16, CI 0.130–0.197, p < 0.001) or to take action to control their salt
intake regularly (OR 0.44, CI 0.379–0.488, p < 0.01); (Table 4.3). Men and younger adults
were also significantly more likely to add salt to food and less likely to control salt intake.
Those living in urban areas, educated to high school level or above, or those with
hypertension were significantly more likely to regularly control their salt intake.

120

Table 4. 3 Associations between sociodemographic variables and salt behaviours of adults in Ghana (n = 6746) and
South Africa (n = 3776) - comparing the odds ratio for sub-optimal salt behaviours, SAGE Wave 2.

Salt Frequently
Added to Food
at the Table

Salt Frequently
Added to Food
during Cooking

Takes Regular
Action to Control
of Salt Intake

OR (95% CI)

OR (95% CI)

OR (95% CI)

Referent
4.80 (4.071–5.611) *

Ref
0.16 (0.130–0.197) *

Ref
0.436 (0.379–0.488) *

Referent
1.40 (1.182–1.605) *

Ref
1.36 (1.118–1.654) *

Ref
0.78 (0.718–0.884) *

Referent
0.78 (0.655–0.920)*

Ref
0.56 (0.450–0.711) *

Ref
1.23(1.096–1.384) *

Referent
0.89 (0.762–1.041)

Ref
0.90 (0.744–1.099)

Ref
1.41 (1.271–1.565) *

Primary school and
below
High school and above

Referent
0.87 (0.741–1.020)

Ref
0.86 (0.710–1.048)

Ref
1.12 (1.004–1.240) *

Normotensive
Hypertensives

Referent
1.11 (0.952–1.299)

Ref
0.88 (0.734–1.067)

Ref
1.48 (1.328–1.649) *

Variables

Ghana
SA
Female
Male
18–49y old
50+y old
Rural
Urban

Note: Referent indicates reference category used for the comparison. Hypertension was categorized as
BP ≥ 140/90 mm Hg or previous diagnosis, logistic regression was adjusted for sex, age category, residence,
educational level and hypertension prevalence, * p < 0.05
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4.4 Discussion
The finding that 80% or more of adults in Ghana and SA frequently add salt to their food
during cooking indicates that discretionary salt use remains high in both countries.
Significant differences were observed between the two countries for various behaviours,
such as a third of South Africans reported adding salt to food at the table as compared to
only a tenth of Ghanaians. Significant differences were also observed between younger and
older adults and between the genders. The most potentially detrimental behaviours were
identified in men and younger adults. The contribution of discretionary salt intake to total
salt intake cannot be under-emphasized even in societies where most salt comes from
processed foods. Health promotion activities are needed to decrease individual level salt
intake [7] in order to decrease salt preferences over time and thus decrease discretionary salt
use [7,36,54].
Knowledge related to the adverse effects of salt on health was poor. Almost one third (n =
2190) of both Ghanaians and South Africans were not aware of the relationship between
high salt intake and the possibility of a serious health problem. This could potentially
explain practices of high discretionary salt use [51, 55, 56]. Conversely, individuals who
know about the health effects of excess salt in the diet have been shown to be more likely to
reduce their salt intake [47]. Knowledge of hypertension may influence both salt and selfcare behaviours [57]. Our results show that responses to salt knowledge, attitudes and
behaviours are significantly related as shown by other authors [52].
Our data indicates participants’ high confidence in their perceived intake of the
recommended levels of salt, since three-quarters of respondents reported that they
consumed “just the right amount of salt.” A limitation of this study relates to potential
under-reporting of salt use, as shown in other studies [47, 50, 58, 59] and responses to salt
questions may not reflect actual intakes. Studies that measured 24 h urinary Na excretion in
addition to self-reported discretionary salt use in the same respondents revealed an
underestimation in reported salt intake [33, 60]. Hypertension levels were high in both
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samples, but we did not investigate whether hypertensive individuals that were receiving
treatment to control their BP had also received advice on salt intake. There is a possibility of
misreporting, as those who have received information on salt use may feel that they
consume the recommended amount. Furthermore, there might be some lack of knowledge
relative to the amount of salt recommended for daily consumption, as was the case in other
studies [52]. This discrepancy between perceived and actual salt consumption has the
potential to result in higher than anticipated salt intakes [61].
Our data indicates a need to intensify consumer education on salt intake awareness in both
countries, including discretionary salt use. Previous research contributing to South African
policy change [33] suggests that further investigation into particular food items that
contribute high amounts of salt to the diet is needed in Ghana. Consistent with other studies
[52], more attention should be directed towards the younger population (18–49y old) and to
men, who reported worse discretionary salt knowledge, attitudes and behaviours. Dietary
salt education and awareness should also be integrated into school curricular and youth
programmes, particularly as hypertension and associated morbidity and mortality typically
occur at younger ages in Sub Saharan Africa (SSA) [62, 63].
Our finding that Ghanaians add more salt to food at home during cooking compared with
their South African counterparts may not be surprising given investment in campaigns to
increase consumption of iodized salt [64-66]. Within Ghana, any action related to salt
reduction for addressing NCDs appears to have been overshadowed by the strong focus on
the prevention of iodine deficiencies [39,40,41,66]. This situation appears in contrast to
WHO guidelines [14], which suggest compatibility of polices on salt reduction and salt
iodisation. The guidelines advise that regular monitoring of salt intake and iodine intake at
country level is needed to adjust salt iodisation over time to ensure that individuals
consume sufficient iodine while reducing overall intake of salt. If salt is sufficiently iodised,
a reduction of salt intake to the recommended level of 5 g per day should still provide an
adequate amount of iodine [43]. Ghana’s strong emphasis on the reduction of iodine
deficiencies provides a unique and untapped opportunity for addressing discretionary salt
use and behaviour change. Salt used in food processing is not included in the mandatory
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Universal Salt Iodisation policies in either Ghana or SA, although there is some evidence
from SA that indicates up to a third of margarines, bread, and savoury snack seasonings
contain iodised salt [67].
We found that South Africans were almost 5 times more likely than Ghanaians to add salt
to food at the table (controlling for sex, age, location, education level and hypertension
prevalence). This finding was expected, as a greater proportion of the cohort in SA lived in
urban areas compared with Ghana. Urbanization is one of the key drivers for excess salt
consumption [15]. Further investigation regarding the effect of acculturation on addition of
salt to food is of interest. The survey was conducted prior to salt legislation being introduced
in SA, therefore it will be of importance to determine how the lowering of salt in processed
foods impacts on both discretionary salt behaviours and actual salt intake levels in SA in the
next wave of SAGE in 2017–2018.
The present study shows that almost two-thirds of the population were not taking any
action to control their salt intake, and this may be explained by the finding that a third of
respondents did not have any knowledge regarding the links between high salt intake and
health problems. Among the key broad strategies for salt reduction is individual
responsibility and action [7], for example, limiting the consumption of salty snacks and
reducing the amount of salt used in cooking. The Health Belief Model explains that
perceived seriousness, perceived susceptibility, perceived benefits and perceived barriers
are critical evaluations an individual undertakes prior to engaging in a health behaviour
[68]. Our data suggests that strategies are required to firstly increase awareness within the
Health Belief Model of health promotion as a means of supporting behaviour change. The
other broad strategy is at a systemic level-including measures like those adopted in SA to
work with food manufacturers to lower salt levels in processed foods.
The findings of the present study were somewhat surprising because, despite the extensive
public awareness campaign in SA to address population salt intake levels and influence salt
related behaviour (Salt Watch) [37,69] and despite that population reporting greater salt
knowledge, it was the Ghanaians who appeared to be more actively controlling their salt
intake (Table 2). This highlights the point that knowledge alone is not sufficient to cause a
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change in behaviour. Consistent with the present study, research from Newson et al. (2013)
[58] showed that almost half of survey respondents were not interested in reducing their
salt intake and had no intention of making any changes to their salt consumption in the
immediate future. With a large hypertension burden [24], it is likely that some South
Africans may not feel empowered to make dietary changes. Additionally, cultural beliefs
and practices that encourage salt consumption are also of concern. Salt use for spiritual and
religious purposes is commonplace in SA [37] and this would need to be considered in
health messages.
The finding that frequent alcohol intake was associated with less desirable salt intake
behaviours has been reported by others [70]. Differences in reported alcohol intake between
Ghanaian and South African study participants are similar to previous analyses of alcohol
consumption from Wave 1 of SAGE which indicated that there were fewer “never” drinkers
(lifetime abstainers) in Ghana than in SA, while the South African cohort had more “at risk”
drinkers [71].
It is well established that reducing dietary salt to 3 g/day leads to a reduction in BP in both
in hypertensives and normotensives [72]. Given the current estimated prevalence of
hypertension in the African region, it is imperative that salt reduction messages are included
in public health campaigns alongside various strategies to support behaviour change while
also modifying salt levels in commonly consumed foods. Provision of practical skills and
strategies to encourage change in salt intake behaviours is key in this regard.
The present study had several strengths which included the use of large, nationally
representative sample sizes in both SA and Ghana. A potential limitation relates to the use
of questionnaire, which might be subject to recall bias and may lead to over reporting or
under reporting. Additionally, oversampling of older people in keeping with the purpose
of the SAGE may limit generalizability of the findings to the population younger than 50 in
both countries. Regardless, these are relatively large representations of the 50+ population,
with younger comparison groups in both countries.
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4.5 Conclusions
This study provided important insights into salt knowledge, attitudes and behaviours
(KAB) in SSA. High discretionary salt use remains common practice in the region and needs
urgent attention in the face of high and rising hypertension levels. Significant differences in
salt KAB were evident between the two countries which suggests the use of different
strategies and approaches for combatting high discretionary salt intake may be appropriate,
although strategies particularly targeting men and younger adults may be beneficial for
both countries. The findings suggest that SA requires investment into public health
campaigns to address the practice of adding salt to foods at the table, while in Ghana a focus
on changing behaviours related to the use of salt in cooking is required. Campaigns and
consumer education strategies—based on the Health Belief Model—may be useful to raise
awareness for salt reduction in SSA.
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Chapter 5
High salt and low potassium intake among adult
Ghanaians: WHO-SAGE Ghana Wave 3
This chapter highlights salt and K intake and their association with BP. The chapter also
draws a relationship between salt intake and salt behaviours.

This chapter is the substantive content of the published work:
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Abstract
Though Ghana has high hypertension prevalence, the country lacks current national salt
consumption data required to build and enhance advocacy for salt reduction. We compared
the characteristics of a nationally representative sample of the World Health Organization’s
Study on global AGEing and adult health (WHO-SAGE), Ghana (n = 3053) and a randomly
selected sub sample (n = 839). We also investigated the relationship between salt intake and
BP among adult Ghanaians in the sub sample (median age = 60, cohort formed 27.5% of the
WHO-SAGE Wave 3 Ghana study). BP was measured in triplicate and 24hr urine was
collected for the determination of urinary Na, K, creatinine (Cr) and iodine levels.
Hypertension prevalence was 44.3%. Median salt intake was 8.3g/day, higher in women
compared to men (median 8.6, interquartile range (IQR) 7.5g/day vs 7.5, IQR 7.4g/day, p <
0.01), younger participants (18-49 yrs) compared to older ones (50+ yrs) (median 9.7, IQR
7.9g/day vs 8.1, IQR 7.1g/day, p < 0.01) and those with higher Body Mass Index (BMI) > 30
compared to a healthy BMI (18.5-24.9) (median 10.04, IQR 5.1g/day vs 6.2, IQR 5.6 g/day, p
< 0.01). More than three quarters (77%, n = 647) of participants had salt intakes above the
WHO maximum recommendation of 5g/d, and nearly two thirds (65%, n = 548) had daily K
intakes below the recommended level of 90mmol. Dietary Na: K ratios above 2mmol/mmol
were positively associated with increasing BP with age. Population-based interventions to
reduce salt intake and increase K consumption are needed.
Key words: hypertension, salt intake, potassium, 24hr urine, Ghana

134

5.1 Introduction
Cardiovascular diseases (CVDs) remain a major contributory factor for mortality and
morbidity worldwide, accounting for 17.9 million deaths in 2016, and representing a third
of all deaths globally [1]. While LMICs already share the greatest impact of CVD-related
deaths, with rates of 300–600 deaths per 100,000 population, these are predicted to increase,
causing premature, avoidable loss of lives [2]. Hypertension is a major risk factor for CVD
and accounted for more than 50% of CVD-specific deaths in 2012 [3]. It has been estimated
that the burden of hypertension will increase to approximately 1.56 billion people globally
by 2025, with larger populations of hypertensives living in LMICs [3-5].
Hypertension is a common condition in Ghana, where its prevalence has increased more
than two-fold over just two decades (1988-2007) [6]. A recent nationally representative
study among participants largely 50y and older, in Ghana, reported the prevalence of
hypertension to be 58.9% in adults with about one-fifth of those with hypertension being
aware of having the condition [7]. Reducing population-level prevalence of hypertension by
30% by the year 2030 is identified by WHO as one of the nine voluntary global targets to
reduce non communicable diseases (NCDs) [8]. Salt reduction has been identified by the
WHO as one ‘best buys’ approach to reduce overall CVD risk through lowering of (BP) [9].
Increased consumption of salt (>2 grams Na/day, equivalent to 5 g salt/day) together with
insufficient K intake (< 3.5 grams/day) are strongly associated with a number of NCDs
including hypertension [10-14]. Several systematic literature reviews, meta-analyses and
randomized-controlled trials have shown that reduced Na consumption results in a decline
in BP in both hypertensives and normotensive adults [13-17], which saves lives [18]. In view
of this, ‘WHO’s SHAKE the Salt Habit’ resource has emphasized the importance of
measuring and monitoring population salt consumption patterns in order to inform
stakeholders about strategies to reduce salt intake and evaluate the effect of any
implemented salt reduction programmes [19]. Though Ghana is committed to the World
Health Assembly’s target of 30% relative reduction in the population salt intake by 2025
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[10], the country has made slow progress towards achieving the target due to other
competing public health priorities and limited resources [20].
Few studies have been conducted to assess salt intake in the Ghanaian population [21]. A
lack of recent, nationally representative data on population salt consumption among adults
has further been a disincentive for advocacy around salt reduction efforts [22]. The current
study was undertaken to obtain a reliable estimate of population salt intake and salt use
behaviour, and to assess the relationship between salt and K intake with BP in Ghanaian
adults.
5.2 Methods
The study methodology has been described in Chapter two. Specific to this chapter, WHOSAGE Ghana W3 dataset was used. Data collection was completed over a period of one year
(July 2018 - June 2019) with n = 1100 24hr urine samples collected nationwide. Out of 3053
participants recruited for WHO - SAGE Ghana Wave 3, 102 (36.1%) were randomly selected
to provide urine samples (nested sub study). Of these, 76.7% (n = 844) had successful (BP)
data and 88.6% (n = 976) had complete urine samples. However, fewer participants (n = 839)
had a complete urine collection, accompanied with survey, anthropometric and valid BP
data (Figure 5.1).
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Main cohort

Nested cohort

N = 4449 participants interviewed

N = 1121 urine samples collected

Deleted:



15 duplicated barcodes
2 triplicated barcodes

N = 1102 samples

N= 16 urine samples replaced with
validation data

N = 957 common subjects (main & nested)
N = 865 with valid urine measurement
(cut-off: Volume≥300ml)

Deleted:






164 urine data only
477 no age recorded
32 low volumes
56 invalid Na figures

N = 3053 main cohort
N = 839 nested cohort

Figure 5. 1 Study flow chart.
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The 24hr urine was collected, thoroughly mixed, volumes recorded, 3 aliquots of 5ml were
generated, and samples kept in cold boxes and transported to NMIMR-UG for Na, K and
Cr analyses. Additionally, iodine was assessed for analysis because Ghana had a universal
iodine programme in place.
Creatinine excretion in this population was much lower than that reported for many other
populations, from which Cr cut-off values have been determined to indicate completeness
of 24hr urine collection [23]. Because of this, only urine volume was used to indicate whether
urine samples were considered to represent completeness. This approach has been used in
other

multi-country

studies

including

the

International

Population

Study

on

Macronutrients and Blood Pressure [INTERMAP] and the International Study of Sodium,
Potassium, and Blood Pressure [INTERSALT] [24]. In the first enumerator areas (EAs)
sampled within the Accra region, some calculated salt values were unfeasibly high (> 40g/d,
n = 40,) due to unacceptable storage conditions [25]. A follow-up validation study conducted
in n = 67 participants included the collection of repeated 24hr urine samples from the same
participants in one EA (Alajo; n = 19), while an additional two non-urine EAs from the larger
survey sample were visited as a comparator (Mataheko; n = 24 and Nima; n = 24). A second
laboratory (Liberty Medical Laboratory, Accra) also performed duplicate analyses in the
validation study. Values for Dosise EA (n = 23) were excluded after the validation study
because they were confirmed as being unfeasible, and the validation study values replaced
original measures for the case of Alajo (n = 16; 3 barcodes of urine samples in validation
study were excluded because they could not be matched with those of the original study)
(Supplementary Table 5.1).
The ratio Na (mmol/L) to K (mmol/L) was created (Na:K) and categorised as low (<2),
medium (2-5) or high (>5). Mean Arterial Pressure (MAP) is the average arterial pressure
throughout one cardiac cycle, systole, and diastole. MAP was calculated using the formulae:
MAP = SBP + 2 (DBP)/3 [26]. Hypertension status was measured as self-reported treatment
or having a measured BP ≥ 140/90mm Hg. Hypertension prevalence, awareness, treatment
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and control were measured. Individuals with no current medication use and a measured BP
<140/90 mm Hg were categorized as non-hypertensive.
5.2.2 Statistical Analysis
Data were analysed using Stata Statistical Software: Release 15 (Stata Corp LLC, 2017;
College Station, USA). Data distribution was checked visually and with the Shapiro Wilks
test for normality. Descriptive statistics of frequencies, percentages and median
(interquartile range, IQR) were used to describe participants’ characteristics. Categorical
variables were evaluated using frequencies, Pearson’s Chi-Square and Fisher’s Exact tests.
Comparison between groups for non-parametric data was examined using Mann-Whitney
U and Kruskal-Wallis tests and Spearman’s Rho was used to test for correlations. Linear
regressions were used to evaluate the associations between variables. To test regression
slopes for equality between the three salt level groups and between the three Na:K ratio
groups, the interaction terms of groups with age was added into the models. To test if a
difference in the group’s coefficients (i.e. slope) was present, the F test was applied. If
significant, post-estimation was pursued to identify which group differed from the others.
5.3 Results
Table 5.1 compares sociodemographic characteristics of the nested sub study sample with
those included in the total Wave 3 survey collection.
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Table 5. 1 Demographic profile of SAGE GHA W3 survey participants and subsample
with valid urine data (urine data considered valid if volume ≥ 300ml)

Characteristics

Main SAGE

Salt sub study

P-value

cohort

sample

(n=3053)

(n=839)

Years

60 (20)

60 (19)

0.3294

18-49y , n (%)

717 (23.5)

174 (20.7)

0.0100

2336 (76.5)

665 (79.3)

0.4494

Age

50+y, n (%)
Sex, n (%)

0.001

Men

1183 (38.8)

371 (32.3)

Women

1870 (61.2)

568 (67.7)

Ethnicity, n (%)

<0.0001

Akan

1544 (50.6)

497 (59.2)

Ewe

216 (7.1)

58 (6.9)

Ga-Adangbe

224 (7.3)

45 (5.4)

Gruma

30 (1.0)

6 (0.7)

Grusi

76 (2.5)

12 (1.4)

Guan

38 (1.2)

16 (1.9)

Mande-Busanga

63 (2.1)

3 (0.4)

Mole-Dagbon

174 (5.7)

24 (2.9)

Other

612 (20.0)

174 (20.7)

Residence, n (%)

<0.0001

Urban

1301 (42.6)

457 (54.5)

Rural

1752 (57.4)

382 (45.5)

Marital status, n (%)

0.002

Never married

208 (6.8)

39 (4.6)

Married/cohabiting

1760 (57.7)

470 (56.0)

Separate/divorced

369 (12.1)

87 (10.4)

Widowed

715 (23.4)

243 (29.0)

Never been to school, n (%)

1119 (36.7)

240 (28.6)

<0.0001

Education (Years)

10 (5)

10 (5)

0.0139

Body Mass Index (BMI, kg/m2)

24.2 (6.8)

25.4 (7.4)

<0.01

Waist to height ratio

0.54 (0.11)

0.56 (0.13)

<0.01

Never used alcohol, n (%)

1865 (61.3)

483 (57.6)

0.052

Never used tobacco, n (%)

2739 (90.0)

759 (90.5)

0.68

Systolic BP (mm Hg)

124 (26.5)

126.5 (29)

<0.01

Diastolic BP (mm Hg)

76 (17)

76.5 (17)

0.83
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Characteristics

Main SAGE

Salt sub study

cohort

sample

(n=3053)

(n=839)

92.5 (19.2)

93.2 (20.7)

0.24

Hypertension, n(%)

1132 (37.6)

370 (44.3)

<0.01

Diabetes, n(%)

157 (5.2)

67 (8.0)

0.01

Mean Arterial Pressure (Map)
mm Hg

Portions of fruit, n(%)

P-value

0.05

Met WHO’s recommendation of
at least 5 servings of friuts and

1591 (57.4)

442 (54.5)

0.14

642 (21.1)

107 (12.7)

<0.01

2527 (83.0)

672 (80.1)

0.05

265 (8.8)

92 (11.0)

0.05

2247 (75.9)

651 (80.0)

0.02

1243 (42.1)

394 (48.5)

<0.01

vegetables
Frequently add salt to food at
table, n(%)
Frequently add salt to food
during cooking, n(%)
Believe they consume too much
salt, n(%)
Believe a high salt diet is bad for
health, n(%)
Regularly control of salt intake,
n(%)

Nested sub sample: all respondent with CAPI data and valid urine, sex and age recorded. Some
variables may contain missing data. Data are presented as median (IRQ) unless otherwise indicated.
Hypertensive by measured BP≥140 and/or 90 mm Hg or previous diagnosis (self-reported).
Ethnicity, marital status, education, alcohol/tobacco use and diabetes prevalence by self-report.
Mann-Whitney Test used to compare medians, Pearson Chi-Square test and Fisher’s Exact Test used
to compare proportional data.

Hypertension prevalence in the nested sub study was 44.3% (n = 370) with 41.4% and 46.1%
for men and women respectively. Of those with hypertension, 59.7% were aware of their
condition (n = 222) of which 69.1% (n = 154) were receiving prescribed antihypertensive
medication. Of those being treated for hypertension, 51% (n = 77) had controlled BP (ie BP
≤ 140/90).
Among participants with both urine, survey data and BP data (n = 839), median intake of
salt was equivalent to 8.3g/day (IQR 7.5) (mean = 10.2g ± 7.2). Salt intake was higher in: (1)
women compared to men; median 8.6 (7.5)g/day vs 7.5 (7.4)g/day, p < 0.01; (2) younger
participants (18-49 yrs) compared to older ones (50+ yrs); median 9.7 (7.9)g/day vs 8.1
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(7.1)g/day, p < 0.01; and (3) those with higher BMI (30+) compared to a desirable BMI (18.524.9); median 10.04 (5.1)g/day vs 6.2 (5.6)g/day, p < 0.01. There was no significant difference
in salt consumption between rural and urban dwellers. Overall, 77.7% (n = 647) of
participants had salt intakes above the WHO maximum recommendation of 5g/d, with
38.9% consuming more than twice this level (> 10g/d, n = 321) and 16.3% consuming more
than three times the recommended level (> 15g/d, n = 137). More men than women (27.1%
(n = 73) vs 19.9% (n = 122); p = 0.02) and older participants than younger ones (24.8% (n =
164) vs 12.1% (n = 21); p <0.01) achieved the WHO’ salt recommendation of ≤ 5g salt/day
(Supplementary Tables 5.2 and 5.3).
According to groupings by salt intake (low, < 5g/d; medium, 5-9g/d; high, > 9g/d), those
with higher salt intakes were significantly younger, had higher BMI, a higher urinary K
excretion, a higher urinary Na: K and lower urinary iodine concentrations. However, BP
and hypertension status did not differ between the groups (Table 5.2).

Table 5. 2 Nested cohort by salt excretion levels, low, medium and high salt
groups, WHO – SAGE Ghana Wave 3 (2019)
Characteristics

Low salt
<5g/d
(n = 186)

Age yrs
Sex male n (%)

64 (20)
n = 185
73 (39.5)

Ethnicity (%)
Akan

n = 184
122
(66.3)
7 (3.8)
14 (7.6)
5 (2.7)
1 (0.5)
3 (1.6)
0 (0.0%)
1 (0.5)
31 (16.8)
n = 185

Ga
Ewe
Mole-dagbon
Mole-busanga
Grusi
Guan
Gruma
Other
Urban (%)

Medium
salt
5-9g/d
(n = 269)
60 (17)
n = 269
90 (33.5)

High salt
>9g/d
(n = 378)

p
value

58 (18)
n = 378
105 (27.8)

< 0.01
0.02

n = 268
168 (62.7)

n = 376
203 (54.0)

0.03

11 (4.1)
18 (6.7)
6 (2.2)
0 (0.0)
3 (1.1)
11 (4.1%)
3 (1.1)
48 (17.9)
n = 269

27 (7.2)
24 (6.4)
13 (3.5)
2 (0.5)
6 (1.6)
5 (1.3)
2 (0.5)
94 (25.0)
n = 378

0.79
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Characteristics

Low salt
<5g/d
(n = 186)

Education (yrs)
BMI, kg/m2

Salt intake g/d

102
(55.1)
n = 118
10 (5)
n = 179
23.8
(6.5)a
n = 186
3.6 (1.5)ab
n = 186
32.0
(25.8)ab
n = 186
1.7 (1.2)ab
n = 150
166.2
(168.5)b
n = 186
129
(31.0)
n = 188
76 (18.0)

Medium
salt
5-9g/d
(n = 269)
149 (55.4)

High salt
>9g/d
(n = 378)

p
value

n = 179
10 (3)
n = 258
25.5 (7.8)

n = 250
10 (5)
n = 356
26.2 (7.5)a

0.07

n = 269
6.7 (2.0)ac
n = 269
54.9
(43.8)ac
n = 269
2.0 (1.4)ac
n = 211
148.2
(131.4)a
n = 266
126 (31.0)

< 0.01

200 (52.9)

<0.01

Pulse pressure, mm Hg

n = 266
49.5 (17.6)

n = 371
13.4 (8.9)bc
n = 378
112.3
(115.8)bc
n = 378
2.3 (1.9)bc
n = 292
117.6
(132.8)ab
n = 375
126.5
(29.0)
n = 379
77.5
(117.0)
n = 375
49.5 (16)

Mean Arterial
(MAP), mm Hg

n = 266
110 (41.0)

n = 376
93.5 (19.4)

0.85

n = 186
94 (50.5)

n = 268
110 (41.0)

n = 378
166 (44.3)

0.13

n = 94
51 (54.8)

n = 110
62 (55.4)

n = 166
108 (65.1)

0.16

n = 51
31 (60.8)

n = 62
47 (75.8)

n = 108
74 (68.5)

0.23

K intake, mmol/d

Na: K
Urinary iodine excretion,
mmol/day
Systolic BP, mm Hg

Diastolic BP, mm Hg

n = 186
50.5
(16.7)
Pressure n = 185
94.2
(21.3)

Hypertension
Prevalence, n (%)
Hypertension
awareness, n (% of
hypertension
prevalence)
Hypertension
medication,

n = 270
75.5 (17)

< 0.01

< 0.01
< 0.01

0.73

0.68

0.20
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Characteristics

Low salt
<5g/d
(n = 186)

Medium
salt
5-9g/d
(n = 269)

High salt
>9g/d
(n = 378)

p
value

n = 31
16 (51.6)

n = 47
22 (46.8)

n = 74
39 (52.7)

0.82

n = 185
6 (3.2)
n = 185
10 (5.4)

n = 269
6 (2.2)
n = 269
24 (8.9)

n = 378
6 (1.6)
n = 378
32 (8.5)

0.44

Tobacco use, n (%)

n = 182
25 (13.7)

n = 269
25 (9.3)

n = 378
29 (7.7)

0.72

Alcohol use, n (%)

n = 182
80 (44.0)

n = 269
115 (42.8)

n = 378
156 (41.3)

0.82

Fruits and Veg., met n = 186
recommendation n (%)
97 (52.2)

n = 269
152 (56.5)

n = 378
193 (51.1)

0.38

Frequently adds salt to food n = 158
at the table, n (%)
24 (13)

n = 269
35 (13)

n = 279
(12.4)

0.65

Frequently adds salt to n = 185
cooking at home, n (%)
149
(80.5)

n = 296
225 (83.6)

n = 378
291 (77)

0.05

Believe that they are eating n = 185
just the right amount of salt 105
n (%)
(56.8)

n = 267
169 (63.3)

n = 376
228 (60.6)

0.18

Believe a high salt diet can n = 180
cause a serious health 144
problem, n (%)
(80.0)

n = 259
207 (79.9)

n = 368
296 (80.4)

0.99

Does something to control n = 183
salt consumption, n (%)
82 (44.8)

n = 260
126 (48.5)

n = 363
182 (50.1)

0.50

current use n
(% of hypertension
awareness)
Hypertension
control, n (% of
Hypertension
medication)
Stroke, n (%)
Diabetes, n (%)

0.37
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Data are presented as median (IQR, interquartile range) unless otherwise stated. BMI, body;
hypertension prevalence, BP ≥ 140/90 or previous diagnosis; Current use of hypertension
medication represents current use in the last two weeks; BMI, body mass index; tobacco use
by self-report; alcohol use by self-report; met fruits and vegetable recommendation indicates
consumed five or more servings of fruits and vegetables a day; salt behaviour responses,
frequently indicates ‘always’ and ‘often’; continuous variables compared using Independent
Kruskal-Wallis Test and categorical variables compared using Pearson Chi-Square Test and
Fisher’s Exact Test. a, b, c; sig at p < 0.05.

In response to the salt behaviour questions (Supplementary Table 5.4), 12.8% (n = 107) of
participants reported that they frequently (always and often) added salt to food at the table
with significantly greater numbers of younger (27.3%, n = 28, p = 0.02) and rural (61%, n =
61, <0.01) dwellers responding affirmatively to this question. More than three quarters
(80.1%, n = 671) of the surveyed population reported that they frequently added salt to food
at home during cooking while 60.9% (n = 508) perceived themselves to consume the right
amount of salt. While 19.9% (n = 126) did not know that a high salt diet could cause a serious
health problem, 48.5%, (n = 394) of the participants reported actively doing something on a
regular basis to control their salt intake. Of those who knew a high salt diet could cause a
serious health problem, 58.9% (n = 378) did something on a regular basis to control their salt
intake.
Almost two-thirds (65%, n = 548) of participants did not meet the daily K recommendation
of ≥ 90mmol [27], with those in the lowest salt intake group having the lowest urinary
concentrations. While 42.6% (n = 141) of urban participants met the guidelines for K intake,
this was the case for only 28.6% (n = 101) of participants residing in rural areas (p < 0.01).
Only 7.6% (n = 63) achieved the recommended Na: K ratio of ≤ 1mmol [27]. There was a
strong positive correlation between 24hr urinary Na and K concentrations (Spearman’s rho
= 0.71, p < 0.01). Linear regression indicated that urinary Na excretion accounted for more
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than half the variability in urinary K excretion (R 2 = 0.51, F (1, 832) = 861, p = <0.01). Urinary
K excretion increased by 0.71mmol/day for each mmol/day increase in urinary Na such that
Na: K ratio was significantly higher in the high salt group compared to the low salt group
(median 2.3 (1.9) g/day vs 1.7 (1.9) g/day, respectively, p < 0.01).
The high Na: K group had a significantly higher BMI than those in the lowest Na: K group
(median 28.1, IQR 8.2 vs 24.8, IQR 7.0, p = 0.01) and had higher number of participants who
reported doing something on regular basis to control their salt intake than those in the
lowest Na: K group (61.5%, n = 15 vs 42.7%, n = 166, p < 0.01) (Table 5.3).

Table 5. 3 Nested cohort by urinary sodium to potassium (Na:K) ratio, low, medium
and high groups, WHO – SAGE Ghana Wave 3 (2019).
Characteristics

Low Na: K (< 2)
n = 399

Age yrs
Sex male n (%)

60 (18)
n = 399
139 (34.8)
n = 397
229 (57.7)
5 (1.3)
31 (7.8)
13 (3.3)
2 (0.5 )
7 (3.0)
12 (3.0)
3 (0.8)
95 (23.9)
n = 398
183 (46.0)
n = 253
10 (4)
n = 387
24.8 (7.0)
n = 398
7.5 (7.4)ab
n = 399

Ethnicity (%)
Akan
Ga
Ewe
Mole-dagbon
Mole-busanga
Grusi
Guan
Gruma
Other
Urban (%)
Education
BMI
Salt intake g/d
K intake, mmol/d

Medium
Na: K (2 – 5)
n = 389
61 (19)
n = 389
116 (29.8)
n = 387
246 (63.6)
29 (7.5)
23 (5.9)
11 (2.8)
1 (0.3)
5 (1.3)
4 (1.0)
3 (0.8)
65 (16.8)
n = 389
240 (61.7)
n = 267
10 (5)
n = 364
25.7 (7.4)
n = 384
8.6 (6.6)ac
n =389

High Na: K ( >5)
n = 41

p value

58 (22)
n = 41
12 (29.3)
n = 41
17 (41.5)
10 (24.4)
1 (2.4)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
173 (21)
n = 41
26 (63.4)
n = 26
10 (6)
n = 39
28.1 (8.2)
n = 40
13.9 (11.9)bc
n = 41

0.44
0.29
< 0.01

< 0.01
0.51
0.04
< 0.01
< 0.01
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Characteristics

Na: K
Urinary
iodine
excretion, mmol/day
Systolic BP, mm Hg
Diastolic BP, mm Hg
Pulse pressure, mm
Hg
Mean Arterial
Pressure (MAP), mm
Hg
Hypertension
Prevalence, n (%)
Hypertension
awareness, n (% of
hypertension
prevalence)
AHT, current use n
(% of hypertension
awareness)
Hypertension
control, n (% of
AHT)
Stroke, n (%)
Diabetes, n (%)
Tobacco use, n (%)
Alcohol use, n (%)
Fruits and Veg., met
recommendation
n
(%)
Frequently add salt to
food at the table, n (%)
Frequently add salt to
cooking at home,
n (%)

Low Na: K (< 2)
n = 399

High Na: K ( >5)
n = 41

n = 398
126 (26)
n = 398
77 (17.0)
n = 398
48 (16.6)
n = 399
93.7 (18.8)

Medium
Na: K (2 – 5)
n = 389
49.5 (38.7)b
n = 389
3.0 (1.3)ac
n = 370
153.9
(164.4)
n = 385
126 (32.0)
n = 385
75 (17.0)
n = 385
51 (17.0)
n = 387
92.5 (21.2)

n = 40
125 (34.0)
n = 40
77 (18.0)
n = 40
51.7 (15.0)
n = 41
91.7 (25.3)

0.03

n = 398
170 (42.7)

n = 387
178 (46.0)

n = 40
18 (45.0)

0.65

n = 170
102 (60.0)

n = 178
106 (59.6)

n = 18
11 (61.1)

0.10

n = 102
65 (63.7)

n = 106
79 (74.8)

n = 11
7 (63.6)

0.22

n = 63
33 (52.5)

n = 78
40 (51.3)

n=7
3 (42.9)

0.89

n = 399
11 (2.8)
n = 399
34 (8.5)
n = 399
45 (11.3)
n = 399
160 (40.1)
n = 399
212 (53.1)

n = 389
7 (1.8)
n = 389
30 (7.7)
n = 389
34 (8.7)
n = 389
172 (44.2)
n = 389
203 (52.2)

n = 41
0 (0.0)
n = 41
2 (4.9)
n = 41
0 (0.0)
n = 41
19 (46.3)
n = 41
24 (58.5)

0.45

n = 399
52 (13)
n = 399
320 (80.0)

n = 389
48 (12.3)
n = 389
311 (79.9)

n = 41
6 (14.6)
n = 41
33 (80.5)

0.88

93.4 (97.8)ab
n = 399
1.4 (0.6)ab
n = 383
129.7 (116.0)a

38.2 (38.4)a
n = 41
5.5 (1.3)bc
n = 40
146.9 (193.9)a

p value

< 0.01
< 0.01

0.25
0.26
0.61

0.69
0.05
0.44
0.74

0.30
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Characteristics

Low Na: K (< 2)
n = 399

High Na: K ( >5)
n = 41

p value

n = 397
247 (62.2)

Medium
Na: K (2 – 5)
n = 389
n = 387
231 (59.7)

Believes that they are
eating just the right
amount of salt n (%)
Believes a high salt
diet can cause a
serious health
problem, n (%)
Does something to
control salt
consumption, n (%)

n = 41
24 (58.5)

0.48

n = 389
304 (78.1)

n = 375
311 (82.9)

n = 40
30 (75.0)

0.18

n = 389
166 (42.7)

n = 375
209 (55.7)

n = 39
15 (61.5)

<0.01

Data are presented as median (IQR, interquartile range) unless otherwise stated. BMI, body; hypertension
prevalence, BP ≥ 140/90 or previous diagnosis; AHT, antihypertensive medication use in the last two weeks;
BMI, body mass index; tobacco use by self-report; alcohol use by self-report; met fruits and vegetable
recommendation indicates consumed five or more servings of fruits and vegetables a day; salt behaviour
responses, frequently indicates ‘always’ and ‘often’; continuous variables compared using Independent KruskalWallis Test and categorical variables compared using Pearson Chi-Square Test and Fisher’s Exact Test. a, b, c;
sig at p < 0.05.

Excluding all participants on treatment for hypertension (n = 154), a Spearman’s rank order
correlation showed no association between Na excretion, K excretion or Na: K ratio and SBP,
DBP or PP. We also found no significant difference between the regression slopes of SBP,
DBP or PP with age in low (<5g/d, n = 154, medium (5-9g/d, n = 220 and high (> 9g/d, n =
302) salt groups (Figure 2). However, there was an association between BP and the age
regression slope according to urinary Na: K ratio. Compared with low Na: K ratio (<2) and
medium Na: K (2-5) ratios, the high Na: K group (> 5) had a significantly steeper slope with
age for both SBP and DBP (p = 0.01 and p < 0.01 respectively). No significant differences for
the slopes in all three Na: K groups was found for PP (Figure 3). Among the high salt group
(> 9g/d), univariate analysis showed a significant relationship between age, father’s
education, diabetes, K and physical activity with SBP while sex, age and father’s education
were associated with DBP.

1
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1

2
3

Figure 5.2 Slope of systolic, diastolic, pulse pressure and MAP with age in low (< 5 g/day, n = 154), medium (5–9 g/day, n = 220) and

4

high (> 9 g/day, n = 302) salt groups excluding those on bp medication.
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Figure 5.2 Slope of systolic, diastolic and pulse pressure with age in low (< 2 mmol/mmol, n = 334), medium (2–5 mmol/mmol, n = 308)
and high (> 5 mmol/mmol, n = 34) Na: K groups excluding those on bp medication.

150

5.4 Discussion
In a nationally representative sample of adult Ghanaians (50y and older), we report that
24hr urinary Na excretion equated to a median salt intake of 8.3g/day, with more than threequarters of participants having salt intakes more than the WHO recommendation of
<5g/day. This is considerably higher than median salt consumption values of 6.8g - 7.2g/day
reported by recent studies from SA [28, 29], a country that has adopted mandatory salt
reduction policies. Our data provides much-needed information required to inform
strategies to meet the WHO global voluntary target for NCD prevention of 30% reduction
in mean population intake of salt, with the aim of achieving a target of less than 5 grams per
day by 2025 [8]. The only other available information on 24hr urinary Na excretion in Ghana
was collected over a decade ago when salt intake was estimated to be 6.0g/day [30]. Over
this time, the Ghanaian food environment has changed dramatically [31, 32] with the
emergence of energy dense, nutrient poor, processed convenience foods such as instant
noodles, salty snacks (e.g. potato, corn, and tortilla chips), visible fat (e.g. butter, margarine,
oils, dressings and gravies), ready-made baked foods (e.g. cookies, cakes, pies and pastries),
desserts such as puddings and cheesecake, and sweetened products (e.g. sugar, syrup, ice
cream, candy, and carbonated and noncarbonated sweetened drinks).

Additionally,

frequent consumption of highly salted foods, such as fish and meat, remains part of the
traditional Ghanaian cuisine, and salt use in cooking, remains high [30, 33].
It is noteworthy that more than three quarters of participants in the current study reported
adding salt to food during cooking. Poor salt use behavior is widespread in the Ghanaian
population; a previous study involving 12 villages in Ghana in 2006 reported that 98% of
participants added salt to food during cooking, while about half (52%) added salt to food at
the table [21]. In comparison to South Africans, Ghanaians reported adding salt to food
during cooking more frequently [33], presumably because mass media public health
campaigns to lower salt use, such as Salt Watch in SA have not yet occurred in Ghana [34].
Further, Ghana’s national salt iodization programme, along with accompanying major
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public health campaigns on iodine consumption [35-38] may partially be responsible for an
increase in discretionary salt intake. However, lack of information on sources of salt
provided from discretionary and non-discretionary sources, as in processed foods, prevents
further hypothesis in this regard.
Despite the current study not including a dietary assessment component, a recent systematic
review of dietary sources of salt in LMICs identified that bread, meat and meat products,
bakery products, instant noodles, salted preserved foods, milk and dairy products, and
bouillon cubes were major sources thereof [39]. In some LMICs, bread alone may contain as
much as 1.36g salt per 100g bread [40]. For many African countries, bread has become a
staple food, such as in some regions of Democratic Republic of Congo, where bread has
replaced cassava [41]. The nutrition transition taking place in Sub Saharan Africa and its
transformation of dietary patterns from a reliance on traditional staples to an increased
intake of energy dense, nutrient poor foods (and often Na rich) foods may partly be
responsible for the observed high salt intake reported by this study. In support of this, the
Ghana Demographic and Health Survey 2014 reported that more than a third (36%) of
participants consumed salted dried fish [42], while in the Ghana National Iodine Survey
Report 2015, consumption of bouillon cubes was frequent and widespread with nearly half
(48.8%) of the participants having consumed this item at least 6 times a week [43].
Awareness of excessive salt intake was low in the current study. Sixty one percent of
participants believed that they were meeting the salt recommendation guidelines, but only
22.3% achieved this. Estimations of dietary salt intake using dietary recall methods usually
indicates a reduced daily intake compared to 24hr urinary collections [44-46]. The tendency
to under-estimate salt consumption is high as many people are unaware of the
recommendation for salt consumption, unable to determine the salt content of everyday
foods such as bread and cereals, or that of composite meals [47-49]. In Ghana, there are no
salt reduction strategies in place such as: mandatory or voluntary levels of salt permitted in
processed foods; regulations for food labelling to indicate salt content in products, or frontof-pack signposting for high salt warnings. In addition, the Ghanaian food composition
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tables are outdated and incomplete in the case of Na [50], making it difficult to assess food
contributors to total salt intake. In view of this, regular monitoring and evaluation of the
food environment and food consumption patterns are warranted.
Potassium excretion, although low (median 63.8mmol /day, IQR 74.8, 65% did not meet
recommended daily intake of K), was higher than that reported by other studies in the
region [28, 29]. The K content of the food items obtained from the 2010-2011 Ghana Food
Balance Sheet indicated that K supply per capita per day was about 9,086mg/day
(233mmol/day), approximately 2.6-fold larger than the WHO recommended level (>
90mmol/day) with yams, cassava and plantains constituting the bulk of K supply [51, 52].
However, it is well known that food balance sheets represent apparent, rather than actual,
food consumption.
Hypertension prevalence in the current study was high (50 +yrs, 52.6%; 18-48yrs, 14.5%),
with less than two thirds (60%) of participants classified as hypertensives being aware of
the condition (i.e. diagnosed), of which 69.1 % were being treated with antihypertensive
medication, half of which had BP levels considered to be controlled (< 140/90mm Hg).
Surprisingly, we found no association between urinary Na, K or N:K ratio with BP in
contrasts to findings from other comparable studies [53-55] but in agreement with others
[28, 56]. A possible reason may be the day-to-day variability in salt intake, which results in
a high intra-individual variability in urinary Na excretion. Furthermore, salt sentivity and
obesity have also been identified to cause variations in BP levels to dietary salt intake,
among African populations [57-60]. Though 24hr Na excretion is the gold standard method
for determination of population Na intake, repeated 24hr collections over periods provide
more accurate estimating an individual’s habitual salt intake [61, 62]. However, this
approach is typically impractical for large population studies such as the one reported here.
Similarly, no difference was found between the slopes of SBP, DBP or PP with age according
to three categories of salt intake, namely low (5g/day), medium (5-9g/day) and high
(>9g/day). However, high and medium urinary Na: K had steeper slopes of BP with age as
compared with those in the low Na: K category. A national survey (WHO-SAGE Wave 2,
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SA) conducted in 2015 reported similar findings [28]. This association was first explored in
the INTERSALT study, the largest multinational study on 24hr urinary excretion and BP
with 10,079 adults across 48 centres worldwide [54]. This implies that a simultaneous
increase in K and a decrease in Na will be beneficial in reducing BP with age and ultimately
hypertension incidence [27, 54]. As such, strategies such as taxes on high-salt products,
labelling and effective communication, voluntary salt commitments by food industries and
legislations for Na reduction are warranted. Similarly, to increase K intake, nutrition
promotion of K rich fruits and vegetables may be needed, along with policies that make
these foods more accessible and affordable.
A strength of the study is the use of a large nationally representative sample of participants
aged 50+ years, in keeping with the aim of WHO-SAGE studies. This design on the other
hand, may limit generalization to the entire population. Another potential limitation is the
recruitment strategy which resulted in more women than men. Women are known to be
more likely to volunteer to participate in surveys than men [63] and this has been observed
in other 24hr urine collection studies [28, 29]. Akan, the largest ethnic group in Ghana is
well distributed over the entire country [42] which is why this group was proportionally
larger than other ethnic groups in the sample. Additionally, the cross-sectional analysis
limits the ability to evaluate the influence of dietary Na and K intake on BP over time. The
choice of urine volumes as a sole determinant of completeness of 24 h urine collections
require explanation. Presently, there is no universally accepted standard for determining
completeness of 24 h urine collections. The International Consortium for Quality Research
on Dietary Sodium/Salt (TRUE), recommends the use of para-aminobenzoic acid (PABA) as
being the preferred method [64] but experiences using PABA in African communities is
limited and experiences from South Africa [65] suggest that participants may forget or
choose not to take their PABA tablets during the urine collection period, thus rendering this
method impractical.

The TRUE consortium recognized a need to establish further additional measures of
assessing 24 h urinary completeness beyond PABA. A systemic review found that no single
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exclusion criteria (24 h urinary creatinine excretion, creatinine index < 0.7, total urinary
volume, a combination of creatinine excretion and total urine volume or self-report of
missing urine) appeared more accurate in identifying incomplete 24-h urine collections than
any others [66]. Importantly, the authors point out that the use of a combination of methods
such as creatinine excretion together with urinary volume may lead to the unnecessary
exclusion of participants with complete urine samples. The reference values used as a cutoff for inadequate urinary collection based on creatinine values has largely been based on
those recommended by Stolarz-Skrzypek et al., namely urinary volume < 300 ml, or
creatinine excretion < 4 mmol or > 25 mmol for women and < 6 mmol and > 30 mmol for men
[28]. The applicability of these creatinine excretion reference values across different ethnic
groups has recently been questioned [66]. While the TRUE authors concluded that a
creatinine index < 0.7 may best increase the sensitivity of eliminating incomplete urine
sampling, they go on to promote the use of similar methodologies used by the INTERSALT
and INTERMAP studies as the preferred method to determine 24 h urinary completeness in
population-based studies [27, 67]. These were as follows: samples that fell outside of the
collection time of 22–26 h; participants’ indication that the collection was incomplete and
that they had spilled ‘more than a few drops’ of urine; or if total urinary volume was
< 250 ml. Given that creatinine is generally variable and largely dependent on muscle mass
and protein intake [62], and the reference cut-off values in African populations have not
been widely validated, we opted to use 24 h urinary volumes ≤300 ml as the measure for
incomplete collections. The generally low creatinine excretion values found across the entire
cohort suggest a possible low dietary protein intake, but a lack of dietary data precludes
further consideration in this regard.
5.5 Conclusions
This nationwide study of Ghanaians, using 24hr urinary collections, reported a high intake
of salt, accompanied by a low K intake. Increasing urinary Na: K ratio was associated with
increasing BP with age. Given the high prevalence of hypertension in the study, our findings
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identify a need for population-wide strategies to reduce dietary salt intake whilst, at the
same time, increase K intake in Ghana.
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Chapter 6
Determinants of change in blood pressure in Ghana: WHOSAGE Ghana Waves 1 – 3
This chapter highlights the change in BP, hypertension awareness, treatment and control
over a period of 11-12y among the same participants. It also identifies the predictors of
change in DBP and hypertension awareness.

This chapter is the substantive content of the published work:
Elias Menyanu, Barbara Corso, Nadia Minicuci Ilaria Rocco, Joanna Russell, Lisa Ware,
Glory Chidumwa, Nirmala Naidoo, Richard Biritwum, Paul Kowal, Aletta E. Schutte, Karen
Charlton. Determinants of change in blood pressure in Ghana: Longitudinal data from
WHO-SAGE Waves 1 – 3. PLoS One. 2021 8;16(1): e0244807. doi: 10.1371/journal.pone.
0244807. PMID: 33417616; PMCID: PMC7793275.
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Abstract
The prevalence of hypertension is increasing in low- and middle-income countries (LMICs),
however statistics are generally derived from cross sectional surveys that utilize different
methodologies and population samples. We investigated BP changes over 11-12years in a
nationally representative cohort of adults aged 50 years and older (n = 820) included in the
World Health Organization’s Study on global AGEing and adult health (WHO-SAGE
Ghana) Wave 1 (2007/8) with follow up in Wave 3 (2019). Participants’ BP were measured
in triplicate and a survey completed at both time points. Survey instruments collected
information on sociodemographic characteristics, lifestyle, health behaviors and chronic
conditions. While no significant difference was found in systolic BP between Waves 1 and
3, diastolic BP decreased by 9.7mm Hg (mean = 88.6, 15.4 to 78.9, 13.6 respectively) and pulse
pressure (PP) increased by 9.5mm Hg (44.8, 13.7 to 54.3, 14.1). Awareness of hypertension
increased by 37%, from (20% to 57%), but no differences were found for the proportion of
hypertensives receiving treatment nor those that had controlled BP. Mixed effects modelling
showed a decrease in DBP was associated with increasing age, living in rural areas and
having health insurance. Factors associated with an increased awareness of hypertension
were residing in urban areas, having health insurance and increasing body mass index
(BMI). While diagnosis of hypertension has improved over time in Ghana, there is an
ongoing need to improve its treatment in older adults.
Keywords
Blood pressure, hypertension awareness, treatment, control, WHO-SAGE, Ghana
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6.1 Introduction
An urgent need to reduce population level BP is recognized globally by health agencies and
governments to minimize the associated outcomes of stroke, myocardial infarction, cardiac
failure, dementia, renal failure, blindness and premature death [1-9]. A 25% relative
reduction in the prevalence of raised BP by 2025 is one of the voluntary global targets of the
World Health Organization (WHO) for prevention of NCDs, and resources have been
developed to assist countries to achieve this target [9, 10]. However, progress towards this
target has been slow, with hypertension remaining a major health challenge in many
countries [9, 11-14].

Worldwide, population level BP has been declining particularly for high and middleincome regions while it has remained stable or has increased among low-income countries.
In an extensive analysis of 1479 national, subnational and community studies conducted
between 1975 and 2015 in 19·1 million participants, significant reductions in mean SBP and
DBP over time were demonstrated (15). In a worldwide study, SBP decreased by 0.8mm Hg
and 1 mm Hg per decade for males and females, respectively, between 1980 and 2008 with
substantial reductions reported in Australia, Western Europe and North America [16].
However, increased SBP has been recorded in the Oceania, east Africa, and south and
southeast Asia for both sexes, and in West Africa for women, ranging from an increase of
0·8-1·6 mm Hg in men and 1·0-2·7 mm Hg in women per decade [16]. Furthermore, studies
examining BP across the life-course indicate that, while SBP typically increases continuously
until age 70 or 80years, DBP typically rises less steeply than SBP and remains constant or
even declines after the ﬁfth to sixth decade of life [17-21]. Consequently, an increased pulse
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pressure (PP) poses a major cardiovascular risk [19, 22-24]. However, it remains unclear how
changes with age in older adults in regions such as Sub-Saharan Africa (SSA) where
population level BP is not declining. With high hypertension rates and low levels of
awareness, treatment and control in the African region [25-29], understanding changes over
time in older adults is essential in order to reduce associated morbidity and mortality.

To better understand the trajectory of hypertension and predictors of change in BP over
time, we aimed to identify changes in population level BP in a nationally representative
longitudinal cohort of Ghanaians over an 11-12year period.

6.2 Methods
Details of the methodology has been described in chapter two. For the purpose of this
analysis, data from participants included in WHO-SAGE W1 (2007/2008) were compared
with those followed up in a preliminary analysis of data from W3 (2019). We followed up
820 participants with valid BP and self-reported hypertension status data from W1 to W3.
The flow diagram (Fig. 1) demonstrates the selection procedure. We compared the 820
subjects (50+ y olds) included in this work with both the 3,904 (=4,724-820, aged 18+)
participants excluded (i.e. not followed-up and not valid BP data) and the 79 (=899-820, aged
50+) subjects followed-up but with no valid BP data. Supplementary tables 2 and 3
(Appendix E) show the distribution of selected socio-demographic and health variables; all
the frequencies were not weighted. The main study outcome for this analysis was BP.
Characteristics of the participants presented in Table 6.1.
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Wave 1

Wave 3

n = 5,573

n = 4,449

Aged 50+

Aged 50+

n = 4,724

n = 3,067

Follow-up subjects (Both w1 and w3) n =
899

Valid BP measurements
and valid SR-hypertension
n = 820
Fig. 6.1 Flow Diagram

Data were analyzed using Stata Statistical Software: Release 16 (Stata Corp LLC, 2019;
College Station, USA). Due to non-responses for some survey items, the number of
responses (n) for each variable are included in the tables. The WHO-SAGE Ghana
participants are allocated a unique 10-digit identifier code that facilitates linking of
participant’s information over the two waves of the study. Categorical variables were
compared using Chi square test while the Wilcoxon Signed Ranked Test was used to
compare continuous variables in the cohort over time. Change in BP was calculated by
subtracting the BP measurement obtained in WHO-SAGE W1 from that in WHO-SAGE W3.
Nonparametric kernel-density plots were constructed with the kdensity command and the
default Epanechnikov kernel function utilized. A kernel density plot is a smoothed
representation of a histogram with the area under the curve representing the proportion of
values compared to all values and sums to 1. Kernel density shows the probability density
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estimates of the distribution. Mixed model effects regression modelling was used to assess
potential predictors of the longitudinal changes in SBP and DBP between W1 and W3. This
statistical method for repeated measurements accounts for correlations among
measurements within an individual and variations across participants [30, 31]. Logistic
regression was used to access factors associated with change in hypertension awareness.

6.3.1 Results
Out of the total W1 sample (n = 5,573), 899 participants were aged 50y+ and were followedup in W3. Of these, 820 respondents had complete data on BP and self-reported
hypertension diagnosis.
Table 6. 1 Characteristics of participants in WHO-SAGE, Ghana W1 and W3 (n = 820)
Characteristic

Wave 1
n = 820
59 (13)

Wave 3
n = 820
71 (13)

P

n = 820
477 (58.2)
n = 427
10 (7)

< 0.001

Years educated for those who have
‘ever schooled’

n = 817
419 (51.3)
n = 390
10 (4)

Marital status: married/ cohabiting,
n (%)

n = 820
489 (59.9)

n = 820
419 (51.1)

< 0.001

Waist to height ratio (WtHR)

n = 815
0.51 (0.1)

n = 747
0.53 (0.1)

< 0.001

BMI

n = 815
22.2 (5.9)

n = 747
23.2 (7.1)

< 0.001

Current alcohol use (%)
Never
Current use
Yes, but not current

n = 820
376 (45.9)
240 (29.3)
201 (24.5)

n = 820
452 (51.1)
133 (16.2)
235 (28.7)

Overall Physical Activity, n
(%)

n = 812
701 (86.3)

n = 820
294 (53.9)

Age in years

<0.01

School attendance
Ever schooled, n (%)

< 0.001

< 0.001

< 0.014
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Diabetes, n (%)

n = 820
17 (2.1)

n = 820
65 (7.9)

0.001

Depression, n (%)

n = 820
13 (1.6)

n = 820
13 (1.6)

0.645

Health Insurance, Yes n (%)

n = 820
307 (37.4)

n = 820
706 (86.1)

< 0.001

2

SBP, mm Hg

n = 820
131.0 (30.0)

n = 820
130.5 (27.4)

0.783

DBP, mm Hg

n = 820
88.6 (20.5)

n = 820
78.9 (18.0)

< 0.001

PP, mm Hg

n = 820
43.0 (16)
n = 820
426 (52.0)

n = 820
52.5 (17)
n = 820
400 (48.8)

< 0.001

Hypertension awareness (% of
hypertension prevalence)

85 (20.0)

228 (57.0)

< 0.001

Hypertension treatment (% of
hypertension awareness)

66 (77.6)

187 (82.0)

0.101

Hypertension control (% of
hypertension treatment)

18 (27.3)

99 (52.9)

0.195

Hypertension, n (%)
Prevalence

< 0.001

All data are presented as median (Interquartile range, IQR) unless otherwise indicated. Whereas walking/cycling
refers to such activities completed in a typical week, overall physical activity represents all activities including
vigorous, moderate, walking/cycling, vigorous fitness and moderate fitness completed in a typical week.
Hypertension prevalence refers to BP ≥140/90 or self-reported treatment while hypertension awareness refers
self-reported diagnosis. Hypertension treatment denotes blood pressure medication use (within the last 2 weeks)
prior to the survey and hypertension control represents medication use with a measured BP less than 140/90 mm
Hg. Continuous variables were compared using Wilcoxon signed-rank test; categorical variables were compared
using the Chi-Square test.

Out of the W1 sample (n = 5,110), 820 participants aged 50yrs+, had complete BP data at both
W1 (median age, 59years) and W3 (median age, 71years) and were included in the analysis.
The sample comprising 433 (52.8%) men and 387 women (47.2%), with 364 (44.4%) and 456
(56.6%) living in urban and rural

areas, respectively. We further examined

sociodemographic and cardiovascular related risk factors and found several changes. There
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was an increase in the proportion of participants reporting ever attended school which may
reflect participation in adult learning literacy programmes in Ghana [32]. WtHR, BMI,
diagnosis of diabetes and having voluntary health insurance increased in the cohort while
current alcohol intake and overall physical activity levels decreased significantly between
W1 and W3 (Table 6.1).

6.3.2 Blood pressure changes within the population
There was no difference in SBP between W1 and W3, however, a significant reduction of
9.7mm Hg W1, mean (SD) = 88.6 (15.4); W3, 78.9 (13.6) in DBP was observed over the 11-12
year follow up period. PP significantly increased by 9.4mm Hg (95% CI, W1 = 43.9-45.8; W3
= 53.3-55.2). Figures 6.1 and 6.2 graphically demonstrate that the distributions of SBP and
DBP in both waves. While the curves are almost overlapping for SBP, the W3 distribution
for DBP is clearly shifted to the left compared to W1.

Figure 6. 2 Non-parametric kernel-density estimates for the distribution of SBP (W1, W3 n = 820)
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Figure 6. 3 Non-parametric kernel-density estimates for the distribution of DBP (W1, W3 n = 820)

Hypertension prevalence decreased significantly by 3.2% over the period (W1, 52.0%, CI =
0.48-0.55; W3, 48.8%, CI = 0.45-0.52). Hypertension awareness increased by 37.0% (p < 0.01)
over time with no differences observed for hypertension treatment nor the proportion of
treated hypertensive participants that had controlled BP (Table 6.1). Fig 6.3 illustrates the
distribution of hypertension prevalence, awareness, treatment and control in both waves by
sex and age. There were significantly more women than men with hypertension in both
waves. Hypertension prevalence was highest among the 50-59year group in W1 (51.9%),
who were aged 62-71 years in W3 (43.8%).
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Figure 6. 4 Top left; hypertension prevalence (W1 n = 426, W3 n = 400), top right; hypertension
awareness (W1 n = 95, W3 n = 245), bottom left; hypertension treatment (W1 n = 66, W3 n = 187),
and bottom right; hypertension control (W1 n = 18, W3 n = 99).
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6.3.3 Predictors of decrease in DBP and increase in awareness of hypertension
A mixed regression model that included change in DBP as the dependent variable found
that the observed DBP decrease from W1 to W3 was associated with increasing age, living
in rural areas, physical activity and having health insurance (Table 6.2). Predictors of
change in prevalence of hypertension were increasing BMI and residing in rural areas
(Supplementary Table 6.1). Female gender, ageing residing in rural areas, increasing BMI
and having health insurance and diabetes predicted an increase in hypertension awareness
over the two time periods (Table 6.3), adjusting for all variables.
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Table 6. 2 Multivariate analysis showing thepredictors of decrease in DBP (WHO-SAGE
Ghana Waves 1 and 3), n = 794

Table 6. 2 Multivariate analysis showing the predictors of decrease in DBP (WHO-SAGE Ghana
Waves 1 and 3), n = 794
DBP mm Hg
Characteristics

Estimate

p-value

95% CI

Sex
Male

Ref

Female

-0.0.02

0.990

-3.415 – 3.19

-0.19

< 0.001

-0.30 - (-0.07)

< 0.002

-5.97 - (-1.10)

Age
Location
Urban

Ref

Rural

-3.98

Marital Status
Married

Ref

Not married

-2.36

0.933

-2.68 - 2.92

-0.30

0.04

-0.58 - (-0.01)

0.059

-16.41 - 0.29

0.477

-24.11 - 4.52

Own education (yrs)
Mothers education
Less than secondary
school completed
Secondary and above
Completed
Fathers Education

Ref

Less than secondary
school completed

Ref

Secondary sch. and
above completed

-8.06

-1.20

Health Insurance
No

Ref
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DBP mm Hg
Characteristics
Yes

BMI

Estimate

p-value

95% CI

-2.60

0.037

-5.03 - 40.16

0.03

0.359

-0.03 - 0.094

0.34

-0.34 - 2.49

0.878

-3.63 - 4.24

Ever used alcohol
No

Ref

Yes

0.81

Diabetes
No

Ref

Yes

0.31

Ever used tobacco
No

Ref

Yes

0.88

0.548

-1.99 - 3.76

-2.65

0.030

-5.03 -0.25

Overall physical activity

Note: Ref represents reference category used for the comparison. Voluntary refers to
contributors to health insurance who were not captured by the insurance scheme as public
or civil service workers, while mandatory refers to contributors who were employees within
the public, civil and private sectors. Overall physical activity represents all activities
including vigorous, moderate, walking/cycling, vigorous fitness and moderate fitness
completed in a typical week. Multivariate regression was adjusted for age, sex, marital status,
years of education, mother’s education, father’s education, health insurance, diabetes and
overall physical activity.
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Table 6. 3 Odds Ratio showing the predictors of change in hypertension awareness
(WHO-SAGE Ghana Waves 1 and 3), n = 369
Hypertension Awareness
Characteristic

OR
(95% CI)

p-

95 % CI

value

Sex
Male

Ref

Female

1.98

0.021

1.10 -3 4.450

1.05

<0.01

0.96 - 1.06

0.017

0.37 - 0.91

Age
Location
Urban

Ref

Rural

0.58

Marital status
Married

Ref

Not married

0.92

0.753

0.54 - 1.56

0.01

0.589

0.96 - 1.10

0.053

0.98 - 13.54

0.644

0.63 - 4.32

Years of education
Mothers education
Less than
secondary/high
school
completed
Secondary/high
school
and above completed
Fathers education

Ref

Less than
secondary/high
school
completed
Secondary/high
school
and above completed
Health Insurance

Ref

3.654

0.60

No

Ref

Yes

1.99

0.008

119. - 3.33

1.05

0.002

1.02 - 1.09

BMI
Diabetes
No

Ref

176

Hypertension Awareness
Characteristic

OR
(95% CI)

Yes
Overall physical

p-

95 % CI

value

74.29

<0.01

3.18 - 16.65

1.44

0.109

0.92 - 2.25

activity
Note: Ref represents reference category used for the comparison. Voluntary refers to contributors
to health insurance who were not captured by the insurance scheme as public or civil service
workers, while mandatory refers to contributors who were employees within the public, civil and
private sectors. Overall physical activity represents all activities including vigorous, moderate,
walking/cycling, vigorous fitness and moderate fitness completed in a typical week. Logistic
regression was adjusted for age, sex, marital status, years of education, mother’s education, father’s
education, health insurance, diabetes and overall physical activity.

6.4 Discussion
The main finding from this 12 year follow of older Ghanaians is an observed reduction in
DBP accompanied by a reduction in hypertension prevalence. While no differences were
recorded in SBP, there was a significant decrease DBP, accompanied by an increase in PP.
DBP decreased for every age decile, with those aged 60-69years at baseline having the
greatest reduction over the period. A rise in hypertension awareness over the time was
expected since older people are generally higher users of health services. Over the past
decade, there has been an increased focus on hypertension screening activities [33] as well
as heightened efforts from the health care system in Ghana to implement strategies to
address NCDS [34-36]. It was not surprising that hypertension was higher among women
than men due to the age of the cohort (50y+).
A lack of change in SBP between the two time periods is in contrast with many other studies
that have reported a rise (18, 20, 21). This may however be explained by the age of the cohort
in W3 (median, 71years), and life expectancy in Ghana (64years) [37]. Due to the median age
of the cohort, survival bias could not be ruled out, however further investigation in this
regard could not be conducted due to lack of access to information on cause and time of
death. The observed decline in DBP with advancing age in this older cohort agrees with
findings from other studies. A review on the epidemiology of hypertension indicated that
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in most populations, DBP remained stable or reduced after age 50-60yrs [21]. Similarly, data
from the Framingham Heart Study, which followed participants for three decades, showed
that DBP varied with ageing, increasing until the fifth decade and gradually declining from
age 60yrs onwards [20]. These age-related phenomena are explained by physiological
changes in arterial structure and function. Aging is associated with an increased thickness
of the arterial wall, nearly 3-fold between the ages of 20y and 90y, even in the absence of
atherosclerotic plaques [38, 39]. An increase in the thickness of the arterial wall is
accompanied by an increase in arterial stiffness [40] which in turn induces a decline in DBP
[41,42-44]. The mechanism behind this decline is unclear, however, structural and molecular
changes in the arteries (i.e. decreased elastin content, increased collagen I deposition and
calcification) have been implicated [41-44]. Due to the fall in DBP and without any change
in SBP in the current study, a reduction in hypertension prevalence was observed. However,
this reduction should not be misconstrued to indicate a reduction in cardiovascular risk
among the cohort. A longitudinal study that evaluated the risk of cardiovascular mortality
emphasized that participants whose DBP decreased with unchanged SBP had a higher
cardiovascular mortality compared to those whose SBP and DBP remained constant over
time [45]. Similarly, Witteman et al. reported that, among females, a decline in DBP during
a nine-year follow-up was associated with an enhancement of atherosclerotic lesions of the
aorta, suggesting that a decline in DBP was a marker for atherosclerosis progression [46],
reflecting prevailing compromise of the coronary circulation [42]. Hypertension is a known
risk factor for atherosclerosis [47, 48]. Additionally, PP increased significantly due to the
declining DBP in the current study, a situation that has the tendency to cause extensive
damage to essential organs such as the brain and kidneys [41]. A large PP is associated with
a greater risk for myocardial infarction, increased coronary disease and stroke even after
effective BP control [23, 42, 49]. PP remains the most powerful independent predictor of
cardiovascular risk in the elderly [18, 50].
The observed rise in hypertension awareness may reflect the older age of the participants
who have experienced more engagement with health services over time, including routine
measurement of BP at clinic visits. Other studies that included largely older participants
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from Ghana, China, India and Mexico reported relatively higher hypertension awareness
figures [25], compared to whole-of-population studies [51]. Despite the influence of
advancing age, increasing hypertension awareness in the Ghanaian population could also
be attributed to several health interventions and programmes that have been implemented
by the Ghana Health Service (GHS) over the past 15-20 years. The government’s broader
development plan was focused on Ghana achieving middle income country status by the
year 2015, through various policies, such as the Ghana Poverty Reduction Strategies (2003–
2005; 2006–2009); as well as those driven by the United Nations’ Millennium Development
Goals, including the Ghana Shared Growth and Development Agenda, 2010–2013 [, 52-54].].
Concurrent policies with varied mandates were also operationalized such as provision of
community-based health planning and services (CHPs), which provided health information
services preventive and curative care for chronic health conditions [55] and increased access
to primary health care for particularly hard-to-reach communities [56]. In addition, the roll
out of the national health insurance scheme in 2003 provided a major boost for services
offered by CHPs and increased access to healthcare services in general, as clients were no
longer required to provide out of pocket payments for some rendered healthcare services
[34]. It is noteworthy that the current study reports of a dramatic increase in voluntary
health insurance between W1 and W3.
Along with CHPs, the Ministry of Health, in 2005, introduced the regenerative health and
nutrition programme (RHNP) as part of its effort to curb the rising trend of NCDs [57] while
in 2014, the ministry collaborated with Novartis Foundation to launch the community-based
hypertension improvement program (ComHIP), which to date, conducts community-based
BP screening and BP monitoring in many parts of the country [33].
The finding that more women were hypertensive than men was expected due to the
biological changes that take place in women after menopause. Estrogen has been cited to
cause endothelial vasodilation, inhibit sympathetic and renin-angiotensin system (RAS)
activity, enhance the production of endothelin, reduce oxidative stress, increase antioxidant
production and reduce inflammation - all of which regulate BP [58-60]. After menopause,
estrogen levels fall causing an increase in hypertension [61-63].
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The current study found that increasing age, residing in rural areas, increasing physical
activity and having health insurance were associated with a reduction in DBP between W1
and W3. The assertion that BP increases with age has been established [ 64, 65], however
age-related BP may differ according to individual circumstances. Our finding that living in
a rural setting was associated with a decline in DBP is consistent with other studies
conducted in Ghana. Data from the Ghana Demographic and Health Survey 2014 which
surveyed 13,265 participants nationwide reported lower BP levels in rural compared to
urban areas [66]. Similarly, sub-population studies conducted in Ghana have reported lower
BP in rural residents compared to their urban counterparts [67, 68]. However, contrasting
findings have been reported in other recent African-based comparison studies, indicating a
rising BP in rural settings [69-71]. The finding that increasing physical activity is associated
with BP reduction is well known (72, 73). In terms of dose-relationship, engagement in more
regular and frequent physical activity results in greater reductions in BP irrespective of age,
sex or ethnicity [74, 75]. Increased awareness of hypertension was associated with ageing,
female gender, higher BMI, diabetes and having health insurance in the current study.
Women were about 2 times more likely than men to be aware of their hypertensive status
in the current study. This may be expected as women are known to generally have more
interaction with clinics and hospitals through maternal and child health programmes and
are known to place more importance on healthcare than men [76]. Furthermore, the
sociocultural context (where men who sought healthcare were seen as feminine, vulnerable
or weak) [77, 78] may be a disincentive for health-seeking behaviours in men. Increasing
BMI predicted hypertension awareness. This association can be attributed to the higher
incidence of hypertension among obese individuals compared to those with ‘healthy
weight’ [79, 80]. Increasing body weight is a growing concern in Ghana [ 81] and a major
modifiable cardiovascular risk factor [27]. Those having diabetes were about 7 times more
likely to be aware of their hypertensive status than non-diabetics in the current study.
Similarly, odds of hypertension awareness among diabetics have been reported (27, 82).
Hypertension is a known risk factor for diabetes (90) and the two conditions mostly coexist
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(83). As such, Ghana has introduced clinics in open food markets specifically for diabetes
(84) and which simultaneously offers opportunity for BP monitoring.
It was not surprising that having health insurance was associated with a decrease in DBP
and an increase in hypertension awareness in the current study. The National Health
Insurance Scheme (NHIS) which provides universal access to health care, has over the years
improved in its efficiency and increased the range of healthcare services it covers,
particularly among those of the lowest socioeconomic status and those most vulnerable
groups in the population [85]. The number of outpatient visits increased sharply and healthseeking behaviour was enhanced as a result of the NHIS roll out [86, 87]. As of 2014, the
NHIS had 40% coverage of Ghana’s population, an increment of 6.3% from 2010 [88, 89].
The NHIS’s widened access to most healthcare facilities in Ghana may have been an
enabling factor in increase in hypertension awareness.
A major strength of the current study was the prospective design that allowed follow up of
the same participants in two large nationally representative studies of persons aged 50 years
and older using the same study design and methodology. Validity of data was achieved
using extensively trained teams of interviewers that used standard protocol and
instruments and inherent quality control measures. Limitations were the high rate of loss to
follow up and the inability to generalize the findings over the entire population because of
the higher age of the cohort.
6.5 Conclusions
Despite a reduction in DBP recorded between WHO-SAGE Ghana W1 and W3 (2007-2019),
hypertension prevalence in W3 remained high. An increase in awareness of hypertension
over this time period suggests improved health services for BP monitoring, but this was not
accompanied by an increase in the proportion of hypertensive participants who were
receiving treatment for the condition, nor improved BP control. Factors associated with a
reduction in DBP included increasing age, residing in a rural area and having health
insurance, while predictors of hypertension awareness included higher BMI and having
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voluntary health insurance. This data suggests that existing health programmes should be
intensified to improve the management of hypertension in Ghana.
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Chapter 7
Salt reduction strategies may compromise salt iodisation
programmes: Learnings from South Africa and Ghana
This chapter discusses salt reduction in relation to its impact on iodine intake. The chapter
emphasizes the importance of population salt reduction but, at the same evaluates its effect
on dietary iodine in Ghana and SA - these countries have adopted and effectively
implemented the universal salt iodization (USI) programme. With SA having successfully
implemented a salt reduction legislation, and Ghana without, the chapter compares iodine
intakes across salt categories in Ghana and SA.
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Abstract
Universal salt iodization (USI) has been adopted by many countries to address iodine
deficiency. More recently, salt reduction strategies have been widely implemented to meet
global salt intake targets of <5g salt/day. Compatibility of the two policies has yet to be
demonstrated. This study compares urinary iodine excretion (UIE) according to 24hr
urinary Na excretion, between SA and Ghana, both with implemented USI, but Ghana
without salt reduction legislation. Participants from World Health Organization’s (WHO)
Study on global AGEing and adult health Wave 3 (2019), with survey and valid 24-hour
urinary data (Ghana, n = 495; SA, n = 707) comprised the sample. Median 24-hour UIE was
compared across salt intake categories <5, 5–9 and >9g/day. In Ghana, median Na excretion
indicated a salt intake of 10.7g/day (IQR 7.6), while median UIE was 182.4 µg/l (IQR 162.5).
In SA, salt and iodine values were lower (median salt 5.6g/day (IQR 5.0); median UIE 100.2
µg/l (IQR 129.6)). UIE differed significantly across salt intake categories (p<0.001) in both
countries but in opposite directions. In Ghana, a weak correlation (r = 0.1501, p < 0.0011) was
observed, compared to a moderate, positive association in SA (r = 0.4050, p < 0.0001).
Participants with salt intakes <5g/day in SA did not meet WHO’s recommended iodine
intake of 150µg/day, but this was not the case in Ghana. Monitoring and surveillance of
iodine status is recommended in countries that have introduced salt reduction strategies in
order to prevent re-emergence of iodine deficiency.
Key words: iodized salt, salt intake, legislation, sodium, Ghana, South Africa
7.1 Introduction
Iodine deficiency disorders remain a major global health issue affecting nearly 2 billion
people worldwide, placing them at risk of irreversible brain damage and cognitive
impairment. Iodine deficiency causes thyroid dysfunction and is implicated in psychomotor
and developmental problems in its mild forms, and cretinism in its most severe form [1].
Populations residing in areas affected by severe ID may exhibit learning difficulties,
particularly in children born to women who were iodine deficient whilst pregnant [2].
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The World Health Organization (WHO) in 1991, attempted to address ID as a public health
concern by recommending universal salt iodization (USI). As such, many countries have
made excellent progress towards achieving the targets of IDD elimination [3].
Ghana launched its USI in 1995 in response to a nationwide survey conducted in 1994, which
reported that IDD was endemic in almost half of the 110 districts of the country [4].
Following the adoption of USI, household access to iodized salt fluctuated in the 20years
that followed [4-6]. Recent studies among Ghanaian school aged children (6-12yrs) and
pregnant women have reported a median urinary iodine concentration (UIC) of 202μg/L
and 155μg/L respectively, indicating adequate iodine intake [7, 8].
Similarly, in SA, low access to iodized salt by much of the population [9] led to
implementation of a mandatory salt iodisation programme in 1995 [10]. Following an
intensive mass education and health promotion programme related to iodine intake,
improved coverage and usage of iodized salt was recorded in the 2005 national survey with
a 15% increase in number of households using iodized salt and a median UIC of 215 µg/L
and 177 µg/L for school children and adult women, respectively. However, since that time,
no further national surveys have been conducted to assess iodine status in SA [11]. South
Africa’s mandatory salt legislation introduced in 2016, in response to WHO’s voluntary
target of < 5g salt per day, may have implications for the adequacy of iodine intake because
of reductions in iodized salt used in processed foods and changes in salt use behaviours [1214], but this is yet to be investigated.
Given that both Ghana and SA have national salt iodization programmes, but only SA has
implemented mandatory salt legislation, a comparison of salt and iodine intake between
these two countries provides an opportunity to investigate the impact of the salt legislation
on iodine intakes in South Africans, using Ghana as a comparator country. It will provide
an updated evaluation of the effectiveness of the salt iodization programmes in both
countries. The aim of is study was to compare urinary iodine excretion across urinary Na
excretion categories in an adult population from both Ghana and SA.
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7.2 Methods
Details of the methodology have been described in chapter two. Specific to this chapter, a
total of 6,973 participants were recruited for the main WHO-SAGE cohort (Ghana; n = 4,449,
SA; n = 2,2524) out of which 5,756 that had valid data (Ghana, n = 3,548; SA, n = 2,208) were
selected using the criteria of urine volume ≥300ml/day and creatinine concentration of
≥3mmol/day [15] and if corresponding survey data were available. Figure 7.1 provides
details of the main sample and the nested sub study for both countries.
Sodium (mmol/l) in the 24 h urine sample was converted to salt intake (g/day) and
categorised according to ow (<5 g/day), medium (5-9 g/day) or high (>9 g/day) salt intakes,
and iodine metrics investigated between these categories. To convert urinary excretion
values to estimated daily iodine intake (μg/day), urinary iodine excretion (UIE; μg/24h) was
divided by 0.92, based on the assumption that approximately 92% of dietary iodine is
excreted in urine. A median UIC of <100μg/l indicates population-level deficiency [16].
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Ghana main cohort

Ghana nested cohort

N=4449 respondents
interviewed

N= 1121 24hr urine
samples collected

SA main cohort

N=2524
respondents
interviewed

SA nested cohort

N= 1189 24hr
urine samples
collected

N=957 common subjects
(main+nested)

N=876 common subjects
(main+nested)

N=586 with valid urine
measurement (cut-off:
Volume≥300ml & creatinine ≥3
mmol/24hrs)

N=887 with valid urine
measurement (cut-off:
Volume≥300ml & creatinine ≥3
mmol/24hrs)

Excluded:

Excluded:









164 urine data only
477 no age recorded
439 invalid urine

313 urine data only
148 no age recorded
169 invalid urine

N = 3053 main cohort

N = 1501 main cohort

N = 495 main + nested cohort

N = 707 main + nested cohort

Figure 7. 1 Flow diagram
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Estimated iodine intake values and UIE analyses were compared across three categories of
24-hour urinary Na values, equivalent to salt intakes of <5g/day, 5–9g/day and >9g/day.
Normality of data was checked by visual inspection of histograms and the Shapiro-Wilk
test. Categorical variables were evaluated using absolute numbers (percentages), Chi square
and Fisher’s Exact tests while the Mann Whiney U and Kruskal-Wallis tests explored
differences between groups for non-parametric data. Spearman’s ranked order correlations
was used to ascertain the relationship between iodine concentrations and estimated salt
intake, body mass index (BMI) and weight. Pearson correlation coefficient was calculated
between log-transformed UIE and estimated salt intake. Data were analyzed using Stata
Statistical Software: Release 16 (Stata Corp LLC, 2019; College Station, USA).
7.3 Results
Out of 2,310 participants who provided urine samples, 52% (n = 1202) who had both valid
urine and survey data and were included in the sample. The sociodemographic
characteristics of the subsample is compared with the main survey sample. Whereas the SA
subsample had significantly older participants than in its remaining main survey, the Ghana
subsample had a significantly higher proportion of younger participants than in its
remaining main survey. Waist to height ratio and diabetes were significantly higher in the
subsamples than in the main surveys in both countries. In Ghana, median UIE was 182.4
µg/ day (IQR 162.5), equivalent to median UIC of 137.3µg/l, while median salt intake was
10.7g/day (IQR 7.6). In the SA subsample, median UIE was much lower at 100.2 µg/day (IQR
129.6), equivalent to median UIC of 90.2µg/l, and accompanied by a lower median salt
intake of 5.6g/day (IQR 5.0). There were no significant differences in UIE according to sex
or age category (50+ yrs and 18-49yrs) in both countries. In the lowest salt category of
<5g/day, UIE indicated suboptimal iodine intake among the SA subsample (72.4µg/l, IQR
75.6) but in Ghana, this was adequate (UIE 135.2µg/l, IQR 102.7) (Tables 1 and 2). A trend
was observed for a decrease in UIE associated with increasing salt intake in the Ghana while
in contrast, UIE significantly increased with increasing salt intake in the SA. (Fig 7.2). Weak
correlations were found between UIE and salt intake in the Ghana subsample (r = 0.1501, p
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< 0.0011) while moderate correlations were found in the SA subsample (r = 0.4050, p < 0.0001)
(Fig 7.2).
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Table 7. 1 Urinary iodine, estimated iodine intake and sodium excretion values by salt intake equivalent
categories, SAGE South Africa W3.
All

Salt <5g/day

Salt 5-9 g/day

Salt >9 g/day

P value

(n=707)

(n=313)

(n=233)

(n=161)

Sodium (mg/day)

2171.4 (1958.9)

1270.5 (646.8)

2564.1 (716.1)

4550.7 (1570.8)

0.0001

Salt (g/day)

5.6 (5.0)

3.3 (1.7)

6.6 (1.8)

11.7 (4.0)

0.0001

UIC (μg/L)

90.2 (107.2)

79.3 (96.8)

95.3 (100.7)

112.5 (126.6)

0.0001

UIC < 50 μg/L, n(%)

165 (23.7)

93 (30.3)

40 (17.4)

32 (20.0)

0.001

24-hour UIE (µg/day)

100.2 (129.6)

72.4 (75.6)

117.3 (124.2)

170.8 (200.7)

0.0001

Estimated iodine intake (µg/day)*

108.9 (140.8)

78.7 (82.1)

127.5 (135.0)

185.7 (218.1)

0.0001

% with daily iodine intake below EAR

302 (43.3)

186 (60.6)

79 (34.4)

37 (23.1)

<0.0001

108 (15.3)

46 (14.7)

39 (16.7)

23 (14.3)

0.745

199 (63.6)

158 (67.8)

103 (64.0)

0.559

for iodine (95 µg/day), n (%)
Frequently add salt to food at table, n(%)

Frequently add salt to food during cooking, 460 (65.1)
n(%)
Believe they consume too much salt, n(%)

59 (8.6)

30 (9.9)

19 (8.4)

10 (6.3)

0.417

Believe a high salt diet is bad for health,

506 (81.6)

230 (81.9)

165 (80.5)

111 (82.8)

0.853

255 (42.7)

114 (42.9)

83 (42.6)

58 (42.7)

0.998

n(%)
Regularly control of salt intake, n(%)

Data are presented as median (interquartile range; IRQ) unless otherwise indicated. Continuous variables compared using independent samples
Kruskal-Wallis test. *Daily iodine intake assumed as 24-hour UIE (µg/day)/0/92 to account for biovariability. UIC: Urinary Iodine Concentration;
UIE: Urinary Iodine Excretion; EAR: Estimated Average Requirement.
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Table 7. 2 Urinary iodine, estimated iodine intake and sodium excretion values by salt intake equivalent
categories, SAGE Ghana W3.
All

Salt <5g/day

Salt 5-9 g/day

Salt >9 g/day

P

(n=492)

(n=45)

(n=140)

(n=307)

Sodium (mg/day)

4163.5 (2980.8)

1573.1 (435.9)

2777.4 (747.6)

5447.7 (3646.6)

0.0001

Salt (g/day)

10.7 (7.6)

4.0 (1.1)

7.1 (1.9)

14.0 (9.3)

0.0001

UIC (μg/L)

137.3 (136.9)

184.9 (204.6)

164.5 (131.4)

118.9 (130.3)

0.0001

UIC < 50 μg/L, n(%)

42 (8.9)

0

3 (2.2)

39 (13.2)

<0.0001

24-hour UIE (µg/day)

182.4 (162.5)

135.2 (102.7)

172.5 (187.4)

200.6 (180.4)

0.0002

Estimated iodine intake (µg/day)*

198.3 (176.6)

146.9 (111.6)

187.4 (155.7)

218.1 (196.1)

0.0002

% with daily iodine intake below EAR for

55 (11.6)

9 (21.4)

20 (14.9)

26 (8.8)

0.025

Frequently add salt to food at table, n(%)

58 (11.7)

4 (8.9)

13 (9.3)

41 (13.4)

0.381

Frequently add salt to food during cooking,

399 (80.6)

40 (88.9)

119 (85.0)

237 (77.2)

0.051

Believe they consume too much salt, n(%)

48 (9.7)

7 (15.6)

8 (5.7)

33 (10.8)

0.096

Believe a high salt diet is bad for health, n(%)

378 (78.3)

34 (77.3)

107 (79.3)

236 (78.4)

0.958

Regularly control of salt intake, n(%)

235 (48.9)

15 (33.3)

75 (55.1)

143 (48.1)

0.038

iodine (95 µg/day), n (%)

n(%)

Data are presented as median (interquartile range;IQR) unless otherwise indicated. Continuous variables compared using independent samples
Kruskal-Wallis test. *Daily iodine intake assumed as 24-hour UIE (µg/day)/0/92 to account for biovariability. Urinary Iodine Concentration; UIE:
Urinary Iodine Excretion; EAR: Estimated Average Requirement.

199

Figure 7. 1 Correlation between urinary iodine concentration and estimated salt intake

7.4. Discussion
Our study found that in a sample of SA adults surveyed after introduction of a salt reduction
policy, those with low salt intakes (<5g salt/day) had inadequate iodine intakes but however
this was not observed in the sample of Ghanaian adults, using 24hr UIE as a biomarker of
intake. Conversely, South Africans with high salt intakes (> 9g/day) had optimal iodine
intakes, but Ghanaians with high salt intakes had suboptimal iodine intakes. This data
suggests that, in Ghana, people who are consuming high amounts of salt may be using non
iodized salt or salt that is not adequately iodized [17], whereas in SA, the strategies being
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used for salt reduction, including the mandatory salt targets for processed food may be
resulting in inadequate consumption.

Table 7. 3 Spearman’s rank-ordered and partial correlations between 24-hour urinary
iodine concentration, estimated salt intake and body size, WHO-SAGE W3, SA.
All

Man

Women

(n=697)

(n=216)

(n=481

r

0.4050

0.4166

0.3999

p

<0.0001

<0.0001

<0.0001

r

0.0210

0.1227

-0.0081

p

0.5944

0.0859

0.8641

r

0.0425

0.1684

0.0103

p

0.2736

0.0161

0.8263

r

0.0460

0.0156

0.0561

p

0.2481

0.8304

0.2416

r

-0.0319

-0.0008

-0.0439

p

0.4429

0.9914

0.3882

Correlation with 24-hour urinary
iodine concentration (µg/day)/;’
Salt intake (g/day)
BMI (Kg/m2)
Weight (Kg)
Waist circumference (cm)
Hip circumference (cm)

Correlations between iodine and body size controlled for salt intake.

Table 7. 4 Spearman’s rank-ordered and partial correlations between 24-hour urinary
iodine concentration, estimated salt intake and body size, SAGE Ghana W3.
All

Man

Women

(n=471)

(n=162)

(n=309)

R

0.1501

0.1494

0.1460

P

0.0011

0.0678

0.0102

R

0.1051

-0.0266

0.1768

P

0.0254

0.7421

0.0023

R

0.1191

0.0136

0.1704

P

0.0107

0.8655

0.0030

R

0.1595

0.1353

0.1873

P

0.0006

0.0922

0.0012

R

0.1466

0.0709

0.2030

P

0.0019

0.3790

0.0005

Correlation with 24-hour urinary
iodine concentration (µg/day)
Salt intake (g/day)
BMI (Kg/m2)
Weight (Kg)
Waist circumference (cm)
Hip circumference (cm)

Correlations between iodine and body size controlled for salt intake
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Data from a sub study of WHO-SAGE SA Wave 2 [14] that were collected immediately prior
to implementation of the salt legislation in 2016; by which time some manufacturers may
have already reformulated their products [18], supports the current finding. The impact of
the SA salt legislation on consumption of iodine has not been thoroughly investigated to
date [19], and with more stringent salt restrictions that came into effect in June 2019 [20],
adverse consequences on iodine intake of the population needs to be carefully monitored.
Fortification levels of iodine in salt may need to be revised accordingly. Based on the current
policy that mandates iodization of table salt, the results could be interpreted that, those in
the highest category of salt intake may have been using more table salt (iodised) thus
contributing to higher iodine intakes but lack of dietary data limits further interpretation. It
has previously been reported that despite manufacturers not being required by law to use
iodized salt in processed foods (only table salt falls under the legislation), commercial use
of iodized salt in processed food production is common. Significant amounts of iodine were
detected in a third of foods surveyed, and these were common brands of bread, margarine
and salty snack flavourings [21]. If food manufacturers have previously used iodized salt
in food processing, then salt reduction legislation may inadvertently reduce population salt
iodine [19].
In relation to Ghana, the finding that, participants who had high salt intakes also had low
iodine intakes, might be explained considering salt use behaviours. Previous studies have
reported that salt intake in Ghana is high, and that only a third of households nationwide
had access to sufficiently iodized cooking or table salt [, 17, 22,]. The 2014 Ghana
Demographic and Health Survey also indicated that 36.6% of women and children live in
environments with no iodized salt [23], and only 4 in 10 households consumed salt with
adequate iodine [24]. Additionally, traditional eateries (i.e. informal eating places outside
the home called ‘chop bars’) are popular in Ghana [25], however, a good number of these
tend not to use iodized salt in their meal preparation [26]. The potential widespread use of
non-iodized salt in Ghana is a practice that requires monitoring as it poses a major setback
to effectiveness of the USI programme. Our data supports findings from surveys that have
202

reported widespread availability non-iodized salt in Ghana, that is related, in part, to
relative affordability of iodized salt and consumer low education on the importance of using
iodized salt [19, 27-29]. Findings from the Ghana Iodine Survey (GIS) indicated that half of
all households in the south-salt-producing areas and approximately half of households in
the mid region of Ghana were accessing salt with no added iodine, thus violating the Public
Health Amendment Law 2012 Act 851 [17, 30]. Only 8.6% of the national sample of
households were using salt with iodine levels in the WHO recommended range of 15-40ppm
for household salt, suggesting that production methods for salt iodisation, may have been
compromised [17, 31]. Chemical analysis of the iodine content in 11 most popular brands of
iodized salt in Ghana indicated that, only 3 brands met recommended 50ppm of iodine at
retail [32]. Both household and market surveys also reported that low availability and high
cost of adequately iodized salt were deterrents to accessing the commodity [29]. In the
current study, despite known inadequacies in the salt iodisation programme in Ghana,
median UIE was considerably higher than in SA. Other sources of iodine warrants
consideration.
Our study found that median salt intake was considerably lower in the SA sample compared
to the Ghana sample as expected because of salt legislation for maximum salt levels
permitted in processed foods [19] and other national health promotion programmes to
reduce discretionary salt intake, such as Salt Watch [33]. The high morbidity and mortality
associated with noncommunicable diseases [34], has resulted in many countries embarking
on salt reduction interventions to reduce hypertension and cardiovascular disease [35],
however such strategies do not exist in Ghana. The current analysis is supported by data
from both WHO-SAGE SA Wave 2 [14] that raised concern that salt reduction strategies may
adversely affect iodine consumption. However, other studies provide conflicting results
[36, 37]. A previous study in South African adults in 2004, reported no difference in median
urinary UIC across salt intakes categories [13]. Reasons are unclear but at that time, it was
assumed that the predominant use of non-iodized salt in the production of processed food
products resulted in lack of a difference in iodine across a range of salt intakes. Additionally,
203

national data collected in 2002 showed that 37.3% of households in SA used non-iodized
salt at home [38].
Our findings highlight a need for health authorities in Ghana and SA to continually monitor
both salt and iodine intakes in order to adjust salt iodization levels as required, to ensure
the compatibility of salt iodisation and salt reduction strategies [39]. Monitoring of salt
iodization at any point along the food supply chain (i.e. production, packaging, storage,
retail outlets and homes) is key in ensuring efficacy of salt iodisation. Greater advocacy
efforts are required to result in implementation of healthy food environment polices geared
towards the prevention of nutrition related-noncommunicable disease (NCDs) in Ghana.
An analysis of 41 food environment policies investigated in the country rated 75% of all
good practice indicators as ‘low’ [40].
It is also timely for SA to reconsider iodine levels in table salt [41, 42] to meet the needs of
those with lowest salt intakes while at the same time avoiding excessive iodine supply to
areas where salt intake is high. In both countries, coordination and collaboration between
government agencies and sectors are needed to harmonize food policies to enhance their
effectiveness. A multi-sectoral approach backed by a strong political or social interest from
government will be most appropriate.
Strengths of the study include: 1) the comparison of salt and iodine intake in two low to
middle income countries, both with mandatory salt iodisation programmes but only one
with a mandatory salt reduction policy; 2) large nationally representative sample of
participants aged 50+ years and; 3) the use of the gold standard method (24-hour urine
collection) for measuring salt intake. Limitations include loss of sample size due to
incomplete survey or urine collections, and gender disparity with more women than men
likely to provide urine samples in both countries. Data collection procedures may have
created a selection bias for greater participation by those who were home or had flexible
employment requirements. . A lack of dietary intake data limits the ability to identify which
sources of food contributed to total salt or iodine intake in both countries. Additionally, this
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study excluded pregnant women and children therefore further study is warranted among
those iodine-sensitive groups.
7.4 Conclusions
While SA’s salt legislation may influence its population iodine intake, salt iodisation
programmes in Ghana require effective regulation. Our findings highlight an urgent need
to continually monitor the effectiveness of salt iodisation programmes especially in
countries where salt reduction efforts are being undertaken to meet WHO’s global voluntary
target of population intake of less than 5g salt/day.
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Chapter 8
Towards Population Salt Reduction to Control High Blood
Pressure in Ghana: A Policy Direction
This chapter completes the study by discussing actions that were taken, after the initial
chapters have provided substantial evidence of sources of dietary salt, level of salt intake,
salt use behaviours, hypertension prevalence and the determinants thereof, in Ghana. The
chapter details a high-level stakeholder engagement conference that was attended by
government agencies, academics, research institutions, non-governmental organizations
and international bodies in Ghana, to evaluate the evidence provided and discuss
population salt reduction strategies to curb hypertension in the country. This chapter
demonstrates roles that government, various agencies, groups and individuals must play to
build advocacy and support for salt reduction. The chapter highlights recommendations
and action plans that were discussed by stakeholders, and which were to be considered in
by the Health Ministry of Ghana.

This chapter is the substantive content of the published work:
Elias Menyanu, Leonard Baatiema, Karen Charlton, Michael Wilson, Ama De-Graft Aikins,
Joanna Russell, Members of the NCDs Support Center for Africa, Towards Population Salt
Reduction to Control High Blood Pressure in Ghana: A Policy Direction, Current
Developments in Nutrition, nzaa084, https://doi.org/10.1093/cdn/nzaa084
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Abstract
Although population salt reduction is considered a „best buy‟ in addressing hypertension
and cardiovascular disease, Ghana shares a high hypertension burden with a seemingly
high salt consumption. This paper discusses best practices in reducing population salt intake
and preliminary data on salt and K intake, and the process to develop a road map and
identification of actions needed to support the development of a strategic national
document towards salt reduction in Ghana. In February 2019, a two-day stakeholder
meeting was held with government agencies, researchers, non-governmental organizations,
civil society organizations and international partners to deliberate on salt reduction
strategies and interventions needed in the face of rising hypertension and other
noncommunicable diseases (NCDs) in Ghana. Recommendations were developed from the
stakeholder meeting and are being considered for inclusion in the revision of Ghana’s
national NCD policy.
8.1 Introduction
Hypertension was highlighted as the leading risk factor for disability and mortality in 2017
Global Burden of Disease Study accounting for 10.4 million deaths and 218 million disability
adjusted life lost years [1]. One-third of the global hypertension burden is experienced in
LMICs where on average one in three adults are hypertensive [2]. Irrespective of age, the
risk of dying from high hypertension in LMICs is more than twice that in high-income
countries (HICs). While HICs experienced 7% mortality due to hypertension, LMICs such
as those from the African region recorded figures as high as 25% for all persons less than 60
years [3]. The sub-Saharan African region had the greatest burden of hypertension globally
as of 2015 [4] and this is projected to increase in the coming decades [5].
Ghana is a country in West Africa with a population of 25,758,108 [6], and that is
experiencing rapid economic growth, along with an increase in health expenditure [7, 8].
Over the past two decades, the country has increased its public healthcare spending by 11%
[9], however this has not translated into an expected improvement in human resources (as
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there is a decline in the number of healthcare personnel) [10] nor enhancement of existing
healthcare equipment and facilities [9, 11]. There has been a reported increase in NonCommunicable Disease (NCDs) in Ghana claiming an estimated 86, 200 lives each year [12].
The severity of hypertension was demonstrated by Addo et al., where nearly half of people
identified with hypertension in Ghana in 2008 had evidence of target end organ damage
[13]. In 2014, health facility-based records indicated that hypertension was the leading cause
of disability among adults in Ghana [14]. More recent estimates of hypertension prevalence
in Ghanaian adults using cohort data of largely 50 years and older, reported a figure of
58.9%, of which 19% aware of their hypertension status. Of those aware of their
hypertension status, 67.6% were receiving treatment but only 11.6% of those being treated
had controlled BP [15]. Whilst families, communities and economies continue to be
impacted by this burden,
current health systems are unable to adequately manage the large numbers of persons with
hypertension [16].
Preventive strategies are urgently required in Ghana to reduce the hypertension burden.
There are two approaches that could be adopted. Reduction in the prevalence of raised BP
could be achieved through a shift in the entire distribution of BP to the left, or through a
targeted approach to condense the high-blood-pressure tail by implementing intensive
clinical interventions to control BP in the hypertensive population [17]. The latter approach
depends on well-resourced health services, while the former requires a public health
approach. A pooled analysis of 88.6 million participants demonstrated that a change in
mean BP of the population is the main driver of the worldwide change in the prevalence of
raised BP [17], providing evidence for the effectiveness of a population-wide strategy.
Habitual consumption of excess salt is well-known major risk factor for raised BP, and
contributes to cardiovascular-related disability and premature deaths globally [18] with one
in ten deaths from cardiovascular disease (CVD) being attributed to excessive salt intake
[19]. Reducing population salt intake has been identified as a voluntary global target to
reducing salt intake by 30% by 2025 and a World Health Organization’s (WHO) “best buy
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“strategy to reduce long-term risk of stroke, coronary heart disease and premature mortality
from NCDs
[20, 21] Considering this target, international best practice policies, guidelines and
interventions have been developed to reduce excessive salt intake at the population level as
part of efforts to prevent and control high BP levels. Currently, populations around the
world are consuming an average of 9-12 grams of salt a day or around twice the maximum
recommendation of the WHO (ie. 5g/day) [22].
It has been estimated that 2.5 million deaths could be prevented each year if global salt
consumption was reduced to less than 5g a day [22]. Despite considerable progress towards
achieving this goal in many countries [23] low-middle-income countries in Africa have been
slow to adopt salt reduction strategies within their public health priorities. Much of the
attention in the past has been on infectious diseases [24] though morbidity and mortality
from NCDs are projected to overtake infectious diseases by 2030 [25, 26]. With the exception
of SA and Mauritius, mandatory legislation to regulate salt content in the food supply has
not been adopted on the African continent [23].
In Ghana, most of the population consume processed foods that are high in salt [14]
and*report a high use of discretionary salt added to foods at the table and in food
preparation [27]. Rapid urbanization, population growth and changing lifestyles have
resulted in a rapid nutrition transition in the country and that has resulted in an increased
intake of processed foods [28]. However, a community-based intervention study has
demonstrated that BP could be lowered through behavior change related to salt reduction
strategies [29]. As well as salt intake, other lifestyle related risk factors for CVD include lack
of physical inactivity, smoking, excessive intake of alcohol and low intake of fruit and
vegetables [30].
To address this gap in policy around the need for public health interventions to address the
rising prevalence of hypertension and other NCDs in Ghana, an international conference on
NCDs was held at the Noguchi Memorial Institute for Medical Research, University of
Ghana from the 15th-16th of February, 2019. The conference was organized by the NCDs
Support Centre for Africa at the University of Ghana, in collaboration with the University
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of Wollongong, Australia, through a grant provided by CDC Foundation with financial
support provided by Bloomberg Philanthropies as part of the WHO-SAGE salt sub-study.
Additional funding support was received from the Ghana National Petroleum Corporation.
Sixty-seven participants attended the conference, including representatives from
government agencies, academia, Non-Governmental Organizations (NGOs), Civil Society
Organizations (CSOs) and international partners. The conference allowed for plenary and
small group discussions to discuss implementation strategies relevant to Ghana, and to plan
the way forward for Ghana to adopt a strategy to reduce population level BP through salt
reduction policies. Specific objectives of the conference included:
1. To provide a platform for academics, policy makers, CSO/NGOs and state actors to be
informed and share experiences/lessons in relation to high BP control using salt
reduction strategies.
2. To support participants to understand and make use of the evidence on the best practice
interventions to reduce excessive salt intake in foods.
3. To provide a road map and identify necessary actions to support the development of a
strategic national document towards salt reduction in Ghana.
4. Identify opportunities for collaboration, capacity building and advocacy to ensure the
development of a legislative instrument on salt reduction in foods.
8.2 Meeting Outcomes
Professor Michael Wilson, Director of the NCD Support Centre for Africa, opened the
conference and expressed his appreciation and gratitude for such a gathering of people with
an intense interest for NCDs in Ghana. Professor Karen Charlton, University of
Wollongong, provided a global overview of progress on salt reduction. While highlighting
the global NCD targets, she reminded participants of governments‟ commitment and
responsibility to salt reduction and ultimately hypertension [22]. Professor Charlton
explained that food reformulation strategies, either through mandatory or voluntary salt
targets have been successful in reducing population salt intakes in the United Kingdom and
Australia [31].
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Multifaceted approaches that include industry salt reduction in foods, food labelling, and
consumer education have been successful in various countries. While stressing the
feasibility of WHO‟s less than 5g salt per day recommendation, she highlighted the need to
also monitor population iodine levels in countries with universal salt iodization [32],
particularly for children and lactating mothers who are vulnerable to iodine deficiency
disorders [33]. Population salt reduction has implication for iodine consumption, as salt is
used as the vehicle for iodine fortification. If salt is adequately iodized, a reduction of salt
to the recommended level should still provide enough iodine [34]. She demonstrated how
WHO’s ‘SHAKE the salt’ package would assist WHO member states with the development,
implementation and monitoring of salt reduction strategies to enable them to achieve a
reduction in population salt intake [35].
8.3 Local Situation
Dr Dennis Laryea, the NCDs program manager of the Ghana Health Service (GHS)
identified a need for more research, to generate local evidence on NCDs to inform policy.
He stressed importance of addressing high salt consumption since hypertension is one of
the top five NCDs, with regards costs to the Ghana National Health Insurance Scheme. The
composition of salt in traditional Ghanaian foods, such as salted fish, is not well
documented. The conference was timely in that the NCD unit of the Ghana Health Service
was in the process of revising its national policy on NCDs and developing strategic plans
for its implementation and thus, relevant insights from the conference will inform its
development.
Dr Sandra Boatemaa, a postdoctoral researcher, provided new (unpublished) data on food
sources that contributed the most salt to the Ghanaian diet. These included bread, bouillon
cubes, salted fish or meat, instant noodles and pizza with rural populations and
communities living in the northern region of Ghana consuming more salty foods than those
in urban areas, or those in other regions of the country [14]. The emergence of energy dense,
nutrient poor, processed convenience foods such as salty snacks, ready-made baked,
desserts and sweetened products has dramatically changed the Ghanaian food environment
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[36]. While more than a third (36%) of participants during the 2014 Ghana Demographic and
Health Survey reported having consumed salted dried fish on a daily basis [14] the Ghana
National Iodine Survey Report 2015 reported frequent and widespread use of bouillon
cubes with nearly half (48.8%) of the participants reporting consumption of more than 5
times a week [37]. The importance of salt in the Ghanaian cuisine was highlighted by
conference delegates as a challenge to changing consumer preferences and food preparation
behavior.
Despite the large body of evidence that supports the association between high salt intake
and hypertension, very little attention has been given in Ghana in terms of salt reduction
policies. Further, only limited small-scale community studies on salt reduction strategies
have been conducted [29]. WHO-SAGE biostatistician, Dr Nadia Minicuci, presented data
that indicated that much of the NCD burden is preventable or modifiable but stressed that
ongoing surveillance is needed to inform policy and to make changes to health systems.
8.4 Interventions to Date
Professor Ama de-Graft Aikins, a social psychologist reported that most of the interventions
to address NCDs in Ghana have focused on strengthening three of the six health system
building blocks, namely: information systems; health workforce; and service delivery [38].
She recommended the scaling up of interventions that work, making use of cost-effective
interventions, addressing NCDs as a developmental issue and empowering communities to
be more aware of the risk factors for NCD development. While identifying NCDs
interventions, Dr Leonard Baatiema, a postdoctoral researcher, drew the attention to the fact
that, despite the increasing burden of NCDs in Ghana, there has not been any systematic
effort to profile existing initiatives and interventions in the country to either prevent or
control NCDs. Interventions to date that have targeted hypertension, diabetes, stroke and
cancer prevention and control have been concentrated in urban cities, mostly Accra and
Kumasi [39-43].
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8.5 New Data on Salt Intake in Ghana
The paucity of salt intake data in Ghana has been a setback to the initiation of population
level salt reduction strategies, as evidence is required to drive political commitment and the
public health agenda [32]. Professor Richard Biritwum, the principal investigator of WHO SAGE, Ghana, provided an overview of the six-country cohort study, with special reference
to WHO-SAGE (Ghana) Wave 3 that has incorporated a nested salt sub-study [44]. This sub
study is the first attempt to measure national population salt consumption and assess its
association with hypertension and co-morbidities in Ghana.
Professor Charlton provided preliminary urinary salt results from WHO-SAGE (Ghana)
Wave 3 for one region (Ashanti) out of ten sampled regions. With a mean salt consumption
of 8.54±5.23g/day for men and 10.33±7.91g/day for women (n = 277), the younger
participants, 18-49yrs (n = 56) consumed more salt (10.91±7.37 g/day) than older adults aged
50+ yrs (n = 221) (9.43±7.00 g/day). It was also noted that, while 73.2% and 79.9% of men
and women, respectively, had intakes above the WHO‟s < 5g/day salt recommendation,
65.8% and 67% fell short of WHO‟s K recommendations of 90mmol//day [45].
Though preliminary, this data obtained from one of the most populated regions of Ghana
suggests that salt intake is excessively high in both men and women, and among both young
and old. Comparatively, salt intakes seem to be higher in Ghana compared to SA [46] while
K intake appears relatively higher in Ghana. In agreement with Professor Charlton’s
finding, Elias Menyanu, a PhD candidate, presented data on salt use behavior from WHOSAGE Ghana Wave 2 data. Compared to South Africans, Ghanaians added more salt to food
during cooking, but had much lower levels of obesity and smaller waist
circumference measures. As would be expected from major differences in obesity, the South
African sample had a higher age-standardised prevalence of hypertension than Ghana [47].
Differences in determinants of awareness, treatment and control of hypertension were also
evident between the countries, at least for women. Such differences would need to be
considered in policy development. It is clear that salt reduction strategies in Ghana would
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need to focus both on salt reduction in the food supply, as well as efforts to raise consumer
awareness on discretionary salt use in cooking and added to foods at the table [27].
8.6 Discussion
Throughout the conference and in break-out sessions, participants highlighted the essential
role of the Food and Drugs Authority of Ghana (FDA) in the monitoring and surveillance
of the food supply, in relation to NCD risk. It was acknowledged that the standards of the
FDA do not include how much Na is permissible in various food products. Additionally,
Ghana does not have food labelling standards nor does it have adequate laboratory facilities
to analyze the Na content of foodstuffs. Representatives from the FDA explained the
difficulties and constraints experienced by the directorate from food industry if such
regulations were to be adopted and enforced.
Another issue that arose from the lively discussion was the fact that the structure of the basic
school level curriculum did not sufficiently inform children with life skills about healthy
eating habits, including salt consumption. It was agreed that the Ministry of Health (MOH),
in collaboration with the Ministry of Education, should make it mandatory to reduce salt in
foods served in schools (particularly schools where the government is implementing the
National School Feeding Programme) [48] as well as in other environments, such as
workplaces and healthcare institutions.
Despite the existence of a national NCD policy in Ghana [12], a need was identified for more
advocacy for NCD prevention, as well as for participants with expert knowledge on NCDs
to make themselves available for media communication. There was also a call for
stakeholders and researchers to better utilize social media opportunities to ensure
dissemination of information on NCDs.
Break out group discussions addressed the following issues, according to the ‘SHAKE the
salt’ framework: (1) institutional nutrition standards (2) industry salt reduction targets (3)
front of pack labels for packaged food (4) reduction of salt in foods prepared outside the
home and (5) behavior change communication to reduce salt use.
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8.6.1 Institutional standards
The main issues raised included the implementation of the policy on NCDs which will
ensure the targeting of foods containing hidden salts (such as processed and restaurant
foods) through legislation and education. Participants discussed a need for the MOH to
liaise with other ministries and agencies such as the Ministry of Food and Agriculture
[MOFA] and Ministry of Tourism, as well as key institutions to provide a consistent message
around salt reduction. The Ghana National Communication Authority (NCA) was
identified as a relevant stakeholder in this regard according to its mandate to advocate for
consumer education and protection rights. Stricter control of food advertising of unhealthy
foods was identified as a priority.
8.6.2 Industry salt reduction targets
There was discussion regarding a need for updated analytical data on food composition in
Ghana. Dietary surveys are required to identify foods that are major contributors to total
salt intake. Voluntary targets for the food industry regarding maximum salt targets
permitted in processed foods were identified as a crucial and the roles of NCA, FDA, NGOs
and CSOs as partners in this process was emphasized.
8.6.3 Front of pack labelling for packaged food
The FDA representatives reported that nutrition information panels will soon become
mandatory for some categories of food products. Food labels are required to be legible and
in bright colors to make them easily identifiable. Discussants argued that the FDA should
develop guidelines for salt content in food items and identify those products with high salt
using consumer signposting warnings, as has occurred in Chile [49]. Similarly, there was
support for restaurants and food outlets to display the salt content of their products. The
FDA was urged to improve its education and advocacy programs to promote healthy diets,
particularly aiming to reach vulnerable and hard-to-reach communities. In addition,
regulation of advertising on food products needs attention by the FDA.
8.6.4 Reduction of salt in foods prepared outside the home
All stakeholders were in agreement of a need to develop a multi-sectoral approach to
addressing excess salt in foods consumed outside of the home, including consumer
sensitization and education on salt use; removal of salt and bouillon cubes from eating
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tables; limiting the consumption of salty snacks; education and training of food vendors;
and enforcement of food regulations by the FDA.
8.6.5 Behaviour change communication to reduce salt use
The socio-cultural context was identified as being essential in considering the development
of health promotion messages on salt reduction. Discussants suggested using sketches and
drama productions in communities to demonstrate the feasibility and benefits of a low salt
diet. Other strategies that were suggested included the use of persuasive salt reduction
messages, the engagement of role models and opinion leaders to act as ambassadors for salt
reduction as well as a national educational campaign on salt reduction.
Several recommendations and associated action plans emerged from the meeting, as
summarized in Box 1. These resulted from consensus reached by participants in plenary
report-back sessions from breakout groups, and represent views that were unanimously
shared by participants.
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Box 1. Recommendations and action plans for salt reduction in Ghana
1.

Participants emphasized the urgent need to raise awareness of the relationship between excess salt intake and the occurrence of hypertension
using various media channels. Given limited policy attention on salt reduction in Ghana, participants agreed on the need for public health
education campaigns to reduce high intake of salt among Ghanaians.

2.

Foods that contribute large amounts of salt to the Ghanaian diet were to be identified alongside a massive consumer education to reduce the
intake of such foods or use healthier alternatives.

3.

The Ghana government and the FDA were to negotiate with food industries and food vendors to voluntary reduce salt content in their products.

4.

The FDA was to initiate processes that will ensure that most food products have labels.

5.

Participants expressed the requirement to explore alternate funding sources to support the implementation of salt reduction interventions.
Domestic funding sources from the state, private individuals and organizations should be explored to support hypertension prevention/control
interventions.

6.

Participants emphasized the need for the provision of adequate resources/facilities for community hypertension screening and information
programmes.

7.

The GHS and MOH as well as corporate bodies were urged to facilitate the establishment of modern laboratories with the capacity to analyze
the Na content and other nutrients in food.

8.

Adequate and accurate salt consumption monitoring and surveillance data are required through national research studies. Periodic capture of
data at both community and population levels must be prioritized. A current national nutrition survey is needed to support salt intake data to
enhance policy formulation.

9. A multisectoral approach was identified as essential in addressing discretionary salt use. Key stakeholders to be included are MOH, GHS,
MOFA, etc.
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8.7 Conclusion
The importance of using multi-sectoral engagement to promote NCDs has been recognized
in the Global Action Plan for the Prevention and Control of NCDs. The outcomes of a highlevel stakeholder meeting held in Ghana has demonstrated the feasibility of such an
approach in population level salt reduction intake in the country, with nine action items
identified for inclusion in Ghana’s national NCD policy.
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Chapter 9
Conclusions and Recommendations

9.1 Overview of core findings
Hypertension is a major burden of disease in many LMICs, including Ghana, a country on
the West coast of Africa [1, 2]. The increasing prevalence of hypertension is largely
attributed to adoption of unhealthy dietary behaviours resulting from the widespread
availability of energy dense nutrient poor (EDNP) foods that are typically high in salt
associated with the nutrition transition that accompanies urbanization [3].
The theoretical framework for the thesis was based on the World Health Organization
(WHO)’s “SHAKE the Salt Habit” (SHAKE) resource which guides countries that are
beginning to address salt reduction strategies. SHAKE recommends firstly identifying
quantities and dietary sources of salt intake in the population of interest, as well as
determining salt use behaviours and consumer awareness of the adverse health effects of
excessive salt intakes. SHAKE also strongly urges intersectoral engagement with key
stakeholders to develop policy action to drive governmental efforts towards the reduction
of salt intake and to result in a population shift to the left in blood pressure distribution and
thereby a lower burden of hypertension [4]. One of the foremost approaches to population
salt reduction recommended by SHAKE is the monitoring and evaluation of diets that
contribute the most salt to food. Data provided in this thesis is the first step in that process
and provides a baseline measure from which further monitoring can be compared.
The body of work in the thesis began with a substantial critical review of existing evidence
to identify modifiable determinants of hypertension with a focus on dietary sources of salt
in LMICs (Chapter 1). Identified dietary risk factors for hypertension included both a high
salt and low potassium intake.

The review also considered available salt reduction
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strategies and the involvement of food manufacturers in setting of voluntary targets and/or
maximum limits of salt in a variety of foods. Additionally, the review identified the key
roles played by governments, institutions and private organizations in population salt
reduction efforts.
A primary aim of this thesis was to obtain a reliable estimate of current population salt
consumption levels, and their relation to blood pressure, in Ghana, for the development of
a road map for advocacy, support and policy formulation towards salt reduction. In order
to achieve this, the thesis comprised five original studies, which culminated in a high-level
stakeholder meeting to obtain consensus on strategies required to address the high
prevalence of hypertension and other NCDs in the country.
By leveraging data collected in various waves (1-3) of the large WHO-SAGE prospective
study, this novel study adds new knowledge about trends in BP, hypertension prevalence,
awareness, treatment, control. In addition to the main survey data, much of this thesis
relates to findings of a nested sub-study in which 24hr urinary sodium and potassium
collections were obtained to provide much needed information on the salt intake of the
Ghanaian population (Chapter 4). This is the first such national data and provides essential
evidence to drive policy, planning and further research on salt reduction. The doctoral
candidate was involved in all aspects of the data collection and execution of the salt substudy and worked closely with WHO-SAGE Ghana Primary Investigator, Professor Richard
Biritwum to this effect.
Comparison of data from Ghana with that of the WHO-SAGE South African sample (Waves
2 and 3) has provided an opportunity to learn from a country that has adopted a mandatory
salt reduction policy that limits maximum salt levels permitted in a wide range of processed
foods. WHO-SAGE South Africa Wave 2 was completed immediately prior to
implementation of the policy that came into effect in June 2016, whereas Wave 3 was
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conducted in the interim period between Phase I and the more stringent Phase II
(implemented in June 2019) stages of South Africa’s salt reduction policy.
The gold standard method to assess population salt intake, namely 24hr urinary sodium
excretion, was used in both Ghana and South African salt sub-studies (Chapter 4). This
method provides an overall quantitative estimation of daily salt intake but does not provide
information on dietary sources of salt, and what proportion of salt comes from discretionary
(i.e. salt added to food at the table or in cooking) versus non-discretionary (salt inherent in
foods, and added to foods during commercial processing) sources. It was not logistically
feasible to include a detailed dietary assessment in the WHO-SAGE surveys, however the
research team did include validated questions on discretionary salt use behaviours in the
main surveys included in both Waves 2 and 3. This allowed comparison between the salt
use South African samples as reported in Chapter 3. Interestingly, South Africans were
almost five times more likely than Ghanaians to add salt to food at the table but less likely
to add salt to food during cooking. To date, little attention, if any, has been given to mass
media health education efforts to encourage salt behaviour change in Ghana. These findings
support a need for efforts in Ghana to raise consumer awareness on discretionary salt use
and provide insight into how to tailor health education and health promotion campaigns on
salt use in both countries.
Due to a lack of detailed dietary intake data, a systematic literature review was undertaken
to identify major sources of salt intake in LMICs (Chapter 3). Processed foods including
breads, meat and meat products, bakery products, instant noodles, salted preserved foods,
milk and dairy products, as well as bouillon cubes, were identified as sources of high salt
intake in LMICs. The review also identified that drinking water, particularly in drought
affected areas, could be a potentially significant source of salt intake. Findings from the
review can be used by countries beginning to consider which foods to target for
reformulation to lower their salt content.
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In order to identify changes in blood pressure that occur with age participants aged 50+y
that were present in the WHO-SAGE Ghana Wave 1 (2007/8) cohort and were again
followed up in the Wave 3 survey conducted twelve years later in 2019, comprised an
analysis to determine the trajectory of BP and its determinants (Chapter 6). Somewhat
surprisingly, in these individuals, a fall in diastolic BP was observed but no change in
systolic BP which resulted in a consequent increase pulse pressure. Increasing pulse
pressure may indicate a higher risk for internal organ damage, myocardial infarctions and
cardiovascular events [5, 6]. A decrease in DBP was associated with increasing age, living
in rural settings and having health insurance. Though no differences existed over time
between the proportion of hypertensives who were receiving antihypertensive treatment,
nor the proportion who had their hypertension controlled, the awareness of having
hypertension (i.e. diagnosis) increased significantly between the two time periods. Residing
in rural areas, having a higher BMI and having voluntary health insurance were associated
with increased hypertension awareness. This suggests that health services have become
better at diagnosing hypertension, but that hypertension remains poorly managed, once
diagnosed. The findings from this study confirm a need to implement non-pharmacological
population-based strategies to reduce blood pressure.
To build advocacy and support for salt reduction intervention in Ghana, a population
estimate of salt and potassium (K) intake, and their relationship with BP was investigated
(Chapter 5). A high salt intake coupled with a low K intake, a relatively higher Na: K and a
steeper slope between the high Na: K ratio and age for SBP and DBP in Ghana, indicated
both a need for salt reduction strategies in the country but also dietary interventions to
increase K intake, commonly found in fruit and vegetables, dairy and animal flesh products.
The chapter also highlighted the tendency for populations to underestimate their salt intake
and further emphasized the need for periodic evaluation of the food environment using
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objective 24hr urinary collections. National dietary surveys are important to elucidate food
sources of salt but these should also be accompanied by an updated Ghanaian food
composition database that will allow determination of salt from dietary reports.
Due to universal salt iodization (USI) being implemented in Ghana, as in many other
countries, to prevent iodine deficiency, the WHO recommends that any assessment of salt
intake should be accompanied with determination of adequacy of iodine intakes since both
metrics can be determined from urinary outputs. For the first time in Ghana, urinary iodine
excretion was compared with salt intake. A novel comparison of iodine-salt intake
associations was undertaken between Ghana and South Africa (Chapter 6) because both
countries have adopted USI but only South Africa has implemented salt reduction. Since
table salt is required by law in both countries to be iodized, it is possible that efforts to lower
salt intake may inadvertently lower iodine intake too. Data from participants included in
the salt sub-study in both countries for WHO-SAGE Wave 3 identified an overall adequate
intake of iodine in Ghana and South Africa, but that urinary iodine excretion differed
significantly across salt intake categories in both countries but in opposite directions. In
Ghana, a moderate, inverse correlation was observed, compared to a moderate, positive
association in SA. Participants with salt intakes <5g/day in South Africa did not meet WHO’s
recommended iodine intake of 150µg iodine per day, but this was not the case in Ghana.
This study suggests that monitoring and surveillance of iodine status is recommended in
countries that have introduced salt reduction strategies (such as South Africa) in order to
prevent re-emergence of iodine deficiency. This important finding highlights a need for
LMICs to consider salt iodization programmes alongside salt reduction strategies to ensure
optimal levels of both iodine intake and reduced salt consumption can be achieved.
The final part of this thesis comprises a high-level stakeholder engagement conference that
was held in Ghana in February 2019 to share the findings of the body of work, and to build
support and advocacy for salt reduction strategies to reduce hypertension in the country
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(Chapter 8). The two-day conference concluded with a 9-point recommendation that is
currently being considered for inclusion in the revision of Ghana’s national NCD policy. The
outcomes of the conference have been published in an open access international, peer
reviewed journal and are available for widespread access by government officials,
academics and community-based organizations alike. Bringing together a wide range of
important stakeholders has allowed an immediate translation of the research findings into
a tool for advocacy for policy change.
Overall, the findings of these study support the hypothesis that salt consumption and
hypertension are both high in Ghana. While no direct association was found between salt
intake and BP, a higher Na: K ratio was associated with increasing BP with age. This
suggests that salt reduction strategies need to be pursued but alongside dietary
interventions to increase dietary potassium intake. Such efforts will require collaboration
between directorates for NCD Prevention and Nutrition.
9.2 Strengths and Limitations
Methodological strengths and limitation of the study have been briefly outlined below.
Specific strengths and limitations for each study have been comprehensively described in
each thesis chapter.
The WHO-SAGE study selects a national sample of predominantly older participants, as
such findings can be generalized over a large proportion of the population. This cohort of
the population form a large number of the vulnerable group in society, as such, this study
provides unique and valuable information about this cohort for policy formulation and
planning purposes.
The WHO-SAGE study makes use of internationally certified instruments and protocols for
data collection. Field workers are extensively trained by WHO experts prior to the
commencement of the data collection.
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The longitudinal nature of the study offered a rare opportunity to understand the trajectory
of BP and its determinants in Ghana. The study was also the maiden attempt to measure
population salt, iodine intake, and salt use behaviours in Ghana. The study provided
population hypertension prevalence, awareness, treatment and control estimates. The
nested sub study utilized the gold standard of 24hr urine collection with volume and
creatinine as a marker of urine completeness. Comparison of constructs between Ghana and
SA offered a unique learning opportunity and data for planning and further research in
LMICs.
The limitations of this thesis include the design of the WHO-SAGE study. The sampling
strategy of the study meant that younger people (18-49) were under-represented, thus
limiting the ability to generalize findings to the entire adult population. Nevertheless,
hypertension is a disease that mostly affects middle-aged and older adults therefore the
importance of the findings should not be minimized. Given the complex nature of
population-based studies such as WHO-SAGE conducted in LMICs that often have poor
infrastructure such as roads, data management issues can be expected and did indeed occur
in some cases where missing data was a challenge. Regardless, the overall large sample size
still allowed meaningful and statistically relevant analyses to be conducted. Another
limitation is the lack of a comprehensive dietary assessment in the WHO-SAGE surveys
which limits interpretation about food sources of population salt and potassium intake.
9.3 Future directions
While this thesis makes a substantial and novel contribution to the literature, it also
emphasizes the need for more research to strengthen the evidence base and break new
grounds.
Based on the findings, the following recommendations from the analysis from Ghana and
South Africa are highlighted for wider application to other LMICs:
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1. Identification of food products that contribute most salt in respective LMICs is required;
2. Governments in LMICs should engage food manufacturers to discuss the upper limits
of salt used in processed foods. Food manufacturers should be encouraged to
voluntarily reduce salt in their food products in the absence of mandatory salt reduction
legislation;
3. Government in collaboration with NGOs and CSOs should intensify public health
education on consumption of excess salt, with particular reference to processed foods;
4. Mass consumer health education is required to sensitize the public on mechanisms to
reduce or make healthier alternative choices to high salt foods, particularly for breads,
processed meat products, bakery products, instant noodles, salted preserved foods and
bouillon cubes; and
5. Public health campaigns on the implications of excess salt intake, should take a settingsbased approach, such as health places, schools and health centers.

Recommendations for Ghana and/or South Africa specifically
1. Interventions are needed to reduce population salt and to increase K intake in Ghana.
It is imperative to identify and increase the intake in order to change dietary Na: K
ratios.
2. Current or updated food frequency tables are required in Ghana for better monitoring
and evaluation of dietary intakes;
3. There is a need to intensity health promotion programmes that will increase knowledge
and instill positive attitudes and behaviours related to lower salt use in both Ghana and
South Africa;
4. There is a need to increase BP screening services within communities in Ghana.
Community centers and marketplaces in Ghana could be additional avenues for BP
screening services to obtain hard-to-reach persons;
5. There is the need to regularly monitor iodine intake in both Ghana and South Africa to
prevent re-emergence of iodine deficiency in the face of salt reduction strategies;
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6. A further study is strongly recommended to ascertain the effectiveness of the more
stringent (Phase II) salt legislation in South Africa.
9.4 Summary
In conclusion, this thesis has provided and addressed gaps in data on population salt intake
and hypertension in Ghana, and made useful comparisons with South Africa. A total of five
studies and one conference report addressed the overarching research question and added
new knowledge to the existing body of scientific evidence. The thesis contributes to the field
of nutrition, ageing, dietetic and public health with each study uniquely designed to address
a specific public health issue. Translational aspects of the research have been addressed
through a stakeholder consultation meeting held in 2019 that resulted in a road map of
activities that are required for policy formulation on population salt reduction.
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Appendices
Appendix A - Risk of bias assessment

Included
Studies

Were the
aims/objectives of
the study clear?

Was the design
appropriate for
the aim(s)
stated?

Was the
sample size
justified?

Was the target
population
clearly
defined?

Was the sample
taken from an
appropriate
population
base?

Was the selection
process able to
select a
representative
sample?

Were measures
undertaken to
address and
categorize nonrespondents?

Yes

Were risk
factors and
outcome
measured
appropriate to
the aims of the
study
Yes

Is it clear
what was
used to
determine
statistical or
precision
estimates?
Yes

Kerry et al.,
2005

Yes

Yes

No

Yes

Yes

Yes

Ferrante et al.,
2011
Charlton et
al., 2005

Yes

Yes

No

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

No

No

Yes

Yes

Liu et al., 2014

Yes

Yes

No

Yes

Yes

No

Yes

Yes

Yes

Zhao et al.,
2015
Health
Promotion
Board,
Singapore,
2011
Du et al., 2014

Yes

Yes

No

Yes

Yes

No

No

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

de Moura
Souza, 2013
Anderson et
al., 2010

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

No

Yes

Yes

Yes
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Appendix B – Instruments for data collection and consent forms

https://www.who.int/healthinfo/sage/cohorts/en/index2.html
www.who.int › survey › SAGESurveyManualFinal
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Appendix C - WHO Research Ethics Review Committee [RPC149]
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Appendix D - University of Ghana Ethical Clearance
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Appendix E - Supplementary Materials

Supplementary Table 3.1 Included articles and their
regions of origin
Reference

Country

Data

Study

Study

Collection

Emphasis

Design

Period
Americas
Ferrante et al.,
2011 [38]
De Moura
Souza et al.,
2013 [49]
Western
Pacific
Liu et al., 2014
[53]
Du et al., 2014
[65]
Anderson et
al., 2010 [55]
Zhao et al.,
2015 [50]
South East
Asia
Khan et al.,
2011 [52]

Health
Promotion
Board, 2011
[64]

Argentina

2006 and
2007
2008-2009

Product
Descriptive
Reformation
Dietary
Descriptive
Behaviour

China

2011

Dietary
Behaviour
Dietary
Behaviour
Dietary
Behaviour
Dietary
Behaviour

Descriptive

China

April to
Dec, 2011
1991 to
2009
1996-1999

Bangladesh

October
2009
through
March
2010
Not
reported

Dietary
Behaviour

Descriptive

Dietary
Behaviour

Descriptive

Brazil

China
China

Singapore

Descriptive
Descriptive
Descriptive
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Reference

Country

Data
Collection
Period

Study
Emphasis

Jordan

Not
reported

Product
Descriptive
Reformation

Iran

Not
reported

Product
Descriptive
Reformation

Bosnia
Herzegovina

Not
reported

Product
Descriptive
Reformation

Silva et al.,
2015 [43]

Mozambique

June, 2012

Charlton et al.,
2005 [54]

South Africa

Not
reported

Kerry, 2005
[51]

Ghana

June 2001
and June
2002

Nwanguma,
2013 [39]

Nigeria

Not
reported

Product
Descriptive
Reformation (Cross
sectional)
Dietary
Descriptive
Behaviour
(Cross
sectional)
Dietary
Cluster
Behaviour
randomized,
controlled
trial
Product
Descriptive
Reformation (Cross
sectional)

Eastern
Mediterranean
Hussain &
Takruri, 2016
[44]
Zibaeenezhad
et al., 2010 [37]
Europe
Vukic et al.,
2013 [46]
Africa

Study
Design
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Supplementary Table 5.1: Na, K, Cl and Cr of original and repeat
data in the same participants in Alajo EA
Na (mmol/l)
K (mmol/l)
Cl (mmol/l)
Creatinine
(µmol/l)
Statitsics
Original Repeat Original Repeat Original Repeat Original Repeat
data
data
data
data
data
data
data
data
Minimum
64.40
65.45
10.70
25.20
61.40
37.95
0.68
1.51
Median
249.40 126.33
78.85
65.43
269.40
93.85
1.94
4.24
Maximum
741.20 250.45
356.00 141.20
951.60 206.80
5.91
15.03
Mean
311.69 135.63
108.23
67.39
355.73 110.20
2.38
4.61
Sd
238.20
53.01
93.32
30.94
271.09
47.95
1.61
3.11
N
16
16
16
16
16
16
16
16
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Supplementary Table 5.2: Urine results for electrolytes,
creatinine and iodine by sex (urine data considered valid if
volume > 300ml), WHO-SAGE Ghana Wave 3
All
Men
Women
P
(n = 835)
(n =269) (n = 566)
24hour Urine Analysis
Sodium, mmol/24hr
n = 829
n = 267
n = 562
0.01
142.3
126.6
146.2 (127.3)
(130.8)
(125.7)
Salt excretion, g/day

Achieving salt
(<5g/day), n (%)
Potassium
mmol/24hr

n = 829
8.3 (7.5)

n = 267
7.5 (7.4)

n = 562
8.7 (7.5)

0.01

n = 276
72 (27)

n = 560
108 (19.3)

0.01

(K), n = 835
n = 269
65.9 (79.5) 62.6
(72.4)

n = 566
65.8 (77.4)

0.38

target n = 836
203 (24.3)

Achieving K target (≥90 n = 835
mmol/day), n (%)
357 (42.7)

n = 269
91 (33.8)

n = 566
200 (35.3)

0.67

Sodium-to-potassium
ratio

n = 829
2.1 (1.7)

n = 267
1.9 (1.5)

n = 562
2.1 (1.7)

0.06

Achieving Na:K ratio n = 825
(≤1.0), n (%)
59 (6.3)

n = 267
21 (7.9)

n = 558
31 (5.6)

0.20

Cr, mmol/24h

n = 835
3.4 (2.4)

n = 269
3.6 (2.6)

n = 566
3.3 (2.3)

0.15

24hr Iodine, µg/l

n = 799
140.8
(140.1)

n = 255
154.6
(152.3)

n = 544
137.8 (137.8)

0.02

Data are presented as median (IQR) unless otherwise stated; Mann-Whitney Test used to
compare medians, Pearson Chi-Square test and Fisher’s Exact Test used to compare
proportional data.
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Supplementary Table 5.3: Urine results for electrolytes, creatinine and
iodine by age (urine data considered valid if volume > 300ml), WHO-SAGE
Ghana Wave 3
≥50 years
18-49yrs
P
(n = 661)
(n = 174)
24hour Urine Analysis
Sodium, mmol/24hr
n = 656
n = 173
< 0.01
136.4 (120.3)
164.3 (138.2)
Salt excretion, g/day

n = 656
8.1 (7.1)

n = 173
9.7 (8.2)

< 0.01

Achieving salt target n = 654
(<5g/day), n (%)
159 (24.3)

n = 173
21 (12.1)

< 0.01

Potassium
mmol/24hr

n = 174
80.4 (93.3)

< 0.01

Achieving K target n = 661
(≥90 mmol/day), n (%)
212 (32.1)

n = 174
79 (45.4)

< 0.01

Sodium-to-potassium
ratio

n = 656
2.1 (1.6)

n = 173
2.1 (1.8)

0.33

Achieving Na:K ratio
(≤1.0), n (%)

n = 653
39 (6.0)

n = 172
13 (7.6)

0.45

Cr, mmol/24h

n = 661
3.4 (2.2)

n = 174
4.1 (2.5)

< 0.01

24hr Iodine, µg/l

n = 629
144.2 (141.6)

n = 170
146.5 (137.5)

0.63

(K), n = 661
61.7 (66.8)

Data are presented as median (IQR) unless otherwise stated; Mann-Whitney Test used to
compare medians, Pearson Chi-Square test and Fisher’s Exact Test used to compare
proportional data.
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Supplementary Table 5.4: Salt knowledge, attitudes and behaviour and fruits and vegetable consumption by age category, sex
and location (n = 837), nested sub study; WHO-SAGE Ghana Wave 3.
All
(n = 837)

Age Category
(n = 837)

p
value

50+ yrs

18-49 yrs

Sex (837)

p
value

Men

Women

Location (837)

p
value

Urban

Rural

Add salt to food at the
table, frequently n (%)

107 (12.8)

n = 664
78 (11.7)

n = 173
28 (27.3)

0.02

n = 270
39 (14.4)

n = 568
68 (12.0)

0.41

n = 456
46 (10.1)

n = 381
61 (16.0)

<0.01

Add salt to cooking at
home, frequently n (%)
How
much
salt
consumed, just the right
amount n (%)
Can high salt diet cause a
serious health problem,
yes no (%)
Do you do anything on
regular basis to control
salt consumption, no (%)
Fruits and vegetable
intake, did not meet
recommendation
n (%)

671 (80.1)

n = 664
520 (78.3)
n = 662
387 (58.5)

n = 173
150 (86.7)
n = 171
120 (70.2)

0.03

n = 270
219 (81.1)
n = 269 178
(66.2)

n = 568
452 (79.6)
n = 565
330 (58.4)

0.69

n = 456
358 (78.5)
n = 455
265 (58.2)

n = 381
312 (81.9)
n = 378
242 (64.0)

0.24

651 (77.8)

n = 643
517 (80.5)

n = 170
134 (78.8)

0.65

n = 264
216 (81.8)

n = 549
435 (79.2)

0.39

n = 444
362 (81.5)

n = 368
288 (78.3)

0.25

394 (51.5)

n = 643
320 (49.8)

n = 169
74 (43.8)

0.17

n = 259
136 (52.5)

n = 553
282 (51.0)

0.69

n = 445
216 (48.5)

n = 366
201 (54.9)

0.72

396 (47.2)

n = 644
312 (47.0)

n = 173
83 (48.0)

0.82

n = 270
126 (46.7)

n = 568
270 (47.5)

0.81

n = 457
209 (45.7)

n = 381
186 (48.8)

0.37

508 (60.9)

< 0.01

0.10

0.09

Data was recorded in frequencies. Chi square tests were conducted.
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Supplementary Table 6.1: Odds ratio showing the predictors of decrease in
hypertension prevalence (WHO-SAGE Ghana Waves 1 and 3), n = 368

Hypertension prevalence
Characteristic

OR

p-value

95 CI

(95% CI)
Sex
Male
Female

Ref
1.08

0.759

0.66-1.76

Age

0.99

0.422

0.98-1.01

Urban
Rural
Marital Status

Ref
0.48

< 0.01

0.30-0.77

Married
Not married
Years of education

Ref
1.80
1.04

0.125
0.076

0.45-1.10
0.99-1.09

0.397

0.23-1.78

Location

Mothers education
Less than
secondary/high school
completed

Ref

Secondary/high school
and above completed

0.64
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Hypertension prevalence
Characteristic

OR

p-value

95 CI

(95% CI)
Fathers education
Less than
secondary/high school
completed

Ref

Secondary/high school
and above completed

0.91

0.727

0.55-1.52

Ref
1.33
0.98

0.138
0.135

0.91-1.01
0.96-1.01

Ref
0.97

0.885

0.67-1.40

Ref
0.57

0.122

0.27-1.16

Ref
0.78

0.284

0.49-1.22

1.04

0.821

0.71-1.53

Health Insurance
No
Yes
BMI
Ever used alcohol
No
Yes
Diabetes
No
Yes
Ever used tobacco
No
Yes
Overall physical activity

Note: Ref represents reference category used for the comparison. Voluntary refers to contributors to health insurance who
were not captured by the insurance scheme as public or civil service workers, while mandatory refers to contributors who
were employees within the public, civil and private sectors. Overall physical activity represents all activities including
vigorous, moderate, walking/cycling, vigorous fitness and moderate fitness completed in a typical week. Multivariate
regression was adjusted age, sex, marital status, years of education, mother’s education, father’s education, health insurance,
diabetes and overall physical activity.
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Supplementary Table 6.2: Characteristics of Wave 1 participants included in the study
(50+y, n = 820) and those excluded (n = 3,904)

Characteristic

Wave 1
included
Age in years, Median (IQR)
n = 820
59 (13)
Location: Urban, n(%)
n = 820
364 (44.4)
Gender: Male, n(%)
n = 820
433 (52.8)
Education: Schooled, n (%)
n = 817
398 (48.7)
Marital
status:
Married/ n = 817
cohabiting, n (%)
489 (59.9)

Wave 1
excluded
n = 3904
64 (17)
n = 3904
1561 (40.0)
n = 3904
1920 (49.2)
n = 3476
1539 (44.3)
n = 3880
2250 (58.0)

p-value

SR Hypertension, n (%)

n = 820
95 (11.6)

n = 3469
490 (14.1)

0.0567

SR Diabetes, n (%)

n = 820
17 (2.1)

n = 3469
150 (4.3)

0.0027

SR Depression, n (%)

n = 820
13 (1.6)

n = 3469
54 (1.6)

0. 9524

SR Health, very good n (%)

n = 820
39 (4.8)

n = 3481
131 (3.8)

0.1893

<.0001
0.0196
0.2080
0.0217
0.3262

248

Supplementary Table 6.3: Characteristics of Wave 1 participants included in the study
(50+y, n = 820) and those followed-up but excluded from analysis (n = 79)

Characteristic

Wave 1
included

Wave 1
followedup but
excluded
n = 79
59 (13)

p-value

Age in years, Median (IQR)

n = 820
59 (13)

n = 820
364 (44.4)
Gender: Male, n(%)
n = 820
433 (52.8)
Education: Schooled, n (%)
n = 818
398 (48.7)
Marital
status:
Married/ n = 817
cohabiting, n (%)
489 (59.9)

n = 79
30 (38.0)
n = 79
31 (39.2)
n = 25
11 (44.0)
n = 77
60 (77.9)

0.2724

SR Hypertension, n (%)

n = 820
95 (11.6)

n = 24
3 (12.5)

0.7520

SR Diabetes, n (%)

n = 820
17 (2.1)

n = 24
1 (4.2)

0.4082

SR Depression, n (%)

n = 820
13 (1.6)

n = 24
0 (0.0)

-

SR Health, very good n (%)

n = 820
39 (4.8)

n = 25
1 (4.0)

1.0000

Location: Urban, n(%)

0.7791

0.0210
0.6422
0.0018
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Supplementary Table 7.1 Demographic profile of SAGE Ghana and South Africa W3 survey respondents and
subsample with urine valid data (urine data considered valid if Volume ≥ 300ml & creatinine ≥3mmol).
Ghana
Main SAGE

Subsample with

cohort

CAPI&urine

(n=3053)

(n=495)

60 (20)

57 (18)

717 (23.5)

South Africa
P-value

Main SAGE

Subsample with

cohort

CAPI&urine

P-value

(n=1501)

(n=707)

0.0002

58 (19)

61 (15)

<0.0001

133 (26.9)

0.0159

399 (26.6)

112 (15.8)

0.0140

2336 (76.5)

362 (73.1)

0.0001

1102 (73.4)

595 (84.2)

0.2393

1183 (38.8)
1870 (61.2)

171 (34.6)
324 (65.4)

539 (35.9)
962 (64.1)

218 (30.8)
489 (69.2)

Age
Years
18-49 years, n (%)
50 plus years, n (%)
Sex, n (%)
Men
Women
Ethnicity, n (%)

0.074

<0.002

Akan
Ewe
Ga-Adangbe
Gruma

1544 (50.6)
216 (7.1)
224 (7.3)

280 (56.6)
34 (6.9)
29 (5.9)

30 (1.0)

3 (0.6)

Grusi
Guan
Mande-Busanga
Mole-Dagbon

76 (2.5)
38 (1.2)
63 (2.1)

7 (1.4)
10 (2.0)
1 (0.2)

174 (5.7)

16 (3.2)

612 (20.0)

112 (22.6)

1301 (42.6)
1752 (57.4)

262 (52.9)
233 (47.1)

Other
Residence, n (%)
Urban
Rural

0.019

<0.0001
Black
Coloured, mixed race
Indian
White

1034 (68.9)
296 (19.7)
72 (4.8)

516 (73.0)
157 (22.2)
15 (2.1)

98 (6.5)

18 (2.6)

Other

1 (0.1)

1 (0.1)

1076 (71.7)
425 (28.3)

456 (64.5)
251 (35.5)

0.001

0.001
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Ghana
Main SAGE

Subsample with

cohort

CAPI&urine

(n=3053)

(n=495)

Marital status, n (%)
Never married
Married/cohabiting

South Africa
P-value

Main SAGE

Subsample with

cohort

CAPI&urine

(n=1501)

P-value

(n=707)

0.324

0.027

208 (6.8)

29 (5.9)

484 (32.2)

202 (28.6)

1760 (57.7)

302 (61.0)

495 (33.0)

213 (30.1)

369 (12.1)

48 (9.7)

132 (8.8)

69 (9.8)

Widowed
Never been to school, n (%)

715 (23.4)

116 (23.4)

390 (26.0)

223 (31.5)

1119 (36.7)

125 (25.2)

<0.0001

127 (8.5)

79 (11.2)

0.041

Education (Years)
Body Mass Index (kg/m2)

10 (5)

10 (4)

0.0098

12 (5)

10 (5)

<0.0001

24.2 (6.8)

25.7 (6.9)

< 0.0001

29.4 (8.9)

29.8 (10.3)

0.0771

0.54 (0.11)

0.56 (0.12)

0.0001

0.56 (0.13)

0.59 (0.14)

<0.0001

1865 (61.3)

283 (57.2)

0.084

1049 (70.3)

511 (72.3)

0.342

2739 (90.0)

453 (91.5)

0.287

1106 (74.1)

528 (74.7)

0.782

124 (26.5)

125.5 (28)

0.3214

130 (23.5)

133.5 (29)

0.0001

76 (17)

76.5 (17)

0.7475

83 (19)

83.5 (20.5)

0.4369

1132 (37.6)

208 (42.2)

0.052

831 (58.8)

447 (65.2)

0.005

157 (5.2)

38 (7.7)

0.023

182 (12.2)

119 (16.9)

0.003

642 (21.1)

58 (11.7)

<0.0001

264 (17.7)

108 (15.3)

0.158

Separate/divorced

Waist to height ratio
Never used alcohol, n (%)
Never used tobacco, n (%)
Systolic BP (mm Hg)
Diastolic BP (mm Hg)
Hypertension, n(%)
Diabetes, n(%)
Frequently add salt to food
at table, n(%)
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Ghana
Main SAGE

Subsample with

cohort

CAPI&urine

(n=3053)

(n=495)

Frequently add salt to food
during cooking, n(%)

2527 (83.0)

399 (80.6)

Believe they consume too
much salt, n(%)

265 (8.8)

Believe a high salt diet is bad
for health, n(%)
Regularly control of salt
intake, n(%)

South Africa
P-value

Main SAGE

Subsample with

cohort

CAPI&urine

P-value

(n=1501)

(n=707)

0.189

965 (64.7)

460 (65.1)

0.860

48 (9.7)

0.503

156 (10.9)

59 (8.6)

0.104

2247 (75.9)

378 (78.3)

0.266

1121 (82.9)

506 (81.6)

0.480

1243 (42.1)

235 (48.9)

0.005

552 (41.1)

255 (42.7)

0.514

Subsample: all respondent with CAPI data and valid urine, sex and age recorded. Some variables may contain missing data. Data are presented as median (IRQ)
unless otherwise indicated. Hypertensive by mesured BP≥140 and/or 90 mm Hg or previous self-reported treatment in the past two weeks prior to the survey.
Ethnicity, marital status, education, alcohol/tobacco use and diabetes prevalence by self-report. Mann-Whitney Test used to compare medians, Pearson Chi-Square
test and Fisher’s Exact Test used to compare proportional data.
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Appendix F – Dietary Sources of Salt in Low- and Middle-Income Countries: A
Systematic Literature Review
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Appendix G - Salt Use Behaviours of Ghanaians and SouthAfricans: A Comparative
Study of Knowledge, Attitudes and Practices

270

271

272

273

274

275

276

277

278

279

280

281

282

Appendix H - Salt and low potassium intake among adult Ghanaians: WHO-SAGE
Ghana Wave 3
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Appendix I - Determinants of change in blood pressure in Ghana: Longitudinal data
from WHO-SAGE Waves 1 – 3.
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Appendix J - Salt reduction strategies may compromise salt iodisation programmes:
Learnings from South Africa and Ghana
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Appendix K - Towards Population Salt Reduction to Control High Blood Pressure in
Ghana: A Policy Direction
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